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Summary
This thesis has focused on identify ing key signalling events d u rin g  
an tigen-driven  B cell development, p a rticu la rly  those concerned w ith  
the regulation  and com m itm ent to apoptosis. The research  com prised 
both biochemical and physiological aspects of cell fate decisions, m ain ly  
focusing on the  im m atu re -m atu re  B cell tran sition , as well as o th e r 
la te r selection events in  the  spleen, lym ph nodes and the  peritonea l 
cavity. W ith respect to the  m olecular aspects, the  w ork h a s  
concentrated m ainly on identifying m itochondria-related  changes an d  
the role of cell cycle proteins in  the  events dow nstream  of B cell 
receptor (BCR) ligation which lead to apoptosis. A novel phospholipase 
Ag-dependent m echanism  of m itochondrial d isrup tion  w as identified as 
being responsible for the  tran sd u c tio n  of an tigen  recep to r-m ediated  
apoptosis of an  im m ature  B cell line, WEHI-231. The product of 
phospholipase A ,^ arachidonic acid, ra th e r  th an  one of its  m etabolites, 
directly causes a  collapse in  the  m itochondrial po ten tial w hich re s u lts  
in apoptosis. R egulation of th is  m itochondrial dysfunction also involves 
the Bcl-2 family. Pro-apoptotic and  anti-apoptotic m em bers of th is  
family are both elevated in  response to BCR stim ulation. N onetheless, a 
rescue signal v ia CD40 elevates Bcl-x^ expression and  preven ts Bid an d  
Bad from tran slo ca tin g  to the  m itochondria. Indeed, Bcl-x^ 
overexpression is sufficient to reverse both BCR and arachidonic acid- 
induced apoptosis in  W EHI-231 cells. In trigu ing ly , th is  novel cPLA^- 
dependent pathw ay of BCR-induced apoptosis in W EHI-231 is executed 
in a C aspase-independent m anner and  hence differs from the  c lassica l 
description of apoptosis. This novel form of apoptosis appears to be 
excuted by C athepsin  B w hich appears to act as an  a lte rn a tiv e  k ille r 
protease to exert the destruction of cell components.
X V ll
In  order to address the  physiological relevance of these findings, an  ex 
vivo model has also been devised to study the  developm ent of im m a tu re  
B cells in  th e  bone m arrow . This model has been used to identify  th e  
m ajor cellu lar in te rm ed iates in  th is  process and to observe some of th e  
signals required  for im m atu re  and tran s itio n a l B cell selection. The 
detection of different B cell populations and determ ination  of th e ir cell 
cycle profiles, a fter BCR stim ulation , h as allowed the de te rm ina tion  of 
sequence of events during  B cell selection. For exam ple, im m atu re  B 
cell apoptosis bears some of the  hallm arks of the  m echanism s identified  
in WEHI-231 B cells. In  addition, th is  model has m ade it  possible to 
exam ine the  key factors reg u la tin g  tran s itio n a l B cell deletion. 
In teresting ly , the  use of X id  mice, w hich are defient in  the  PTK Btk, 
showed th a t  B tk  w as essen tia l for the  m atu ra tion  of tran sitio n a l B cells 
in response to BCR stim ulation . Moreover, it w as show n th a t  
tran s itio n a l B cells can undergo apoptosis in response to an ti-F as  
trea tm en t and th is  m ay involve also a  collapse in  the  m itochondria l 
potential. F u rth e r work w ith  cells from mice im m unocom prom ised by a 
parasite-derived molecule, ES-62 w hich is capable of desensitising  BCR 
stim ulation  in vivo, showed th a t  such proteins can also compromise th e  
m atu ra tion  of B cells in  the  bone m arrow. This resu lts  in  the  b reak in g  
of tolerance and g rea ter ra te s  of B cell m atu ra tion , p resum ably  as a 
consequence of ES-62 ra is ing  the  th resho ld  of apoptosis. T aken  
together, these observations challenge the  in structive  model for B cell 
selection, which relies on BCR-specificity being the sole d e te rm in an t of 
cell fate  decisions. This new evidence suggests th a t  B cell selection m ay 
also be dependent on stochastic pa ram eters such as Fas expression, cell 
density  or o ther environm ental factors.
X V lll
Sim ilar investigations were perform ed on B cells from the  periphery , 
which are involved in cell fate determ ination , in  particu lar, B cells from 
G erm inal C entres and  the  peritoneal cavity. I t w as estab lished  th a t  
apoptosis and proliferation of B cells differed depending on th e ir  
m atu ra tio n  and activation sta tu s .
These novel observations tracked  the  form ation of G erm inal C entres, a t 
both sites, ex vivo. The m olecular m echanism s regu la ting  the  responses 
of G erm inal C entre B cells were also explored. Two m ain  observations 
were made. F irstly , Btk^ G erm inal C entre B cells were found to be 
hyperproliferative in  response to BCR stim ulation , w hilst non- 
G erm inal C entre B cells were found to be hyposensitive. Secondly, 
BCR-induced apoptosis of G erm inal C entre B cells appeared  to be 
C aspase-dependent, sim ilarly  to th a t  observed for tran s itio n a l B cells. 
F urtherm ore , using  HEL-BCR transgen ic  mice, it was show n th a t  th e  
prim ary  and secondary responses to an tigen  are d ifferent in  the  sp leen  
and in the  lymph nodes.
Finally, B-1 cells from the  peritoneal cavity were show n to exh ib it 
restric ted  proliferative responses and  did not respond strongly  to a 
secondary stim ula tion  via the  BCR. In  addition, and  in  co n tra st to th e  
situa tion  in im m ature  B cells, b u t sim ilar to G erm inal C entre  B cells, 
BCR-induced apoptosis of B-1 cells appears Caspase-dependent.
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Chapter 1. INTRODUCTION
1.1 B cells in the humoral immune response
B cells are the principal com ponent of the  hum oral im m une response. 
These cells can ,p roduce  specific antibodies to foreign an tigens after a 
carefully conducted m echanism  of B cell development. D uring  th is  
process, B cells arise  from the  p lu ripo ten t stem  cells genera ting  a 
population of an tibody-secreting  cells w ith  a diverse reperto ire  of 
specificities. In  order to achieve th is  diversity, B cells undergo th re e  
processes: lineage com m itm ent, proliferative expansion and  cell selection 
[1-3].
In  addition to the  generation  of antibodies, B cells have o ther functions. 
F irst, they  can act as an tigen  p resen ting  cells and activate  T helper cells. 
In  th is context, B cells can play a  part, together w ith  o ther an tig en  
presen ting  cells, in the  Th type responses.
Second, m em ory B cells respond rapidly  to a secondary challenge by 
antigen. In  para lle l to the  p rim ary  antibody production, B cells in th e  
G erm inal C entres achieve a h igher affinity to an tigen  due to som atic 
m uta tions w ith in  th e ir im m unoglobulin (Ig) genes and  Ig isotype 
sw itching. In  the  secondary response, specific m em ory B cells w ill 
respond more quickly to antigen , d ifferentiate  into p lasm a cells and  
secrete large quan titie s of highly specific antibodies. This phenom ena of 
enhanced secondary hum oral response enables vaccination  as a 
preventive step  again st pathogens.
1.2 Determination of B cell repertoire 
1.2.1 D evelopm ent o f im m ature B cells
B cell developm ent can be divided into two stages; an  an tigen - 
independent stage w hich is carried  out en tirely  in  the  bone-m arrow  (or 
foetal liver); and  an  an tigen-dependent stage w hich s ta r ts  in the  bone 
m arrow  and continues in  the  peripheral lymphoid organs such as th e  
lym ph nodes and the  spleen (fig. 1).
The lineage com m itm ent of B cells s ta r ts  from the  recen tly  identified  
common lymphoid progenitor and  continues though m ultip le  stages. B 
cell m arkers (B220 and CD 19) are  expressed for the  firs t tim e on pro-B 
cells. Soon after the  generation  of pro-B cells, th ey  express th e  
recom bination activator p ro teins RAG-1 and -2, w hich are required  for Ig 
gene rea rrangem en t. RAG-1 and -2 expression is essen tia l for th e  
developm ent of a  la te r stage of pro-B cells (sometimes called pre-BI), w hen  
D J rea rran g em en ts  of the  Ig heavy chain occur. This is illu s tra ted  by 
knock out mice for RAG-1 or -2, w hich do not develop B cells beyond th e  
early  pro-B cells. L ate pro-B cells express on th e ir  surface the  accessory
com ponents of the  B cell receptor (BCR), Iga  and Ig|3, together w ith  th e
chaperone pro tein  calnexin. Ig a  and  Igp transduce  a constitu tive  signa l
which is essen lia l fbr^B cell su rv ival in  prp:B and pre-B cells (fig. 2)._Late pro-B cells develop to pre-B cells, w hich  express on th e m  surface a
pre-B cell receptor. The pre-BCR com prim ises a fully a rran g ed  m u (p)
heavy chain (V(D)J) together w ith  surrogate  ligh t chains m ade of VpreB
and X5. This functional BCR has a crucial role in  B cell developm ent, as
knock out studies revealed not only th a t  VpreB and X5 a re  essen tia l for 
pre-B stage of development, b u t also the  lineage-restric ted  tra n sc r ip tio n  
factor Pax5, Igp, and  m aybe m ost im portantly  the  m u chain  itself. K nock­
out mice w hich are deficient in  the  tran sm em brane  dom ain of the  m u 
chain (term ed pm(TM) knock out), lack all peripheral B cells [4]. I t  seem s, 
though, th a t  the  requ irem en t is sim ply for a functional heavy chain a t  
th is  stage, since knock-out mice in  w hich m u chain  has been replaced by 
delta chain, have apparen tly  norm al B cell developm ent [5]. S u p p o rtin g
evidence in  th is context is provided by Syk'^' mice, w hich do not p rogress 
into the  pre-B cell stage e ither as Syk, a tyrosine k inase, has a  non- 
red u n d an t role in  tran sd u c in g  signals from the BCR into the cell. 
Finally, by the  end of pre-B cell stage, both heavy and  ligh t chains a re  
rearranged . Surface IgM is expressed as the clonatypic com ponent of th e  
BCR, in  association w ith  Ig a  and  Igp. Only one of the  a lte rn a tiv e  alleles
for each Ig chain  is expressed in  an  allelic exclusion process w h ich  
ensures th a t  only one type of IgM is expressed on each ind iv idua l 
im m ature  B cell.
1J2J2 Selection into the naive B cell pool
O ut of the  2x10^ IgM^ B cells th a t  develop daily in  the  bone m arrow  of th e  
mouse, about 10% reach the  spleen and only 1-3% en te r the  m atu re  B cell 
pool [61. A com parison of the  heavy chain  reperto ire  in  pre-B cells an d  
m atu re  B cells shows clearly th a t  the  reperto ire  in  the  bone m arrow  is 
m uch broader th a n  in the  periphery  [71. Im m ature  B cells em erge from 
the pre-B cell stage w ith  a wide varie ty  of specificities of th e ir  su rface  
IgM. This varie ty  is due to the  random  usage of V D J dom ains in  the  Ig 
rearrangem ents of pre-B cells. In  the  pre-BCR stage, a  functional BCR is 
needed in  order to assure  the  cell th a t  it  can develop fu rth er [3]. However, 
im m ature  B cells a re  negatively selected in order to avoid self-reactiv ity . 
G eneration  of self-reactive B cells is avoided by one (or more) 
m echanism s:
(i) clonal deletion - the  self-reactive im m ature  B cell undergoes 
program m ed cell death  (apoptosis).
(ii) anergy - the  self-reactive im m atu re  B cell becomes non-responsive 
and is unable to differentiate.
(iii) receptor editing - the  self-reactive im m ature  B cell dow nregulates its  
BCR and rea rran g es  its  Ig genes using  RAG proteins, once again, in a 
m anner sim ilar to pre-B cells.
It was long though t th a t  the  varie ty  in  newly form ed B cells in  th e  
periphery  reflects these  selection m echanism s. Recently, how ever, 
ano ther phenotype of selection-sensitive B cells w ere identified as a n  
in term ediate  stage (or stages) betw een im m ature  and  m atu re  B cells ([8]
and fig. 2). These cells, know n as tran s itio n a l B cells, are  IgM^ 
CD24/HSA^^'^ as are  im m atu re  B cells, b u t they  express h igher levels of 
B220 and Bcl-2 together w ith  low expression of IgD on th e ir  surface [6]. I t  
is also known th a t  tran s itio n a l B cells can em igrate  from the  bone 
m arrow  to the  periphery  [91.
The discovery of tran s itio n a l B cells has provided a new model for th e  
effects of surface Ig cross-linking on im m ature  and tran s itio n a l B cells: 
W hen im m ature  B cells encounter sufficient BCR stim ulation , reflec ting  
self-reactivity, nearly  h a lf  of them  m ay undergo receptor ed iting  [10, 11]. 
The s treng th  of signal needed to induce receptor ed iting  is d isputable and  
th is m echanism  does not produce a full explanation  for the  evidence 
known regard ing  im m atu re  B cell selection. F irstly , a  large num ber of 
im m ature  B cells are lost before they  reach  the  periphery  as tra n s itio n a l 
B cells. Moreover, it is well docum ented th a t  im m atu re  B cells can be 
induced to undergo apoptosis in  response to BCR cross-linking. M ore 
recently, it  w as shown th a t  the  bone m arrow  environm ent, and m ore 
specifically ThyT" "^^  ^ cells (of unknow n lineage), can pro tect im m atu re  B 
cells from apoptosis [12]. Therefore, the  question of the  ex ten t of deletion 
of im m ature  B cells by antigen  in  the  bone m arrow  in vivo rem ains open. 
Thus, cells ta rge ted  for deletion by self-antigens m ay be tran s itio n a l B 
cells in  the  bone m arrow  and the  spleen ra th e r  th a n  th e  im m atu re  B cell 
population in  the bone m arrow  [13-151. Furtherm ore, since tran s itio n a l B 
cells are  Fas^, i t  is feasible th a t  they  could be deleted not only directly  by 
antigen bu t also by cells expressing FasL  [8]. A lthough it  w as shown th a t  
tran sitional B cells in  the  spleen depend on BCR stim ulation  for su rv iva l, 
some questions rem ain  unsolved [16]. The view th a t  only a sm all 
proportion of im m ature  B cells m ight be deleted by negative selection, 
implies th a t  BÜR-driven B cell m atu ra tio n  m ay involve a positive 
selection event. Such an event m ay enable a res tric ted  num ber of 
tran s itio n a l B cells to fully develop [17]. I t is h a rd  conceptually to 
u n d ers tan d  a m echanism  of negative selection w hich occurs in th e  
periphery. Because tran s itio n a l B cells in  the  periphery  m ay en co u n te r 
both self and  nonself antigens, it is not clear how these  types of an tig en s  
can be discrim inated. Moreover, the  roles for T cell help and Fas-induced  
deletion, w hich m ay help to explain negative selection in  the  periphery .
have not been resolved as well [91. Thus, T cells m ay provide a rescue  
signal (CD40L, IL-4) to tran s itio n a l B cells, b u t equally m ay provide 
death  signals (via FasL).
Once the B cell survives the  selction processes, it  is recru ited  to the naive  
B cell pool in  the periphery. Naive B cells are  activa ted  by a n tig en s  
th rough  th e ir BCR receptor and th en  proliferate in  w h a t is u su a lly  
described as clonal expansion [181. A lthough activation  depends on th e  
BCR, T cell-derived factors can promote B cell surv ival and  even 
proliferation in  th is  stage, nam ely CD40 and IL-4 receptor ligation [19]. 
In the  spleen, B cells exist in  th ree  zones: the  follicles, the  G erm inal 
C entres (w ithin the  follicles) and  the  m arg inal zones (which do not ex ist 
in the  lym ph nodes). The naive pool consists of recircu lating  B cells and is 
activated  in  the  follicles. Some cells will en te r the  G erm inal C en tres, 
w here they will undergo som atic m uta tion  and class sw itching  from IgM  
to IgG or o ther isotypes and become e ither m em ory cells or antibody- 
secreting p lasm a cells [20]. The G erm inal Centre reaction is discussed in  
fu rther detail below. The function of m arg inal zone B cells, together w ith  
the way they  are generated, is still under dispute. In  some aspects, th ey  
are  rem iniscent of B-1 cells [21], a  p a rticu la r sub-lineage of B cell w hose 
developm ent is discussed separately , in  section 1.2.4.
1.2.3 The Germ inal Centre and B cell m em ory
Memory B cell generation  rep resen ts a biological phenom enon in  w h ich  
som atic m u ta tion  of im m unoglobulin molecules occurs w ith in  days to 
weeks of an tigen  encounter. G erm inal C entres (GC) w ith in  the  follicles of 
peripheral lymphoid organs have a critical role in  the  cellu lar an d  
m olecular events th a t  underlie  m em ory B cell generation. This is 
especially tru e  for som atic m uta tions w hich are p a r t  of affin ity  
m atu ration  of peripheral B cells (reviewed in [20, 22]). N onetheless, m an y  
of the  m ost crucial aspects of m em ory B cell generation  rem ain  h ig h ly  
controversial, including  the  m echanism  of som atic m u ta tion  and th e  
m eans by which B cells w ith  increased affinity are  selected.
A prim ary  encounter w ith  an tigen  stim u la tes specific B cells not only to 
d ifferentiate into antibody-form ing cells (AFCs), b u t also to give rise to a
population of m em ory cells [14, 15, 23]. M emory B cells are  though t to be 
solely derived from GC B cells. In  the  p rim ary  response, GCs first appear 
a t day 4 -5  after im m unization, achieve th e ir m axim um  cell num ber by 
day 10-11, and^ decline after about th ree  weeks. A fter im m unization , 
activated antigen-specific splenic B lymphocytes firs t pro liferate  in  the  T 
cell zone of the  w hite pulp in  the  spleen, w here an tigen -activated  T and  B 
cells m ake physical contact, during  T cell-dependent im m une responses 
(fig. 3). Most of the  activated  B cells develop locally into foci for AFCs, 
while a m inority  of antigen-specific B cells m igra te  back into th e  
lymphoid follicles to form GCs. A lthough neighbouring  AFC and GC B 
cells are frequently  descended from the  sam e p a ren ta l cells, only the  cells 
th a t  en ter the  GC m icroenvironm ent become m em ory cells. M emory B 
cell d ifferentiation takes place in  two phases: (i) in  cen trob lasts, w h ich  
populate the dark  zone of the  GC, som atic m u ta tions occur in  the  V
i.
region of rea rran g ed  Ig genes; (ii) The selection of B cells exp ressing  
an tigen  receptors w ith  high affinity for the  an tigen  ligand occurs la te r in  
the ligh t zone, by im m une complexes cap tured  on follicular dend ritic  
cells.
A lthough it  is now generally  accepted th a t  the GC reaction  is cen tra l to 
memory B cell generation, m em ory B cell generation in  the  absence of GC 
has been observed [22]. N onetheless, u n d e rs tan d in g  the  ce llu la r 
in teractions w ith in  GC th a t  a re  responsible for m em ory B cell g en era tio n  
and survival rem ains an aim for fu tu re  research. W hile it  is clear th a t  
the  CD40-CD40L in te rac tion  is essential, th e  tim ing of these  
in te rac tions as  ^well as the  role of other m olecular in te rac tions and  
cytokines rem ains controversial [24, 25]. I t is clear th a t  besides B-T cell 
in terac tions, GC dendritic  cells a re  required  for the  GC reac tio n  
although  the  n a tu re  of th e ir  involvem ent is still largely  obscure [26]. 
Recently, it w as dem onstra ted  th a t  T cells a re  essen tia l for c lass 
sw itching of centroblasts to certain  isotypes of Ig [27].
In  mouse and m an, it  is now possible to use cell surface m arkers to 
identify, isolate and analyse cells a t each of the progressive stages from 
en try  to exit from GC [17, 28]. I t  has been possible to isolate from follicles 
sm all, resting , u n m u ta ted  cells w ith  an  early  GC phenotype, w hich a re  
the likely o rig inators of GC B cell clones. F u rtherm ore , the  v a rio u s
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progressive GC-derived subsets can be shown to differ in th e ir  
stim ulatory  requ isites and  susceptib ility  to apoptosis [17, 22, 28], Indeed, 
in  the  course of ^ heir generation GC cells can re-express th e  RAG-1 and - 
2 proteins w hich are requ ired  for gene rea rran g em en ts  [22]. F inally, GC 
cells th a t  survive and  m atu re , u ltim ately  leave the  follicles, how ever, 
th e ir  exact fate and longevity rem ain  controversial [26, 29]. Indeed, it  
appears th a t  there  m ay be d istinc t subsets of m em ory B cells w h e re in  
peripheral localization and  longevity m ay be in te rre la ted .
1.2.4 The B-1 cell hneage
B-1 cells were first decribed in  1983 as Ly-1^ B cells [30]. In  the  m ouse, 
th is subset of self-renew ing B cells is found p rim arily  in  the  peritonea l 
cavity although^ sm aller num bers of B-1 lym phocytes populate th e  
spleens and lym ph nodes of adu lt mice [31]. The B-1 subset exhibits h ig h  
frequencies of cells bearing  receptors specific for m u ltiv a len t self­
antigens. The restric ted  diversity  of B-1 cells include broad specificities 
for phosphatidylcholine, im m unoglobulins, DNA, m em brane pro teins on 
erythrocytes and thym ocytes, as well as env ironm ental an tigens and  
common pathogens such as lipopolysaccharides and phosphorylcholine. 
B-1 cells secrete large quan tities of IgM, IgG3, and IgA and  are p resum ed  
to be responsible for n a tu ra l im m unity. B-1 cells are  therefore especially  
im portan t in  new borns w here adaptive B-2 cells only s ta r t  to develop (see 
below). B-1 cells are also involved, both in  m ouse and m an, in th e  
generation  of ^ome disease-associated autoantibodies. The level of 
m u ltivalen t antibodies (i.e. antibodies to common antigens) m ay be 
regu la ted  by controlling the num bers of these in trin sica lly  activa ted , 
self-regenerating B-1 cells [32].
B-1 cells are  categorized as e ither B -la  cells, w hich express CDS, or B -lb  
cells, which are very sim ilar to B -la  cells bu t do not express CD5. Both B- 
l a  and B -lb  cells are  phenotypically  IgM^‘ IgD" CD23 Mac-1^ [6]. The 
m echanism  of generation  of B-1 cells from B cell progenitors w as for a 
long tim e unclear [33]. Only recently, a com prehensive model for th e  
developm ent of B-1 cells has em erged (reviewed in  [32]). According to th is  
model, positive selection in  the  foetal bone m arrow  gives rise  to both B - la
and B -lb  cells. In  order to achieve th a t, p a rticu la r m u heavy c h a in s  
specific to m u lt& alen t an tigens are  used in  the  gene rea rran g em en ts  of 
the  BCR. The sam e an tigen  can induce negative selection in  B-2 cells and  
positive selection in  B-1 cells a t the  same tim e, and  vice versa  if  th e  
specificity to an tigen  is different as a resu lt of d istinct m u chain  usage in  
each lineage [33, 34].
In  the  adult, the  p icture  of B-1 developm ent is still som ew hat m uddled. 
There is evidence th a t  B-2 cells can be converted to B -lb  cells [32]. The 
m eans by which th is process occurs are poorly understood. I t is well 
docum ented, though, th a t  in certa in  knock out mice, such as Lyn  ^ and  
CD19 ^, the  num erical balance betw een B-1 and B-2 populations is 
disturbed. In  Lyn knock out mice, B-1 cell num ber is h igher th a n  no rm al 
although  periph^eral B-2 cell a re  absen t [35]. In  con trast, in  CD19  ^ m ice 
B-1 cells are absen t w hilst B-2 cells expand [361. I t  is likely th a t  th is  
evidence reflect a  different role for these specific B cell com ponents in  
each developm ental process [371 and in  o ther responses such as 
proliferation in  response to BCR cross-linking [38].
1.3 Known mediators of apoptosis
1.3.1 T he m ito c h o n d r ia  is  a t th e  c en tre  o f  th e  c e ll d e a th  
p rogram m e
Cell death  can èccur th rough  apoptosis or necrotic death  pathw ays. In  
contrast to necrosis, which is a disorderly mode of cell death , apoptosis is 
an orderly process th a t  proceeds th rough  several m orphological ph ases 
[38a]. Necrotic cells tend  to swell and bu rst, a process w hich can induce 
inflam m ation. In  con trast, cells undergoing program m ed cell death  go 
th rough  changes w hich ensure  release of condensed bodies w hich a re  
phagocytesed by o ther cells. F irst, cells which undergo apoptosis release  
contact w ith  neighbouring  cells and become detached from th e  
surrounding  tissue [39]. There is th en  a m arked condensation of both th e  
nucleus and the  cytoplasm, causing  the cells to sh rink  significantly  in  
size. The nuclear envelope and  the  nucleolus b reak  a p a r t as ch ro m a tin  
condenses and is cleaved in  the  nucleus into m ultip le fragm ents of -1 8 0
base pairs. The p lasm a m em brane also begins to bleb, and  the  blebs can  
divide the  cells into sm aller apoptotic bodies. Finally, apoptotic bodies a re  
rapidly  phagocyte sed by the  su rround ing  cells and  degraded in  
lysosomes.
In the  p ast several years, m itochondria have been found to play a key role 
in  apoptosis, beyond its  trad itiona l role as the  energy supplier of the  cell. 
In  some cases, m itochondria release  cytochrome C and  other p ro teins, 
such as apoptosis inducing factor (AIF), into the  cytoplasm. The
m itochondria also undergo a loss of inner m em brane po ten tia l (AT^) and
m itochondrial perm eability  tran s itio n  occurs. I t  h as  also become c lear 
th a t in  concert vvith m itochondrial function, proteins from the  Bcl-2 and  
Caspase fam ilies largely determ ine the  fate of the  cell (fig. 4). Hence, in  
most cases of apoptotic cell death, decision of cell fate is dependent on
m itochondrial events. These events can be divided into four types:
(i) Morphological changes and red is tribu tion  of m itochondria  - early  in
apoptosis, the m itochondria will red is tribu te  in  the  cytosol in  a m a n n e r  
which is cell dependent, b u t usually  consists of some condensation v isib le 
under the  microscope [38a]. There are  fu rth er in te rn a l changes in  th e  
inner m itochondrial m em brane, including depolarisation  of th e  
m itochondrial m em brane potential, AY^. One crucial event is opening of 
the  m itochondrial perm eability  tran s itio n  pore (FTP), w hich is located in  
the  m em brane junctions of the  m itochondria. A lthough th is event is 
poorly charecterised, it is widely though t th a t  upon opening of th e  
channel, the  cell is sentenced to die [40].
(ii) Bcl-2 fam ily pro teins ta rg e t the  m itochondria - the  m itochondria  is a 
m ain site for the activ ity  of Bcl-2 fam ily proteins, a lthough  the  n a tu re  of 
th e ir action is largely  undeterm ined  (see below).
(iii) Reactive oxygen species (ROS) are generated  in  the  m itochondria - 
the  partic ipation  of various ROS in  apoptotic events is observed in m an y  
system s [41, 42]. The regu la tion  of these phenom ena in  the  cell d ea th  
context is still obscure, a lthough  our knowledge about how ROS a re  
generated  has expanded considerably [43]. There is also some in d ire c t 
evidence th a t  Bcl-2 fam ily m em bers, such as Bcl-2 and Bcl-x^, 
partic ipa te  in  th is  regu la to ry  m echanism  [44]. I t is however, u n c le a r
w hat is the  involvem ent of ROS in  the energetic im balance re su ltin g  
from apoptosis-related m itochondrial dysfunction [45, 46].
(iv) C aspases act both upstream  and dow nstream  of the  m itochondria - 
in itia to r C aspases are  pro teases th a t  m ainly m ediate the  ta rg e tin g  of 
pro-apoptotic proteins (such as Bid) to the  m itochondria. E ffector 
C aspases are activated  dow nstream  of m itochondrial events such as th e  
release of cytochome C (see below). Caspase-2 and -9 m ay also be re leased  
from the m itochondria itse lf  during  apoptosis [47].
There is a bi-directional and  complex in terac tion  betw een apoptosis and  
the  cell cycle m achinery. On one hand , it  is w ell-docum ented th a t  m an y  
components w hich control the  progress of cell cycle also have a role in  
regu la ting  cell death. These include m ainly regu la to rs of the  and  Gg 
checkpoints, such as p53, Rb and E2F (see section 1.3.4). These p ro te ins 
have also been shown to be involved w hen the cell cannot overcome s tre ss  
and it decides to in itia te  the  cell death  program m e. On the  o ther hand , 
m any proteins which are usually  regarded  as restric ted  to the  reg u la tio n  
of apoptosis, such as those belonging to the  Bcl-2 and  C aspase fam ilies, 
have recently  been shown to in te rac t w ith  the cell cycle m achinery. The 
full description of th is  side of the  equation is still lacking, b u t some
im portan t observations have been made. These include enforcem ent of
cell cycle a rre s t by over-expression of Bcl-2 [48] and cleavage of m any cell 
cycle proteins, such as Rb, by C aspases [49, 501. The significance of th e  
la tte r  phenom enon is unclear because caspase cleavage can e ith e r  
activate or deactivate proteins, depending on th e ir  struc tu re .
Lastly, an  in te res tin g  link w as suggested betw een the  cell cycle
regu la ting  m achinery and the  m itochondria. A lthough it  has been know n 
for some tim e th a t certa in  pro teins tran sac tiv a te d  by p53 a re  
m itochondrial [51], it now has being shown th a t  p53 itse lf can
translocate  to the  m itochondria [521. The outcome of th is  event rem a in  
obscure.
1,3.2 Bcl-2 fam ily o f proteins
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The Bcl-2 gene fam ily com prises struc tu ra lly  re la ted  p ro teins w hich form  
homo- or heterodim ers and act e ither to promote or an tagonise  apoptosis 
by acting on the  m itochondria and o ther sites in  the  cell.
The pro-apoptotic m em bers of the  Bcl-2 family (Bad, Bak, Bid, Bax) have  
been proposed to act by inactivating  dim ers of an ti-apoptotic Bcl-2 fam ily 
m em bers such as Bcl-2, Bc1-Xl and M cl-l [53], w hich act to p reserve  
m itochondrial in tegrity . Bad activation generally  appears to be 
controlled by the  protein  k inase  A kt [541. A lternatively , Bcl-2 has been 
shown to ta rg e t Raf-1 to the  m itochondrial m em brane in  order to 
phosphorylate Bad [55]. Phosphorylation  of Bad leads to its  in te rac tio n  
w ith  14-3-3 proteins and  therefore, as it  can no longer complex w ith  Bcl- 
2, renders it inactivated . In  addition, Bax and  Bak have also been 
recently  proposed to m ediate Bcl-2/Bcl-XL-independent m echanism s of 
apoptosis [56].
Bcl-2 fam ily m em bers have generally  been shown to be located in th e  
m itochondrial m em brane and nuclear envelope of cells, and  are  known to 
have an ti-oxidant properties and  preven t leakage of cytochrome C from 
the m itochondria. N onetheless, th e ir  exact mode of action is still u n c le a r  
(reviewed in  [571). Based on s tru c tu ra l sim ilarities and  differences th e  
following model has, however, emerged: the anti-apoptotic m em bers of th e  
Bcl-2 family all share  4 homology dom ains (denoted B H l to BH4). In  
contrast, the pro-apoptotic m em bers lack a t least one dom ain and some 
(such as Bad and Bid) have only a BH3 domain. This dom ain, however, is 
regarded as being requ ired  for in te rac tions betw een different Bcl-2 
family m em bers [50]. Following apoptotic signals, pro-apoptotic p ro te in s 
such as Bax heterodim erise w ith  anti-apoptotic p ro teins such as Bcl-2 a t 
the m itochondrial m em brane [58]. The in te rac tion  blocks the  an ti- 
apoptotic capabilities of the  Bcl-2-like proteins. The actual m eans by th is  
is achieved are still to be elucidated, b u t they  could be re la ted  to th e  
proposed function of these  p ro teins as ion channels [59, 60]. Thus, th e  
overall s truc tu re  created by the  BH dom ains is rem iniscence of d ip h te ria  
toxin [61] and studies in  artifical lipid m em branes have show n th a t  Bcl-2 
family proteins can form ion channels w ith  different affinities to an ions 
and cations [62, 63].
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Two observations, however, have questioned w hether all Bcl-2 fam ily 
function can be a ttr ib u ted  to channel form ation:
(i) Upon its  cleavage by Caspases, Bid has been shown to activate  Bax by 
inducing its  translocation  to the  m itochondrial m em brane [64]. After its  
activation by Bid, Bax oligomerises and triggers the  release of 
cytochrome C. Hence, Bid m ay not posses any in trin s ic  ion ch an n e l 
abilities of its  own.
(ii) Bax is known to associate w ith  the  m itochondrial FTP and to 
influence its s ta te  v ia unknow n m echanism , w hich is th o u g h t not to 
require  ion tran sp o rt th rough  Bax itse lf  [62].
Indeed, the  Bcl-2 fam ily have some other capabilities in  exerting  an ti- 
and pro-apoptotic functions, by inducing regu la tion  of ce llu la r 
hom eostasis in  term s of controlling pH, Ca^^ and o ther factors reg a rd in g  
not only the  m itochondria b u t also the  ER [65]. F u rtherm ore , th e ir  
in terac tion  w ith  the cell cycle m achinery  rem ains obscure. For exam ple, 
Bcl-2 proteins can rescue cells from apoptosis, b u t not from grow th a r re s t  
which usually  accom panies it  [58, 66]. N onetheless, th e ir
phosphorylation sta te  changes w ith  cell cycle progression, su g g estin g  
th a t  they have a protective role during  these vu lnerab le  tim es [67]. T his 
evidence points again to a connection betw een m ain tenance  of 
m itochondrial energetic balance and  cell survival.
1.3.3 Caspases and other kUler proteases
C aspases are an  im portan t group of cysteinyl a sparta te -specific  
proteases w hich were identified as homologues of the  cell death  pro tein , 
CED-3 from the  nem atode C. elegans. Caspases act by cleaving key ta rg e t  
proteins resu ltin g  in  the  system atic  disassem bly of the  apoptotic cell by
(i) ha lting  cell cycle progression; (ii) disabling hom eostatic and rep a ir  
m echanism s; (iii) in itia tin g  the  detachm ent of the  cell from its  
su rround ing  tissue  s tru c tu res; (iv) d ism antling  s tru c tu ra l com ponents 
such as the  cytoskeleton and (v) flag the  dying cell for phagocytosis 
(reviewed in  [68, 691). Indeed, over-expression of active C aspases is 
sufficient to cause cellu lar apoptosis [69]. The Caspase fam ily contains 14 
different m em bers, w hich are  able to recognise and cleave sim ilar, b u t 
not identical, four amino acids sequences ([50]; tab le  1). C aspases a re
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expressed as inactive pro-C aspases and Caspase activation  occurs in a 
cascade fashion w ith  the  in itia l activation of an  in itia to r C aspase se rv ing  
to activate dow nstream  effector C aspases by proteolysis ([50] and fig. 4). 
All pro-Caspases consist of a large and  sm all su b u n it and  a pro-dom ain. 
The pro-dom ains of C aspases possess two types of adap to r motifs, w h ich  
serve them  in  th e ir in te rac tions w ith  other p ro teins (reviewed in  [68, 
70]): the C aspase activation  and rec ru itm en t (CARD) or the  d ea th  
effector dom ain (DED). These motifs are essen tia l for in te rac tions w ith  
death  dom ain (DD) pro teins w hich are  dow nstream  of certa in  d ea th  
receptors (see below) and crucial for the  activation of in itia to r C aspases. 
In  a fully processed and  activated  Caspase, the large su b u n it and  sm all 
subun it a re  covalently linked and  the  pro-dom ain is cleaved out ([50] and  
fig. 4).
A lthough the precise m olecular m echanism s of effector C aspase 
activation  are as yet unknow n, it  has recently  been observed th a t  
proteolysis and  activation of effector C aspases is fac ilita ted  by binding to 
cytochrome C w hich is released  from the m itochondria  during  th e  
process of apoptbsis. The exit of cytochrome C from the  m itochondria is 
controlled by the  Bcl-2 fam ily of apoptosis regu la to rs , and  causes th e  
indirect activation  of these caspases [71]. Cytochrome C, together w ith  
dATP and a cytosolic factor term ed Apaf-1, assem ble an  in itia to r complex 
called the apoptosome [72]. This complex in itia te s  the  cleavage of 
Caspase-9 into a m atu re  active form. This active protease, in  tu rn , 
in itia tes a series of effector C aspases [731. This in itia tio n  is regarded  as 
"point of no retu rn", w here cell disassem bly cannot be reversed  due to th e  
ensuing quick and broad destruction  of cell com ponents [73]. The c e n tra l 
effector Caspase, Caspase-3, norm ally  exists as a 32kDa inactive p ro te in  
precursor th a t  is converted proteolytically to a 20kDa and a lOkDa 
activated  heterodim er by both Caspase-9 and C aspase-6 . In  addition, 
Caspase-3 is also able to cleave and  activate C aspase-6, a process w h ich  
am plifies Caspase-cascade events [731. D ow nstream  ta rg e ts  of C aspase-3 
are: (1) DNA fragm en ta tion  factor (DFF40/CAD), a heterod im er th a t  
functions to trigger fragm en ta tion  of genomic DNA into nucleosom al
segm ents; (2) PKCô, w hich is activated  by its  cleavage; (3) the  DNA
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repa ir enzyme poly(ADP ribose) polym erase (PARP); as well as m any  
o ther proteins [50].
Cell death  receptors such as Tum our Necrosis F ac to r-a  and  Fas, m ediate
rapid  apoptotic cell death  pathw ays in  a num ber of cell types b u t
p a rticu la rly  in cells of the  im m une system. TNF-ot and  Fas u tilise  a
specific in itia to r Caspase, C aspase-8, to activate the  effector C aspases. 
Apoptosis is in itia ted  by directly  rec ru iting  pro-C aspase-8 to th e  
accessory d ea th  dom ain tran sd u c in g  m olecules (such as F  ADD, TRADD, 
RIP and RAIDD), w hich are  associated w ith  these  receptors [50]. 
C aspase-8 is cleaved to its  m atu re  form during  the  death  recep to r 
ligation, as a resu lt of its in teraction  w ith  the  death  dom ain pro teins [68]. 
M ature C apsase-8 acts in  two ways: firstly, i t  d irectly  cleaves Caspase-3; 
Secondly, it cleaves Bid, w hich in  tu rn  translocates to the  m itochondria  
to activate the  cytochrome C cascade ([64] and see above).
A lthough for some tim e, C aspase activation  w as regarded  as abso lu te  
requ irem en t for cell death , th is  has been d ispu ted  recently . The 
existance of a lte rna tive  m echanism s has emerged. B orner and M onney 
[741 suggested th a t  these a lte rn a tiv e  m echanism s m ay u tilise  o th er 
cysteine and serine proteases and  calpains. There is a grow ing num ber of 
reports of C aspase-independent d ea th  pathw ays [75, 76], along w ith  some 
evidence re la ting  to the  partic ipa tion  of a lte rn a tiv e  p ro teases in  
apoptosis is docum ented [77, 78]. An apoptotic process w hich u tilise s  
exclusively non-Caspase pro teases to achieve full execution of the  cell h a s  
not been described yet.
1.3.4 The cell cycle m achinery
The cell cycle is the  elaborate m echanism  by w hich the  eukaryotic cell 
divides into two d au g h te r cells. The cell cycle com prises m ultip le  stages 
w ith  m any safeguards to assu re  precise division w ith  unchanged  DNA. 
These stages, commonly know n as phases, are closely regu la ted  by p a irs  
of proteins - cyclins and th e ir  dependent-k inases (cdks) ([79] and  fig. 5). 
W hen a cell exits its quiescent stage (called Gq), it en te rs  a p re p a ra to ry  
phase known as G^. In  th is phase, controlled by cyclins of the  D-type an d  
cdk-4 and -6, the  cell grows to a sufficient size and  syn thesises th e
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proteins needed for RNA and DNA synthesis and division. Cells can  
a rre s t in  if any of these requ irem en ts are not m et (see below). If 
cleared p ast the  checkpoint, the  cell will th en  progress into DNA 
synthesis, know n as S phase, w hich is regu la ted  by cyclins A and E an d  
cdk2. W hen syn thesis is completed the  cell en te rs a second p re p a ra to ry  
phase, Gg. Here the  cell checks th a t  all copies of DNA are u n ch an g ed  
before i t  can divide. F inally  the  cell undergo m itosis, phase M, and divides 
into two cells. Phases Gg and M are regulated  by cyclin B and cdc2.
Cells can be a rrested  in both G^ and Gg. In m any cases, leng thy  a r re s t  
leads to apoptosis and  certa in  com ponents of the  cell cycle m ach in e ry  
(such as p21 and p53; see below) are required  for th is  tran sition . In  some 
cases, grow th a rre s t is also a  requ irem en t for apoptosis [80]. The G^ 
checkpoint (also known as S ta r t res tric tion  point), approxim ately  two- 
th ird s  into th is  phase, is regarded  as crucial for cell fate decisions [81]. 
This checkpoint is regu la ted  by the  retinoblastom a suscep tib ility  p ro te in  
pRb and a series of cdk inh ib ito rs (ckis): p l5 , p l 6, p l 8 , p l9  and p 21 
(reviewed in [82, 83]). p21 function is well characterised  and  it  is th o u g h t 
to be im portan t m ainly in  the  regu la tion  of d ifferen tiation  induction  in  
concert w ith  grow th a rre s t [84, 85]. p i 9^^^ stabilises the  p53 pro tein  by 
blocking nucleo-cytoplasm ic sh u ttlin g  of Mdm2, w hich degrades p53 ([86, 
87] and fig. 6). L ittle is known about the  function of p l5  and p l 8 [88]. p l 6 
appears to act to p reven t cell cycle progression. This activ ity  can by 
reversed by the  transcrip tion  factors from the  E2F fam ily and is th o u g h t 
to be crucial to cancer developm ent [88, 89].
C om m itm ent to apoptosis requ ires the  activation  of the  E2F and DP 
fam ilies of tran scrip tio n  factors [90]. All E2F/DP dim ers in te rac t w ith  
sim ilar, b u t not identical, DNA consensus sequenses [91]. E2F fac to rs 
usually  cooperate w ith  p53 in ac tiva ting  various apoptosis-related  genes 
([92, 931 and see below), th rough  the  co-activator p300 [94]. Some 
evidence, though, exists for p53-independent activ ity  of E 2F factors [95, 
96]. A nother family of proteins w hich in te rac t w ith  E 2F tra n sc r ip tio n  
factors is the  pRb family of "pocket" proteins. The pRb proteins are  active 
only while they are not phosphorylated by cdks or tyrosine k inases [97]. 
The in te rac tion  of E2F and DP factors w ith  DNA is e ith er inh ib ited  by 
proteins from the  pRb family [98] or altered  by them  [91]. E2F-1, -2 and  -3
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form dim ers w ith  the  transcrip tion  factor DP-1 [99]. DP-1 dim ers are  up- 
regu la ted  during  [100] and are controlled by pRB [79]. E2F-4 and -5 
complex w ith  DP-2 and p e rs is t du ring  Gq [100]. DP-2 dim ers a re  
regulated  by the  pRb re la ted  proteins, p l0 7  and  p l3 0  [99]. These p ro te ins 
displayed in some cases a pRb-independent activity [101, 102], w hen p l0 7  
closely im ita tes repression  by pRb of E2F via HDAC-1 (H istone 
deacetylase-1) [103].
The tum or supressor p53 sits in  the  centre of a com plicated netw ork, 
which responds to a  varie ty  of stim uli and  exerts a whole range of actions 
([104] and fig. 6). Investiga tions of DNA dam age checkpoints revealed  
th a t  p53 is the  m ain  “gatekeeper” in  the repa ir or death  decisions in  th e  
cell (reviewed in  [105, 106]). Recently, however, some of the  activ ities of 
p53 have been a ttrib u ted  to its  close homologues, p63 and p73 [107, 108]. 
All of the m em bers of the  p53 fam ily share  the  sam e DNA b ind in g  
consensus sequence. Thus, these  proteins were shown to play a p a rt in  
both apoptosis [109, 110] and developm ent [109, 111].
The p53-m ediated stress response includes th ree  stages:
(a) stab ilisa tion  of p53 pro tein  [112] and its  action as an  an ti-o x id an t 
[113].
(b) translocation  to the  nucleus [114].
(c) activation  and suppression  of p53-responsive genes [115]. The 
m echanism s involved in  th is  stage are still elusive b u t phosphory la tion  
of Ser-15 on p53 is considered as the m inim al req u irm en t for its  
tran sac tiva tion  [116, 117].
N um erous genes contain  p53 response elem ents and  p53 activ ity  is, in  
fact, executed by different p53 containing complexes [115]. A few p ro te ins
have been suggested to “cross ta lk ” w ith  p53 in  th is, including  N F-kB in
association w ith  p300 [118]. Sim ilarly, the cell cycle regu la to r ATM is 
thought to be necessary for both grow th a rre s t and  apoptosis m ediated by
p53 [80, 119]. Both N F-kB and ATM them selves have a role in cell fate  
decisions and in tegration  betw een all of these factors is likely to be a t th e  
DNA transcrip tion  level.
p53 has also been linked to m itochondrial function and  th rough  th is to 
determ ining the fate of the  cell. For example, p53 appears to regu la te  th e
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transcrip tion  of both Bcl-2 [120, 1211 and Bax [122] and  hence can control 
the  levels of pyo- and anti-apoptotic complexes m ade of Bcl-2 fam ily 
m em bers. p53 can also induce a rise in  ROS content [123, 124], leading to 
an oxidative degradation of m itochondrial components [51]. In  addition, it  
has been shown th a t  p53 can inh ib it the  expression of COX-2, an  
inducible enzyme responsible for p rostag landin  production ([125] and see 
section 1,4.2.3) which m ay influence fu rth e r in te rce llu la r phenom ena. 
Moreover, p53 has been recently  shown to tran slocate  to th e  
m itochondria [1261, presum ably  to directly exert these  actions. 
In terestingly , a  Caspase substra te , the  DNA repa ir pro tein  PARP, a lte rs  
p53 DNA binding by an  unknow n yet m echanism  [1271.
Mdm2 is an  oncogene w hich regu la tes p53 activity. A lthough p53 itse lf  
regulates Mdm2 tran scrip tio n  [1281, Mdm2 drives p53 to ub iqu itin - 
m ediated degradation  [129]. In teresting ly , using a proteosome inh ib ito r, 
lactacystin  [130], it  w as shown th a t  both Mdm2 and Bax are degraded by 
ub iquitination  [131]. Moreover, the  proteasom e has been proposed to p lay  
a key role in the regu lation  of p53-m ediated apoptosis in lym phocytes 
[1321. p53 has also been suggested to in te rac t w ith  the  E 2F/pRb 
m echanism  [92], presum ably  via direct in teraction  betw een Mdm2 and  
pRb [97]. A re la ted  event to th is  in te ra tion  is the  cleavage of pRb by 
Caspase activity [133], which was m ay also be m ediated by p53 [49].
1.4 Apoptosis of B cells
The first observations th a t  different responses to antigen , via the  BCR, 
occur a t d istinct stages in developm ent were dependent on im m atu re  
anim al models and neonatal an tigen  exposure [14, 1341. The difference 
betw een the  responses of im m ature  and of m atu re  B cells to a n tig en  
receptor ligation w as the  first example, and perhaps best example, of th e  
role developm ent plays in  governing lymphocyte responses [135]. 
C ross-linking B cell receptors on im m ature  B cells aborts B cell 
development in vivo. The BCR also tran sm its  a signal th a t  is sensitive to 
m etabolic inhib itors and  th a t  preferentially  inactivates im m atu re  B cells 
in vitro [136, 137]. In  vitro, stim ula tion  of m atu re  B cells w ith  an ti-IgM
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antibodies triggers a m itogenic response th a t  is affected by the  degree of 
cross-linking and  the  presence of co-stimuli, such as CD40 ligation. 
E xperim ents track ing  antigen-specific monoclonal B cells in  tra n sg e n ic  
mice have reinforced the  notion of different responses to the  sam e a n tig en  
by im m ature  and  m atu re  B cells [138]. A para lle l s itu a tio n  exists in  T 
cells, w here extensive receptor cross-linking by anti-CD 3, su p e ran tig en s , 
a lloantigens, or v iral an tigens triggers apoptotic deletion of im m atu re  
thym ocytes b u t triggers proliferation of m atu re  T cells [139, 140],
1.4.1 The B cell receptor and its im m ediate signalling m ediators
Cross link ing  of the  B cell receptor leads to activation  of m ultip le  
pathw ays. N uràerous signalling  events induced by the  BCR w ere 
investigated  in  the  la s t decade, due to th e ir  im portance in B cell 
developm ent (reviewed in  [3, 12, 18]; see section 1.3). The BCR com prises 
two components: clonatypic surface Ig (heavy and ligh t chains) and th e
accessory moleules, Ig a  and Igp. While surface Ig has an tigen  b ind ing
ability  bu t no signalling  capacity, the  accessory m olecules co n ta in  
im m unoreceptor tyrosine-based activation  motifs (ITAM). These m otifs 
m ediate the  signal tran sduced  by the  BCR th rough  the  tyrosine k inases  
from the  Src-family, such as Syk and Lyn [141]. These k inases a re  
responsible for the  activation of a  num ber of key pathw ays:
(i) The PI-3K pathw ay: th is  pa thw ay  is activated  directly  by Syk and  
indirectly  by Ras to convert PIPg into P IP3. This event serves to ac tiv a te  
m any PH -containing proteins such as Vav, Akt, PLCy and B tk  [142].
(ii) A ctivation of phospholipase C (PLC)-y and Calcium  m obilisation:
activation of tyrosine k inase B tk triggers PLCy to produce IP3 and DAG. 
IP 3 ligates its  receptors on the  ER, which mobilise Ca^^ in  response. 
Calcium  m obilisation has m any effects such as activation  of the  calcium
sensitive pro tein  C alcineurin  and NF-kB. Calcium  and IP 3 activates th e  
conventional (a, p, y) isoforms of pro tein  k inase C (PKC) [143]. DAG is 
sufficient to activate the  novel (Ô, e, 0, T|) PKC isoforms [144].
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(iii) The Ras pathw ay: activation of the  Grb2:Sos pro tein  complex leads to 
activation of Ras. D ow nstream  of Ras, the  classical MAPK/ERK p a th w ay  
is activated  th rough  Raf-1 [145]. In  addition, Ras activa tes the  PI-3K  
pathw ay .
(iv) Phosphorylation of the  G uanine exchange factor Vav activates th e  
Rho fam ily of GTPases (such as Rac and cdc42), w hich in  tu rn  ac tiv a te  
the MAPKs p38 and JN K  and ultim ately , actin  polym erisation [18].
All pathw ays were shown to deliver the BCR signal to a varie ty  of 
transcrip tion  factors in the  nucleus in  order to execute the  tra n sc r ip tio n  
of a varie ty  of genes. F u rtherm ore , investigation  into th e ir  collaborative 
n a tu re  has elucidated the im portance of adap tor molecules such as 
BLNK/SLP-65. For example, BLNK w as shown to in te rac t in p ara lle l
w ith  G rb2, Vav and PLCy together w ith  Nek, an  activator of NF-kB [146].
1.4.1.1 B ru ton 's k in a se  (Btk) an d  Xid p h en o ty p e
The X-chromosome linked im m unodeficiencies in  CBA/N mice (Xid) and  
m an (XLA) are genetic diseases caused by a lte ra tio n s of the  s tru c tu re  of 
the protein tyrosine kinase Btk. Both Xid and XLA defects are  in trin sic  to 
the B cell lineage and are charac terised  by a p a rtia l block in  pre-B-cell 
developm ent in the  bone m arrow , a m oderate (Xid) or severe (XLA)
reduction in  m atu re  B cell num bers in  the  peripheral lym phoid o rg an s$
and low tite rs  of circulating antibodies (reviewed in  [147]). B tk, a m em ber 
of the  Tec family of protein  tyrosine kinases, w as shown to be essential for
both PLCy activation  and calcium  signalling [3, 142] and  therefo re
rep resen t a crucial com ponent of the  BCR-sensitive pathw ays. The 
m atu re  B cells from Xid mice exhibit poor activation  in  response to BCR 
stim ulation, because of th e ir failure to activate A kt [142]. The dual role of 
B tk in  both selection of im m atu re  B cells and activation  of peripheral B 
cells pinpoints it  as crucial regulator of B cell fate [148-152].
1.4.2 The W EHI-231 m odel and developm ental-stage dependent 
BCR signalling
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L ittle is known about BCR induced signalling events in  im m ature  B cells, 
especially in vivo. A ttem pts to resolve th is question  by ex vivo 
experim ents w ith  prim ary  cells provided contrad ictory  evidence 
(reviewed in [91). For example, while in some system s BCR cross-link ing  
induced m ainly receptor editing [7], o ther studies sugested  th a t  deletion 
of im m ature  (or transitional) B cells is the  principal m echanism  for B cell 
selection [12, 153].
A widely used model for tolerance susceptib ility  in  im m atu re  B cells is 
the m urine lym phom a B cell line W EHI-231. I t is well estab lished  th a t  
th is IgM^ IgD^° j^3 cell line undergoes apoptosis w hen stim u la ted  via its  
BCR [154, 155]. This cell line can be rescued by T h2 type response as 
dem onstra ted  by using  e ither Th2 clone, D10.G4 [156], anti-C D 40 
antibodies [157, 158] or IL-4 trea tm e n t [157, 159], Hence, the  W EHI-231 
model is used to investigate  how the balance betw een the  death  and  
rescue processes is achieved.
1.4.2.1 C alciu m  m o b ilisa tio n  an d  PLCy a c tiv a tio n
Calcium m obilisation from in te rn a l stores is a well docum ented apoptotic
event in im m ature  B cell lines stim ula ted  via th e ir  BCR [160-163].
Release of calcium from in te rn a l stores is induced by the  production of
À
the second m essenger IP 3 by the  BCR-coupled PLCy [159] and can induce
m ultiple events in  the  cell [43, 63, 164-166]. It is unc lear w hich of th ese  
events are  in fact developm ental stage dependent, since the  BCR u tilise s  
calcium m obilisation also in  m atu re  B cells [43, 167]. An in tr ig u in g
possibility is the  involvem ent of PKC isoforms, some of them  known to be
calcium dependent (a, |3, and  y, for review see [144]). Overall PKC
activation  was suggested to have a role in  the grow th inhib ition  of
im m ature  B cells [134, 136, 161, 168]. The o ther second m essenger
produced by PLCy, DAG, can act alone on novel PKC isoforms (ô, e, q, and
0; [154]). M any^other possible candidates for calcium -related  s ig n a llin g
in B cell developm ent are aw aiting  exploration. One such p a th w ay  
involves the  phospholipase cPLA^ [169, 170]. This pro tein  is calcium  
dependent and has been shown to be expressed in  B cells w hen BCR
2 0
signalling leads to cell death  [171]. Therefore, cPLA^ m ay provide a 
component of development-specific calcium response (see below).
1.4.2.2 cPLAg an d  its  ro le  in  ly m p h o cy te  se le c t io n
The m ajor source of eicosanoid and re la ted  compounds in  m am m als is th e  
arachidonic acid (AA) cascade. Upon cell stim ulation , AA, or u n d e r 
certa in  circum stances o ther p recursor fatty  acids, a re  liberated  from th e  
m em brane phospholipids v ia  activation  of lipid-cleaving enzymes, su ch  
as phospholipase Ag (for review see [1721).
The phospholipase Ag (PLA^) enzym es hydrolyse fa tty  acid from the  sn-2  
position of phospholipid w ith  the concom itant production of lyso- 
phospholipid. M am m alian cells contain s tru c tu ra lly  diverse forms of 
PLAg including secretory PLAg (sPLAg), calcium -independent PLAg 
(iPLAg), and  the  85-kDa cytosolic PLAg (cPLAg) [173, 1741. cPLAg shares no 
homology w ith  other PLAg enzym es and is the  only well ch arac te rized  
PLAg th a t  p referen tia lly  hydrolyses sn-2  arachidonic acid. I t should be 
noted, however, th a t  although  sPLAg and iPLAg do no t exhib it acyl ch a in  
specificity they  can also m ediate arachidonic acid release  depending on 
the cell type and agonist involved [175-178]. Arachidonic acid is itse lf a n  
im portan t regu la to r of specific cellu lar processes including  regu la tion  of
PKC and PLCy and m odulation of Ca^^ tran sien ts . A rachidonic acid can
also be converted to eicosanoids, po tent inflam m atory  lipid m ediators. 
This can occur enzym atically  th rough  the  lipoxygenase or 
cyclooxygenase pathw ays for the  production of leukotrienes, lipoxins, 
throm boxanes, or p rostag landins. Arachidonic acid is also subject to non- 
enzym atic, free rad ical oxidation to bio active isoprostanes and  
isoleukotrienes. The im portan t role of arachidonic acid in  ce llu la r 
activation ensures th a t  its  levels are tigh tly  controlled. 
cPLAg plays a  role in m ain ta in in g  arach idonate  levels and  is subject to 
complex m echanism s of regu la tion  a t both the  tran sc rip tio n a l and  post- 
tran s la tio n a l levels [179]. An increase in  in tra ce llu la r  calcium  is 
necessary  for cPLAg translocation , and cPLAg phosphorylation, all of 
these enhance enzym atic activ ity  and can act together to fully ac tiv a te  
cPLAg (reviewed in  [180]). In teresting ly , phosphorylation of cPLAg m u st
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precede the increase in  in trace llu la r Ca^^ to fully activate  the  enzyme for 
arachidonic acid release in  HER14 cells, and  th is  suggests th a t  cPLAg 
m ay not be available for phosphorylation if it is first tran slocated  to 
m em brane. However, there  is evidence suggesting a lte rn a tiv e  p a th w ay s 
for regu lation  of cPLAg activation and  arachidonic acid release. In  
m acrophages and  neu trophils , PMA can induce an  increase in  
phosphorylation and cataly tic  activ ity  of cPLAg as well as arach idon ic  
acid release, a:cd th is  occurs w ithou t an  increase in  in tra c e llu la r  
calcium. The properties of cPLAg are  consisten t w ith  the  enzyme being  
cytoplasmic in  res tin g  cells a t 50—100 nM calcium  and  tran slo ca tin g  to 
the m em brane w hen in tra ce llu la r  calcium  levels increase. I t  is well 
docum ented th a t  arachidonic acid release is triggered  in  cells by m any  
calcium -m obilizing agonists.
The cPLAg activation  pathw ay  involves also an  agon ist-induced  
phosphorylation of cPLAg a t Ser-505 by m itogen-activated  p ro te in  
kinases (MAPKs) and calcium -dependent translocation  of cPLAg form 
cytosol to m em branes w here the  su b s tra te  is localised. P hosphory la tion  
of Ser-505 is im portan t in the  activation  of cPLAg in vivo since over­
expression of m u tan t cPLAg (S505A) in  Chinese h am ste r ovary cells fails 
to enhance agonist-induced arachidonic acid release as seen w hen w ild 
type enzyme is expressed [181]. O ther k inases such as PKC and p ro te in  
k inase A can phosphorylate cPLAg in vitro, b u t th is does not re su lt in a 
significant increase in  cPLAg activ ity  or a gel shift [180], However, th e re  
is evidence for a role for PKC in  the  activation of PLAg and regu la tion  of 
arachidonic acid release. PKC activation  can play a  role by triggering  a 
k inase cascade leading to MAPK activation  [171]. However, there  is no 
evidence th a t  PKC directly phosphorylates cPLAg in vivo.
C ellular oxidants have also been shown to activate  cPLAg [182, 183]. In  
vascu lar sm ooth m uscle cells, hydrogen peroxide (HgOg) induces se rine  
phosphorylation and activation of cPLAg. In  th is system , cPLAg ac tiv a tio n  
and arachidonic acid production are im plicated in  the  induction  of c-fos 
and c-jun and the  m itogenic response induced by HgOg. In  co n tra s t, 
trea tm en t of kidney epithelial cells w ith  HgOg has been show n to ac tiv a te  
cPLAg, which contributes to oxidant-induced cytotoxicity.
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cPLAg is a widely d istribu ted  enzyme, and the tran sc rip t is expressed a t a 
fairly  constan t level in  all h um an  tissues w ith  som ew hat elevated levels 
in  lung  and the  hippocam pus. At the  cellu lar level, cPLAg is enriched in  
m ononuclear phagocytes bu t has been found in m ost cells [172]. One 
notable exception is th a t  m ost m atu re  T and B lym phocytes do no t 
contain cPLAg, w hereas i t  is p resen t in  thym ocytes, im m atu re  and  GC B 
cells [171]. The an tigen  receptors on m atu re  B and T cells a re  not coupled 
to the  activation of cPLAg and arachidonic acid release. Moreover, phorbol 
esters such as PMA, w hich can activate cPLAg via MAP k inase  in  m ost 
cell types, also failed to induce the  release of arach idonate  from m a tu re  
lymphocytes, suggesting  th a t  cPLAg pathw ay m ay not be functional in  
these cells. In teresting ly , w estern  blot analysis revealed th a t  cPLAg is 
not expressed in  m atu re  B or T cells and  th a t cPLAg expression could n o t 
be up-regulated  in  lym phocytes following cu ltu re  w ith  a range of 
cytokines m ost likely to be involved in  an  im m une response. In  c o n tra s t, 
cPLAg was shown to be expressed and activated  in thym ocytes and  
im m ature  B cejls under conditions in w hich ligation  of the an tig en  
receptors led to grow th a rre s t and/or apoptosis. T aken together, th ese  
d a ta  suggest th a t  cPLAg does not play a role in an tigen  receptor m ediated  
lymphocyte activation, b u t m ay be involved in  the  m olecular m echan ism s 
underly ing  lymphocyte m a tu ra tio n  and/or self to lerance by clonal 
deletion.
1.4.2.3 F u rth er  p r o c e ss in g  o f  a ra ch id o n ic  a c id
Arachidonic acid, w hich contains four double bonds, is converted via th e  
COX pathw ay into the  prostag landins of the  2-series (PDGg, PGEg, PGFg^, 
PGIg, TXAg). D uring  the  COX reaction  two m olecules of the  dioxygen a re  
introduced, one a t C^  ^ and  the  second a t the  C^ g of the  AA backbone.
Both COX-1 and COX-2 are located w ith in  the  ER and the  n u c le a r  
envelope. COX-2 is, however, more concentrated  in  the  nuc lear envelope 
th a n  COX-1. This observation suggests th a t  COX-1 and  COX-2 in  the  ER 
and COX-2 in  the  nuclear envelope constitu te  independen t p rostano id  
biosynthetic system s [172]. COX-2 is especially im portan t because it is 
upregu la ted  in certa in  types of cancer and is though t to support th e ir  
proliferation [184].
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Lipoxygenases (LOXs) catalyse the  oxygenation of p o ly u n sa tu ra ted  fa tty  
acids containing a t least one 1,4-pentadienyl system  to th e ir  
corresponding 1-hydroperoxy derivatives [172]. LOXs are classified w ith  
respect to th e ir positioned specificity of AA oxygenation. In  m am m alian  
cells, there  are th ree  m ajor types of LOXs; 5-LOX, 12-LOX and 15-LOX. 
In teresting ly , the  m ain  product of COX-2, PGEg, acts th rough  G -protein  
receptors of B cells to induce cAM P-mediated apoptosis [185]. The 
function of PGEg was suggested to be biphasic, causing  grow th in h ib itio n  
a t low concentrations and apoptosis a t h igher concentrations [186]. O ver­
expression of Bcl-2 in  im m ature  B cells failed to stop PGEg-induced 
apoptosis [185]. In  thym ocytes, PGEg was shown to cause apoptosis by 
stab ilization  of c-Myc, b u t w ithout any effect on Bcl-2 expression [187]. 
In teresting ly , Bcl-2 expression in  CH31 B cells inh ib ited  PGEg-induced 
apoptosis [1851. In  contrary , PGEg abolished apoptosis caused by COX-2 
inhibition, in colon cancer cells, by m odulating Bcl-2 expression [188]. 
A lthough LOXs are p resen t in  B cells, there  is no evidence yet of th e ir  
involvem ent in cell signalling of these cells [179, 189].
1.4.2.4 C eram ide p ro d u ctio n  d ow n stream  o f  BCR stim u la tio n
The sphingom yelin pathw ay is in itia ted  by hydrolysis of the  phospholipid 
sphingom yelin (N -acylsphingosine-l-phosphocholine) w hich is 
preferentially  concentrated in  the  p lasm a m em brane of m am m alian  cells. 
Ceramide, generated  by sphingom yelin hydrolysis, acts as a second 
m essenger and in itia tes  cell type specific signalling [1901. Apoptosis is 
only one of m any reported effects in response to ceram ide g en era tio n  
although it is a  commonly reported event (for review  see: [191]).
Moreover, a num ber of cellu lar sphingom yelinases have been 
characterised  and they  are defined by th e ir pH optim a as e ither n e u tra l  
or acid. N eu tra l sphingom yelinase is found in  m any, if  not all, tissues. 
N eu tra l sphingom yelinase displays a  pH optim um  of 7.4, while acid 
sphingom yelinase, posses optim um  pH betw een 4.5-5.5. A sy n th e tic  
m echanism  also exists for the  generation  of ceram ide, w hich under some 
circum stances can be regu la ted  for induction of apoptosis.
E arly  studies suggested th a t  ceram ide m ediates the  apoptotic response of 
W EHI-231 cells to anti-IgM , corticosteroids and irrad ia tio n  [192].
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F urtherm ore , resistance  to anti-IgM -induced apoptosis in  a W EHI-231 
subline was found to be due to insufficient production of ceram ide [193]. 
In  W EHI-231 cells, n e u tra l sphingom yelinase w as long though t to be to 
source for BCRrinduced ceram ide [194]. Conflicting studies, how ever, 
suggested th a t  apoptosis in  W EHI-231 cells is m ediated by e ith e r  
ceram ide production de novo from pa lm ita te  [195] or acid 
sphingom yelinase [194]. S tudies in  W EHI-231 cells suggested PKC 
inhibition combined w ith  ceram ide production synergise to prom ote 
apoptosis [196]. Moreover, PKC inhibition  in  these  cells increased  
ceram ide production over baseline levels w ith  a  concurren t decrease in  
sphingom yelin due to activation  of n eu tra l sphingom yelinase [197]. In  
contrast, in o ther system s, activation  of PKC w as show n to block 
radiation-induced generation of ceram ide and  apoptosis [198].
In a num ber of system s, o ther th a n  lymphocytes, ceram ide was linked to 
the arachidonic acid cascade. Ceram ide stim u la tes the  tran sc rip tio n  of 
COX-2 and cPLAg [199]. I t is possible th a t ceram ide acts to am plify th e  
m agnitude of signals dow nstream  of the  cPLAg pathw ay. F u rth e rm o re ,
sphingosine generation  has been shown to synergise w ith  TNFot
signalling  to effect cPLAg activ ity  [200]. In  con trast, m em brane soluble 
ceram ide (c^-ceramide) and  one of its  m etabolites w ere show n to in c rease  
COX-2 levels in  fibroblasts b u t not to influence cPLAg [201].
1.4.2.5 C ell c y c le  re la ted  e v e n ts  in  th e  a p o p to s is  an d  r e sc u e  o f  
WEHI-231 c e lls
A netw ork of nuplear proteins w as suggested to m ediate the  dow nstream  
effects of IgM cross-linking in  W EHI-231 cells (for review see [98]). I t is 
unclear, though, how BCR-induced grow th a rre s t and  apoptosis a re  
controlled by th is netw ork [202]. P roteins linked to apoptosis, such as Bcl- 
2 fam ily m em bers, m ay also influence the tran sc rip tio n a l reg u la tio n  
during  the  cell cycle [203, 204], a  suggestion w hich w as also raised  for 
BCR-induced cell death  of W EHI-231 cells [159]. A nother im portan t link  
betw een the  cell cycle and  apoptosis is th a t an  abortive en try  into the  cell 
cycle m ay be a  prim ary  reason  for apoptosis [205].
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The signalling events following BCR stim ula tion  of im m atu re  phenotype 
B lym phom as are very diverse. W hile apoptosis of various cell types 
th rough  the TNF and TNF-R receptor fam ilies is re la tively  fast (about 4 
hours un til DNA ladders appear), the  program m ed cell death  of 
im m ature  B cells takes su b s tan tia lly  longer (at least 24 hours in  W EHI- 
231 cells). This m ay reflect a  difference in the regu la tion  of BCR induced  
apoptosis. A few attem pts have been m ade to estab lish  an  explanation  for 
how th is  regu la tion  is achieved. An im portan t suggestion is th a t  
apoptosis of im m ature  B cells requires growth a rre s t and th a t  the  rescue  
process is essentially  the  reversal of th is  a rre s t ([154, 156, 157, 159, 206] 
and see below). This theory  is supported by the  involvem ent of two 
phenom ena observed dow nstream  of BCR-induced apoptosis: 
destab ilisation  of the  transcrip tion  factor c-myc, a crucial m ediator of cell 
fate decisions [206-208] and the  involvem ent of Gj cyclin-cdk complexes in  
th is  process [159, 209],
Stim ulation of the  BCR on of W EHI-231 cells leads to a tran s ie n t increase  
in c-myc transcrip tion , followed w ith in  hours by a drop in  c-myc mRNA 
levels to below background [98], This evidence suggest th a t  elevation of c- 
myc expression predisposes im m atu re  B cells to apoptosis, as shown in  
other system s [210], Surprising ly , trea tm e n t w ith  an ti-sense  to c-myc 
mRNA stabilises i t  and  in  fact blocks both growth a rre s t and apoptosis in  
WEHI-231 cells. I t w as suggested th a t  m ain tenance  of c-myc levels is 
therefore essen tia l for norm al cell survival in  these  cells. Therefore, 
d istu rbance of c-myc mRNA levels leads to cell death  [98]. This view is 
supported by studies showing th a t  increase in  c-myc expression can lead 
to susceptibility to cell death  [83].
Evidence from different groups regard ing  the role of cyclins and th e ir  
coun te rpart k inases (Cdks) in  BCR signalling is incom plete and  
som etim es contradictory. For exam ple, an  im portan t study  reported  th a t  
im m ature  B cells en te r b u t do no t progress beyond th e  early  Gj phase of 
the  cell cycle in  response to an tigen  receptor signalling  [159]. 
N onetheless, both im m atu re  and m atu re  B cells showed BCR-induced 
increase in  Cyclin D2 and Cdk4, which are essen tia l for early  G^ phase  
progress. In  contrast, w hilst cross-linking of sig  on W EHI-231 cells also 
reduced the  Cyclin A:Cdk2 complex activ ity  [98, 209], in  m atu re  B cells
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such a signal caused an increase in Cyclin A [211], Cyclin E and Cdk2 
levels [159]. In con trast to th is  evidence, observations of CD40 s ig n a llin g  
in WEHI-231 cells suggested th a t  rescue signals are  actually  m ediated  
by both re-induction of Cdk4 and Cdk6 to resum e th e ir  norm al expression  
levels and  th is  is sufficient for passing  the  res tric tio n  point even in  
the presence of apoptotic signals m ediated by IgM [212].
U ntil recently, apoptosis in  im m ature  B cells was generally  considered to 
be p53-independent [98]. However, new da ta  has showed th a t  p53 
expression peaks 6h r  after anti-IgM  stim ula tion  [114]. However, th is  
experim ent w as res tric ted  to only a  12h r tim e-course and involved 
exogenous p53 being m icroinjected under se ru m -sta rv a tio n  s tress . 
Moreover, it w as recently  reported  th a t  during  BCR-induced apoptosis, 
p53 disassociates from NF-kB [213], in con trast to the  expected 
participation  of the  la tte r  in  grow th a rre s t and  cell death . This has ra ised  
new doubts about the  im portance of p53 in inducing  th is  type of 
apoptosis.
Some studies illu s tra te  a crucial role for two cyclin inh ib ito rs, p21 and  
p27, in  B cell signalling. This is a  significant observation since th ese  
inhib itors m ediate m any of p53 in te rac tions w ith  the  cell cycle 
m achinery  and the  pRb fam ily [82, 105, 214], alongside some p53- 
indepedent activ ities [215, 216]. The cell cycle a rre s t  accom panying  
apoptosis in W EHI-231 cells w as suggested to be m ediated by both p 21 
and p27 [114, 217, 218]. F u rtherm ore , p27 is capable of inh ib iting  cyclin  
A:cdk2 complexes, w hich were shown to be essen tia l for BCR sig n a llin g  
in  WEHI-231 cells [217]. p27 levels were also reported  to be down- 
regu la ted  by CD40 signalling in  W EHI-231 cells [218]. However, p27 
knock out mice did not show any defects in  lym phocyte d ifferen tia tion^  
Dysfunction of o ther cyclin inhib itors, p l5 , p l 6 and p l9 , w as observed in  
diffuse large B cell lym phom as [88].
The cell cycle a rre s t of W EHI-231 cells after IgM cross-linking was also 
shown to correlate w ith  the  dephosphorylation of pRb [98, 217], w h ich  
denies exit from G  ^ [209]. In terestingly , pRb is dephosphory lated , as well, 
by sphingosine, a  ceram ide m etabolite [219]. A lthough it  has long been
* J. M . Roberts, Fred H utchinson C ancer R esearch Center, Seattle, personal com m unication .
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assum ed th a t  plib /E 2F complexes play th e ir classical role in  m odu la ting  
apoptosis/survival decisions in  B cells [98], there  h as  been very  little  
evidence to support th is  assum ption. In  Bcl-x^ tran sfec ted  W EHI-231 
cells, BCR stim ulation , induces grow th a rre s t b u t does not kill. R ecently, 
it was shown th a t  in  these cells, p l3 0  replaced p l0 7  in  E 2F -1/D P-1 
complexes This effect was reversed by CD40 ligation [220]. A lthough th is  
study did not find any role for pRb, quiescence in  h u m an  B cells w as 
shown to be m ain ta ined  by pRb/E2F-4/DP-1 complexes [221], T his 
evidence suggest th a t  different pocket-protein/E2F/D P complexes m ay  
determ ine the  fate of B cells during  th e ir development.
Taken together, it  seems likely th a t  grow th a rre s t of im m atu re  B cells 
would be the  crucial point w hen they  could be still rescued after BCR 
cross-linking. Im portan tly , over-expression of Bcl-2 in  im m atu re  B cells 
rescues them  from apoptosis, b u t fails to in itia te  cell cycle p rogression
[222]. This evidence suggests two independent m echanism s of BCR- 
induced apoptosis of im m atu re  B cells, one for grow th a rre s t  and second 
for death. In  o ther system s, it w as shown th a t  ca tastroph ica lly  high cdk 
activity  is sufficient for the  induction of apoptosis [204]. Therefore th e  
possibility th a t  the  m echanism s of grow th a rre s t and apoptosis in  W EHI- 
231 cells are closely linked cannot be entirely  excluded (for review see 
[98]).
1.5 Aims
This study had  th ree  closely re la ted  aims:
(i) To estab lish  the  involvem ent of m itochondrial and  cell cycle re la ted  
events in BCR-m ediated apoptosis of W EHI-231 im m ature  B cells.
(ii) To extend th is  knowledge into p rim ary  im m ature  and tran s itio n a l B 
cells w ith  em phasis on the  factors required  for th e ir  developm ent.
(iii) To draw  parallels betw een selection of B cells in  the  bone m arrow  and  
th a t of B cells in  the  G erm inal C entres and in  the  peritoneal cavity.
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Stem  cell prO“B cell Pre-B  cell
A ntigen-independent
+ Ag
# 4 - 0 im m ature B cell m IgM /m IgD
Plasm a cell / m ature B cell 
m lgM ^/mlgD^
M em ory B cell
A ntigen-dependent
+ A g
A poptosis or 
anergy
Fig. 1
F ig u re  1; T he c la s s ic a l m od el for  B c e ll  d ev e lo p m en t. The
developm ent of B cells can be divided into two stages; an tigen - 
independent and  and antigen-dependent. The first positive selection 
checkpoint is a t the  pro-B to pre-B transition , and  cells th a t  express th e  
pre-BCR expand. At the  im m atu re  B cell stage in  the  bone m arrow , cells 
m ay be elim inated, th e ir  receptors m ay be edited, or they  m ay be 
otherw ise anergised by self-antigens. These im m ature  B cells m ay also be 
positively selected to em igrate to the  periphery. B cells em erge from th e  
bone m arrow  into the  periphery  w here they  en te r the  follicles an d  
acquire the ability  to en te r the  rec ircu la ting  naive B cell pool. BCR- 
m ediated signalling  perm its the  m ain tenance  of pe riphera l B cells. A 
secondary selection process during  affinity m a tu ra tio n  occurs in th e  
Gem inal C entres (see fig. 3).
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F ig u re  2: C h an ges in  su rfa ce  e x p r e ss io n  an d  recep to r
rea rra n g em en t d u r in g  B ce ll d ev e lo p m en t. The various stages of B 
cell developm ent in the  bone m arrow  can be identified by various cell 
m arkers. P an  B-cell m arkers, CD19 and B220/CD45R, appear on the  cell 
surface as early  as the  pre-B stage. A m atu re  form of surface IgM ap p ea rs  
in im m ature  B cells and  directs th e ir  negative selection. IgD is firs tly  
expressed on tran s itio n a l B cells and enables them  to em igrate  to th e  
periphery  and there  to undergo fu rth e r selection. P eriphera l m atu re  B 
cells also co-expyess IgM and IgD.
Arrows indicate a rre s ts  in  developm ent of various knock-out mice models. 
These observations are useful in  assesing  the role of different m olecules 
in B cell development.
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follicular m an tle
light zone
FDC+Ag
dark zone
Fig. 3
F ig u re  3: M ature B ce ll d ev e lo p m en t in  G erm in al C entre. R esting  
u n m u ta ted  naive B cells (1) in  the  follicular m antle  are activated  in  a T 
cell dependent m anner, then  m igrate  into B cell follicles (2), w here th ey  
differentiate  into p ro liferating  cen trob lasts (3); th e re  they  form the GC 
dark  zone, w here som atic m u ta tion  in  the variable region of the  Ig genes 
occurs. The cen trob lasts d ifferentiate  into centrocytes (4) th a t  undergo  
positive selection depending on the  affinity of th e ir  m u ta ted  a n tig en  
receptors in  the  ^ GC light zone. Low affinity and autoreactive cen tro b la s ts  
(4) th a t  are not selected undergo spontaneous apoptosis. The positively 
selected high-affinity  centrocytes (5) m ay undergo CD40-induced isotype 
sw itching, become protected from Fas-induced apoptosis, and  
differentiate into e ither p lasm a cells (6) or into m em ory B cells (7).
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C asp ase P ro d o m a in A ctiv e A c tiv a t io n Tetra-
(Z ym ogen len g th  and su b u n its ad ap ter p ep tid e
len g th  in  kDa) m o tif in  kD a p referen ce
Apoptotic in itia to rs
C aspase-2 (51) Long, CARD 20 /12 RAIDD DXXD
C aspase-8 (55) Long, DED 18 / I I FADD (L7V7D)EXD
Caspase-9 (45) Long, CARD 17 710 APAF-1 (I7V7L)EHD
C aspase-10 (55) Long, DED 17 712 FADD U nknow n
Apoptotic effectors
Caspase-3 (32) S h o rt 17 712 NA DEXD
C aspase-6 (34) S ho rt 18 711 NA (V7T7DEXD
Caspase-7 (35) S h o rt 20 712 NA DEXD
Cvtokine processors
Caspase-1 (45) Long, CARD 20 710 7CARDIAK (W7Y7F)EHD
Caspase-4 (43) Long, CARD 20 710 U nknow n (W7L7F)EHD
Caspase-5 (48) Long 20 710 U nknow n (W7L7F)EHD
Caspase-11 (42) Long 20 710 U nknow n U nknow n
C aspase-12 (50) Long 20 710 U nknow n U nknow n
Caspase-13 (43) Long 20 710 U nknow n U nknow n
Caspase-14 (30) S h o rt 20 710 NA
T able 1: C asp ase  c h a r a c te r is t ic s  and  a c t iv a t io n , adapted from
[223].
32
Is
9O)\
y
■D
Q.
Q-
T 3
T 3
Q.
00 03 
o_ o ,
X rb
03 db 
X to
aq-
4\
F ig u re  4: Tw o P r in c ip a l S ig n a llin g  P a th w a y s  o f  A p op tosis . One
pathw ay involves ligation of death  receptors, re su ltin g  in  th e  
rec ru itm en t of the  adap to r pro tein  FADD th rough  in te rac tio n  betw een 
the  death  dom ains (DD) of both molecules. The death  effector dom ain 
(DED) of FADD in tu rn  rec ru its  pro-Caspase-8, w hich is cleaved and  
activated  a t the  receptor complex. A nother pathw ay, w hich is trig g e red  
by m any apoptotic stim uli, is in itia ted  a t the m itochondria. An early, no t 
w ell-understood step is the  m itochondrial release of cytochrome C in to  
the  cytosol which, together w ith  dATP, binds to the  CED-4 homolog 
A pafl. This event unm asks the  CARD m otif in A pafl and  allows b in d in g  
of pro-Caspase-9 th rough  CARD/CARD in teraction . The m itochondria l 
bu t not the  death  receptor pa thw ay  is inhib ited  by Bcl-2 . A ntiapopto tic  
m em bers of the  Bcl-2 fam ily m ay in terfere  w ith  the  relocalization of 
cytochrome C or w ith  the  b inding  of cytochrome C to Apaf-1. Follow ing 
activation  of the  in itia to r caspase C aspase-8 or Caspase-9, the two 
pathw ays converge on the  activation  of effector Caspase-3, -6, and -7, 
which finally cleave various death  substra tes . Because C aspase-8 cleaves 
Bid and  generates a tru n ca ted , proapoptotic B H 3-containing frag m en t 
(tBid) th a t  induces cytochrome C release, both pathw ays cross- 
com m unicate. Caspase-8, in  tu rn , can be also activated  by C aspase-6 
following Caspase-9 cleavage, thereby am plifying the  apoptotic signal.
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F ig u re  5; P r o g e ss io n  o f  th e  c e ll cycle . M any cell fate  decision a re  
taken  a t the S ta r t restric tion  point, two th ird s  into phase. In  order to 
pass th is point Rb has to be phosphorylated  to allow E2F DNA binding. 
Inh ib ito rs dow nstream  of p53, such as p21 and p27, also regu la te  th is  
restric tion  by binding to Cdks and inh ib iting  the  cataly tic  activ ity  of 
Ckis (see also fig. 6).
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Fig. 6
F ig u re  6: T he p53/Rb n etw ork . The balance betw een com ponents of 
the  Rb/p53 netw ork decide w hether the  cell will progress to S phase and  
will u ltim ately  divide. p53 is a t the  centre of th is  netw ork, reg u la tin g  th e  
expression of m any com ponents not shown here such as Bcl-2 fam ily 
m em bers, m itochondrial proteins and others. Mdm2 binding  to p53 
casues the  degradation of the  la tte r  and  pl9^^^ stabilizes p53 by blocking 
nucleo-cytoplasmic sh u ttlin g  of Mdm2 [86].
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Chapter 2. MATERIALS AND METHODS
2.1 Antibodies and protein conjugates
2.1.1 N on-conjugated antibodies
Protein^ S o u rce H ost C lo n e  
or ID
D ilu t io n U sa g e '
A1 S an ta  Cruz goat T-18 1:500 WB
ANT" Gift from Dr. 
P. Schmid, 
Ht^rmel Inst,, 
U niversity  of 
M inneso ta
ra b b it 1:2000 WB
BAD T ran sd u c tio n
L aborato ries
m ouse 32 1:500 WB
p S e r l l 2 -
BAD
New E ngland 
BioLabs
ra b b it 9291 1:1000 WB
p S erl3 6 -
BAD
New E ngland 
BioLabs
ra b b it 9295 1:1000 WB
B ak“ O ncogene m ouse TC102 1:500 WB/IP
B ax ' P h a rM in g en m ouse 6A7 1:500 WB
Bcl-2^ T ran sd u c tio n
L aborato ries
m ouse 7 1:500 WB
Bcl-x' T ran sd u c tio n
L aborato ries
ra b b it B22630 1:1000 WB
B cl-xJ Zymed m ouse 2H12 IP
BID S an ta  Cruz goat M-20 1:500 WB
CD40 - rat^ FGK.45 Stim ul.
cdk4 S an ta  Cruz ra b b it C-22 1:1000 WB
A ntibodies w ere origanlly raised against the m urine form  o f  the protein unless indicated.
 ^ A bbreviations: W B: W estern B lotting; IP: Im m unoprécipitation; Stim ul.: Stim ulation; IF: 
im m unofluorescence. ■
R aised against the human foiTn o f  the protein. C rossreactive w ith m ouse.
 ^ From  hybridom a ce ll line, see  antibody purification, section  2 .3 .9 .
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Protein^ S o u rce H o st C lo n e  
or ID
D ilu t io n U sa g e '
cP L A / D iagnostics
Scotland
sheep S572 lOpl IP
cPLAg^ The B inding 
Site
sheep IjJil IF
cytochrom e
C
P h arM in g en m ouse 7H8.
2C12
1:500 WB
cytochrom e
c
S an ta  Cruz ra b b it H-104 1:1000 WB
F(ab’)2
frag m en t 
an ti-IgG +  
IgM (H+L)
Jackson
L aborato ries
goat S tim ul.
HDAC-1' S an ta  Cruz ra b b it H-51 1:500 WB
M c l-l' T ran sd u c tio n
L aborato ries
m ouse 11 1:1000 WB
m dm 2^ S an ta  Cruz m ouse SM P14 1:500 WB
Ig m u chain - ra t" B7.6 Stim ul.
p l 6 S an ta  Cruz ra b b it M-156 1:500 WB
p53 ' Oncogene m ouse Pab421 NA IP
p53^ S a n ta  C ruz ra b b it FL-393 1:500 WB
p53 ' D iagnostics
S cotland
ra b b it S238-
120
1:1000 WB
p S erl5 -p 5 3 ' New E ngland  
BioLabs
ra b b it 1:1000 WB
pl30^ S an ta  Cruz ra b b it C-20 1:500 WB
PA RP' S an ta  Cruz goat N-20 1:1000 WB
cleaved
PARP
New E ngland 
BioLabs
ra b b it Ip l IF
RAG-1 S an ta  Cruz ra b b it K-20 5pl IF
Rb" Pl}.arM ingen m ouse G3-245 1:500 WB/IP
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Secondary antibodies and strep tav id in  conjugates:
P r o te in s H o st C o n ju g a te S o u rce
goat/sheep IgG donkey HRP D iagnostics Scotland
m ouse IgG goat HRP D iagnostics Scotland
rabb it IgG donkey HRP D iagnostics Scotland
stre p ta v id in - HRP D iagnostics Scotland
2.1.2 Flow  cytom etry and cell separation
All antibodies were titra te d  per batch  and  used accordingly (fig. 7). The 
m agnetic beads were used according to the  m an u fac tu re r 's  in s tru c tio n s  
(see section 2.3.5.1).
P r o te in C o n ju g a te S o u rc e H o st C lo n e
A nnexin B iotin Roche -
B220
(CD45R)
Allophyto- 
cyanin (APC)
P h arM in g en r a t RA3-
6B2
C D llb PE P h arM in g en r a t M l/70
CD19 - P h arM in g en r a t 1D3
CD43 M agnetic
beads
M iltenyi Biotech r a t
CD44 FITC P h arM in g en r a t 1M7
CD5 PE Serotec m ouse KT25
Fas (CD95)" - Serotec m ouse LOB3
Fas" B iotin P h arM in g en h a m s te r Jo2
FITC M agnetic
beads
M iltenyi Biotech m ouse
HEL^ FITC Gift from Dr. P. 
Garside, Dept, of 
Immunology, Uni. 
of Glasgow
R aised against the horse form  o f  the protein. C rossreactive w ith m ouse.
 ^ Conjugated protein for the detection  o f  apoptotic ce lls , see  section  2 .3 .11 .2 .
'  Protein conjugate for the detection o f  B ce lls  bearing B C R  sp ecific  for chicken egg  ly so sy m e (H EL)
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P r o te in C o n ju g a te S o u rce H o st C lo n e
Ig delta- 
ch a in
H ybridom a cell 
line
1.19
Ig kappa- 
ch a in
B iotin Serotec r a t MRC
OX-20
Ig kappa- 
ch a in
B iotin Zym ed r a t LO-
MK-1
P e a n u t
A gg lu tin in
(PNA)^
B iotin Pierce
PNA FITC Sigm a -
Secondary antibodies and  strep tav id in  conjugates:
P r o te in s H o st C o n ju g a te S o u rc e
goat/sheep
IgG
donkey B iotin D iagnostics Scotland
mouse Ig 
gam m a chain
goat B io tin S igm a
rabb it IgG donkey B iotin D iagnostics Scotland
rabb it IgG donkey FITC D iagnostics Scotland
ra t  Ig ra b b it FITC DAKO
ra t  Ig goat FITC P h a rM in g e n
ra t  IgG goat APC C altag
stre p ta v id in - APC P h arM in g en
stre p ta v id in - FITC Pierce
s tre p ta v id in Perid in in  Chlorophyll- 
a P ro tein  (PerCP)
P h a rM in g e n
stre p ta v id in - Texas Red V ector
from M D 4 transgenic m ice. See  section  2 .3 .1 .
 ^ Protein conjugate for the detection  o f  G erm inal Centre B ce lls  (section  5 .4).
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2.2 Other reagents
D e sc r ip tio n  [com m on nam e] S o u rce
3.3'-dihexyloxacarbocyanine iodide [DiOCg (3)] M olecular Probes
5,6,7-trihydroxyflavone [Baicalein, 12-LOX 
inhib itor]
Alexis
5-/6-carboxyfluorescein d iacetate , 
succinimidyl ester [CFSE]
M olecular Probes
Ac-Asp-Glu-Val-Asp-CHO [Ac-DEVD-CHO, 
Caspase-3 inhibitor]
Calbiochem
Acrylamide/Bis Solution, 29:1 Bio-Rad
Antimycin A [Respiratory chain complex IV 
inhibitor]
Calbiochem
Carbobenzoxy-L-Ieucyl-L-leucyl-L-Leucinal 
[MG-132, Proteosom e inhibitor]
Calbiochem
Cyclosporin A Calbiochem
cytosolic Phospholipase Ag assay  k it C aym an
Duck egg lysosome [DEL] Gift from Dr. P. 
Garside, Dept, of 
Immunology, Uni. of 
G lasgow
E64d [EST, P an  C athepsin  inhibitor] Calbiochem
ECL w estern  blotting reagen t A m ersham
E thyl 3 ,4-dihydroxybenzylidenecyanoacetate 
[Pan LOX inhibitor]
Alexis
Foetal C alf Serum  [FCS] Gib CO
Fum onisin B^ [FB^, Ceram ide synthase 
inhibitor]
Calbiochem
G lu tam ine Gibco
L-N®-(l-Iminoethyl)lysine [L-NIL, iNOX 
inhibitor]
Alexis
Lactacystin  [Proteosome inhibitor] Calbiochem
MEM non-essential amino acids Gibco
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D e sc r ip tio n  [com m on  nam e] S o u rc e
MicroBCA pro tein  assay Pierce
M itoTracker G reen M olecular Probes
N-(2-Cyclohexyloxy-4-nitro- 
phenyD m ethanesulfonam ide [NS-398, COX-2 
inhib itor] ,
C albiochem
N-Acetyl-Asp-Glu-Val-Asp- pN A  [Caspase 3 
su b s tra te ]
Calbiochem
N-A cetylsphingosine [cg-ceramide] BioMol
N-benzyl-oxycarbonyl-Arg-Arg- pN A  
[Cathespin B substra te]
Calbiochem
N-benzyl-oxycarbonyl-V  al-Ala-Asp( OMe)- 
fluorom ethylketone [zVAD-fmk, P an  Caspase 
inhib itor]
C albiochem
N-benzyl-oxycarbonyl-V  al-Glu(OM e)-Ile- 
Asp(OMe) -fluorom ethylketone [zVEID-fmk, 
C aspase-6 inhibitor]
Calbiochem
N^-M onom ethyl-L-Arginine [L-NMMA, All 
NOS inhibitor]
Calbiochem
N ifluril, 2-[[3-(Trifluoro-m ethyl)phenyl] - 
am ino]-3-pyridinecarboxylic acid [Niflumic 
Acid, COX-2 inhibitor]
A lexis
Oligomycin [Respiratory chain  complex V 
inhib itor]
Calbiochem
p53 w estern  b lo tting  s tan d ard C albiochem
Penicillin /S trep tom ycin Gibco
Propidium  lodidp C albiochem
Rhodam ine 123 M olecular Probes
RPMI-1640 m edia Gibco
Sodium Pyruvate Gibco
SP Sepharose FastF low A m ersham
ViaLight HS ATP k it L um itech
['H]-Thym idine A m ersham
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All other reagen ts purchased  from Sigm a and were a t the  h ighest g rade  
available.
2,3 Methodjs
2.3.1 A nim als
BALB/c mice aged 8-12 weeks w ere used unless otherw ise stated . These 
mice, as well as IgM BALB/c (gift from Prof. F. B rom bacher, U n iv e rs ity  
of Cape Town, South Africa), Xid (CBA/N) and ES-62 trea ted  BALB/c, 
were kept in the  anim al facility of D epartm en t of Im m unology,
U niversity  of S trathclyde, Glasgow. IgM  ^ BALB/c and  Xid (CBA/N) m ice 
were kept a t the  b a rrie r  facility un til sacrifice. MD4 (BCR-HEL,
C57/CBA) and Ipr mice were kept in  the  anim al facility of U niversity  of 
Glasgow and were provided by Dr. P. G arside and  Prof. F. Y. Liew from 
the D epartm ent of Immunology. These mice were used a t the  age of 10-18 
weeks.
2.3.2 ES-62 m inipiim ps
The following procedures were preform ed by Dr. M aureen  D eehan and  
were designed to mimic the  in vivo release of p a rasite -d eriv ed
im m unom odulatory molecule, ES-62 by the  rodent flarial nem atode A,
viteae.
2.3.2.1 P r im in g  o f  o sm o tic  m in i-p u m p s
Alzet Osmotic M ini-Pum ps model 2002 (Alza) were loaded w ith  200pl of 
either lOpg, 20pg, 40pg, 80pg ES-62 or PBS pH  7.4 and  were left 
overnight a t room tem pera tu re  subm erged in sterile  0.9% saline solution, 
according to the  m an u fa tu re r 's  instructions.
2.3.2.2 S u rg ica l im p la n ta tio n  o f  o sm o tic  m in i-p u m p
Five groups of m ale BALB/c mice of a t least 20g and  6-8 weeks old w ere 
anaesthetised  w ith  H alothane-RM  (Aventis P a s te u r MSD) in  a Og/NgO 
mix, under sterile conditions. The back of the  neck w as sw abbed w ith
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d isin fectan t (0,1% benzalkonium  chloride) and  the  a rea  shaved. A m id­
scapular incision was m ade and the  connective tissue  severed to create a 
pocket to in se rt the m inipum p. The pum p w as placed, according to 
m an u fac tu re r’s in stru c tio n s w ith  the  flow m oderator in se rted  first. The 
wound was su tu red  and  the  an im al observed u n til consciousness w as 
regained. All anim als were housed individually. A nim als were sacrificed 
on day 14 by cardiac puncture. Once sacrificed, spleen, lym ph nodes and  
peritoneal cells w ere harvested  from each mouse.
2.3.3 P re-iinm iin isation  o f MD4 m ice
The following procedure was preform ed by K aren Sm ith. MD4 HEL-BCR 
mice were injected subcu taneously  w ith  e ith er PBS, lOOpg DEL 
(+Freund’s complete ad juvant) or lOOpg HEL (+F reund’s complete 
adjuvant). The anim als were sacrificed after 8d.
2.3.4 C ell m aintenance and sdm ulations
The m urine B cell lym phom a, W EHI-231 and the  h u m an  leukem ia T cell 
line Ju rk a t  were purchased  from ECACC and frozen stocks were kept in  
cryostorage. All cells w e re . cu ltu red  in  RFMI-1640 m edium  contain ing  5% 
foetal calf serum , L -glutam ine (2mM), penicillin  (lOOU/ml) and  
streptom ycin (100 pg/ml) (RPMI complete) a t 37“C in  5% CO^. RPM I 
complete m edia for W EHI-231 cells and p rim ary  cells w as supp lem ented  
w ith  2-m ercaptoethanol (50pM). For DNA synthsis assays the  m edia w as 
supplem ented w ith  MEM non-essential amino acids (1:100) and sodium  
pyruvate (O.lmljl).
Cells were seeded a t the  following densities for stim ulation: 0.5-1x10® 
cells for W EHI-231 and  J u rk a t  cells and 0.5-5x10® cells for p rim ary  cells. 
S tim ulations lasted  2 days (42-48h, unless indicated  otherw ise in  text) 
and were te rm ina ted  by a w ash  in  cold PBS (1.37M NaCl, 3mM KOI, 
lOmM Na^HPO^, 2mM K H f O J .
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2.3.5 Prim ary cell purification
For bone m arrow  cultu res the  bone m arrow  was flushed w ith  R PM I-1640 
m edia out of the fem ur bones. The brachial, axial, ingu inal an d  
m esenteric lym ph nodes were pooled together for lym ph node cultures. 
Bone m arrow, lym ph nodes and spleens were m ashed th rough  a w ire  
mesh, in  RPM I-1640 media. The re su lta n t single cell suspensions w ere 
underla id  by 1ml cold FCS and left for 5m in on ice to remove fat. The 
upper layers were tran sfe rred  to fresh  tubes and centrifuged th ro u g h  
another layer of FCS (1ml). Cells were recovered from the  pellet, 
resuspended and  cultured.
Peritoneal B cells w ere retrieved  from peritoneal cavity w ashes (7ml from
each mice). The w ashes w ere incubated  in culture flasks for Ih  a t 37°C.
The incubation was repeated  once m ore and the non-adheren t cells w ere  
collected (typically -70%  B cells by flow cytometry).
2.3.5.1 P u r ifica tio n  o f  B c e lls  from  sp leen s or  lym p h  n o d es
Single cell suspension (6ml; equ ivalen t to 2 spleens or lym ph node sets) 
were layered over H ystopaque-1077 cushions (3ml) and  centrifuged a t  
400g, for 30min a t 20°C. Cells a t the  in terface were rem oved and  d ilu ted
out w ith  m edia to 50ml and th en  centrifuged a t 630g for lOm in a t 4°C. 
The su p e rn a tan t w as discarded and  cells were resuspended  in  50ml cold 
MACS buffer (PBS/0.5% Bovine Serum  Albumin/2mM  EDTA). The cells
were centrifuged a t 430g, for 5m in a t 4°C and resuspended  in 50ml cold 
MACS buffer and  counted. The cells were centrifuged again  before 
resuspending  in  cold MACS buffer (2x10* cells/ml), and  passing  th ro u g h  
gauze, to remove clumps. Cells w ere incubated for 20m in a t 4°C w ith
anti-CD43 beads (lOOpl CD43^ beads/2xl0* cells) and th en  allowed to 
pass th rough  a CS-type depletion m agnetic colum n (M iltenyi Biotec). 
Purified m atu re  B cells, w hich are CD43‘, were collected from the  first 10- 
15ml of buffer. P u rity  (as determ ined  by B220 stain ing) w as a t least 95% 
B cells.
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2.S.5.2 D ep le tio n  o f  IgD*^  ^ B  c e lls
A sim ilar protocol to B cell isolation was employed w ith  m inor changes. 
Bone m arrow  cells were incubated  w ith  an ti-delta  chain  (1:50) and  a n ti-  
rat-lgG-FITC (1:100) according to flow cytom entry protocol (section  
2.3.11). Im m ediately afterw ards, the  cells were incubated  w ith  an ti-F IT C  
m agnetic beads, according to the  m anu fac tu rer 's  in structions. A positive 
depletion was perform ed on a RS-type selection m agnetic  co lum n 
(Miltenyi Biotec), and negative cells collected as run -th rough . Due to th e  
lack of sensitiv ity  of th is  m ethod, only highly expressing  cells (such as 
IgD^’ B cells) are trapped  on the  column, as verified by flow cytom etry.
2.3.6 DNA Synthesis (PH] thym idine uptake)
Exponentially growing cells (5x10^ cells/well for W EHI-231 cells, 5x10® 
cells/well for p rim ary  cells) in  RPM I-1640 complete m edium  
(supplem ented w ith  sodium pyruvate  and non-essen tia l am ino acids) 
were stim ulated  for 44h a t 37°C in  5% CO^. At 44h, the  cells w ere p u lsed  
w ith  0.5pCi/well of [*H]-thymidine before cu ltu ring  for a  fu rth e r  4h. The 
cells were harvested  and  the  level of pH ]-thym idine incorporated  in to  
DNA m easured by liquid sc in tilla tion  counting, using  a  W allac 1205 
B etaplate  reader.
2.3.7 Lysate Preparation
WEHI-231 cells ^(10^ cells) w ere stim ula ted  as indicated  and  reac tio n s  
were te rm ina ted  by the  addition of 2 x ice-cold lysis buffer: 50mM T ris- 
HCl (pH 7.4), 150mM sodium  chloride, 2% NP-40, 0.25% sodium  
deoxycholate, Im M  EGTA, lOmM sodium ortho v an ad a te , O.SmM 
phenylm ethylsulfonylfluoride (PMSF), lOpg/ml chym ostatin , lOpg/m l 
leupeptin, lOpg/ml an tipa in , and  lOpg/ml pep s ta tin  A. L ysates w ere  
solubilised for 30m in on ice before centrifugation  a t 19,800g for 15m in. 
The resu lting  su p ern a tan ts  w ere stored a t -20°C un til they  w ere used.
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2.3.8 Iniim m oçrecipitation
Whole cell lysates w ere pre-cleared w ith  lOjLil of pro tein  G bead s lu r ry
and incubated for Ih  a t 4®C on an  orbital ro tator. Sam ples w ere 
centrifuged to remove beads (19,800g, 30min, 4®C) and  th e  s u p e rn a ta n t  
was decanted. Sam ples were d ilu ted  to Im g/m l w ith  lysis buffer (w ithou t 
protease inhibitors) and incubated  w ith  antibody (l.Spg  per 10® cells) 
overnight a t 4®C, on a orbital ro tator. P ro tein  G s lu rry  (25|il) w as added
and incubated for 4h a t 4®C, on an  orbital ro tator. Sam ples w ere 
centrifuged a t 19,800g for 30m in a t 4®C. The bead pellet contains th e  
im m une complexes. The beads w ere w ashed four tim es a t 19,800g for 
30min a t 4®C, w ith  1ml of ice-cold lysis buffer (w ith p ro tease  in h ib ito rs) 
and 2xloading buffer (60 |u l1) w as added. Before use, the  sam ples w ere
boiled for 5min to separa te  the  im m une complexes from the  beads. The 
sam ples were th en  centifuged for 2m in a t 13,000g and the  s u p e rn a ta n t  
was used for SDS-PAGE and w estern  blotting.
2.3.9 SDS-PAGE
Protein lysates (lOOpg/well as determ ined by MicroBCA pro tein  assay) or 
im m une complexes w ere resolved by SDS-PAGE. A ru n n in g  gel (7.5-12% 
acrylam ide, 0.38M TRIS-HCl pH 8 .8, 0.15% am m onium  p e rsu lp h a te , 
0.15% SDS, 0.07% TEMED) w as set betw een glass p la tes w ith in  a 
purpose built Bio-Rad kit. On top of the  ru n n in g  gel, a  s tack ing  gel (5% 
acrylam ide, 0.062M TRIS pH 6 .8, 0.1% am m onium  persu lphate , 0.1% SDS, 
0.07% TEMED) was layered and a comb was used to create  wells for 
sample loading. The sam ples w ere loaded and electro -separa ted  u n d e r  
constant cu rren t (100-200mA) using  the  following electrophoresis buffer: 
4 ImM  TRIS, 19mM Glycine, 3.5mM SDS. E lec tro -tran sfe r onto PVDF 
m em brane preform ed w ith  tran sfe r buffer (48mM TRIS, 1.3mM SDS, 20% 
m ethanol) in a purpose bu ilt Bio-Rad kit, under co n stan t e lectric  
potential (~30mV for a t least 2h).
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2.3.10 W estern b lotting
SDS-PAGE blots were blocked for non-specific pro tein  binding  a t room 
tem pera tu re  for Ih  w ith  10% non-fat dried  m ilk in  PBS/Tween 20 (0.1%) 
under constant agitation. The m ilk solution w as w ashed w ith  
PBS/Tween 20 and the  p rim ary  antibody w as th e n  incubated  w ith  th e  
blot for l-2h  a t room tem pera tu re . The blots w ere w ashed 6 tim es for 
15min w ith PBS/Tween 20 before addition of the  appropria te  HRP 
conjugated secondary antibody (1:3000) in  5% non-fat dried m ilk for Ih  
w ith  constant agitation. The blots w ere w ashed again  6 tim es for 15m in 
w ith  PBS/Tween 20 and th en  w ere developed w ith  ECL reagen t and  
exposed to film. P resta ined  m olecular w eight m arkers  were used to 
elucidate the m olecular w eights of unknow n proteins. Even p ro tein  
loading/sam ple recovery of gels w as determ ined by Ponceau Red sta in ing . 
For stripp ing  of the  gel blot in  order to re-expose to a different antibody, 
the  blots were incubated in stripp ing  buffer (lOmM Glycine, lOmM NaCl, 
pH 2.6) for Ih  a t room tem perature .
2.3.11 Antibody purification
Purified monoclonal anti-IgM  antibodies (anti-m ouse m u-chain) and an ti- 
CD40 antibodies were produced from the  B7.6 and  FGK45 hybridom as, 
respectively.
For purification of anti-IgM , B7.6 hybridom a su p e rn a ta n t w as filtered 
th rough  0 .2pm  filters, to avoid cell debris. The filtered  su p e rn a ta n t w as 
loaded overnight onto a purification  column (Protein  G-agarose). After a 
w ash  w ith  50ml PBS, the  antibody was eluted w ith  15ml 0.2M Acetic 
acid. The eluted antibody w as m ixed im m ediately  w ith  1.5M TRIS-HCl 
pH 8.8 solution (10% of to ta l volume). The m ixure w as dialysed overn igh t 
against PBS and the antibody concen tra tion  w as determ ined a t Aagonm 
using  a spectrophotom eter (Becton DU640; A=1.43 is equivalent to 
Im g/m l protein).
For purification of anti-CD40, FGK45 hybridom a su p e rn a ta n t w as m ixed 
overnight a t 4?C w ith  equ ivalen t volume of sa tu ra te d  am m onium  
su lphate  solution. The m ixture w as centrifuged a t 10,000g for 15min a t 
4®C. The pellet was resuspended  in  200ml M alonate buffer (44mM
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Malonic acid disodium, 12mM Malonic acid, 8.5 mM betaine) and loaded 
overnight on a SP Sepharose FastF low  column. After a  w ash w ith 50m l 
M alonate buffer, the antibody w as e luted w ith  15ml 0.5M N aC l/M alonate 
buffer. The eluted antibody w as dialysed overnight against PBS and th e  
antibody concentration  w as determ ined a t Aggonm using  a 
spectrophotom eter (A=1.43 is equivalent to Im g/m l protein).
2.3.12 F low  cytom etry
Cells (10® per sample) were s ta in ed  w ith  the  appropiate antibodies for 
15min a t 4°C and w ashed w ith  PBS/2mM EDTA (EDTA is added to 
prevent cells from clumping). For non-conjugated antibodies, secondary  
antibodies were used repeating  the  sam e procedure. For example, for 
detection of Ig kappa chain, cells were incubated  firs t w ith  an ti-kappa- 
biotin conjugated antibody, w ashed, incubated  w ith  streptavidin-A PC , 
and w ashed again. Cells th en  w ere acquired on a  Becton D ickinson 
FACScalibur flow cytom eter and  analysed  using CellQ uest software.
2.3.12.1 A ssesm en t o f m ito ch o n d r ia l p o te n tia l
Incorporation of the cationic lipophilic dye DiOCg (3) into th e  
m itochondria ih? propotional to the  m itochondrial tran sm e m b ra n e  
potential, Cells were firs t s ta ined  if required, for e ither Ig kappa
chain or PNA (for bone m arrow  cells and G erm inal C entre cells, 
respectively). Cells were w ashed w ith  PBS/2mM EDTA, incubated  for 
30min w ith  50nM DiOCg (3) a t room tem pera tu re  and  th en  w ashed ag a in  
in  PBS/2mM EDTA. An exam ple of m itochondrial po tential profile is 
given in fig. 8 .
2.3.12.2 A n a lysis  o f  A n n e x in  V  b in d in g  to  p h o sp h a tid y lse r in e  o n  
th e  ce ll su rface
Cells to be exam ined for annexin-V  binding were w ashed in PBS an d  
incubated for 30min a t 4°C w ith  annexin  V-biotin conjugate, a t a defined 
calcium  concentration (9mM H EPES, 140mM NaCl, 5mM CaClg, pH 7.4), 
according to the  m anufactu rer's instructions. The cells were w ashed an d
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th en  incubated w ith  streptavidin-FIT C  for 15min and  w ashed in th e  
calcium  buffer.
2.3.12.3 C ell cy c le  a n a ly s is
For p rim ary  cells, cell s ta in ing  was perform ed as described above an d  
then  cells were fixed w ith  70% ethanol, for 15min a t 4°C, Cells w ere 
w ashed in PBS/2mM EDTA and incubated for 30m in in  250pg/m l 
propidium  iodide (PI; in  PBS/2mM EDTA) and analysed  for P I 
incorporation as a m easure  of DNA content.
W EHI-231 cells become autofluorescent w hen using  the  above m ethod. 
Therefore, such cells were incubated  in  a non-fixing solution (0.1% 
Sodium C itrate, 0.1% T riton X-100, 50pg/ml PI) for 15m in a t 4°C and th e n  
analysed.
An example of how DNA content was determ ined is given in  fig. 9.
2.3.13 Intracellu lar stain ing and innnun^ohistochennstry
Cells (10® per sam ple) were w ashed in  PBS and fixed in  fixation buffer 
(4% w/v form aldehyde in  PBS, pH=7.4). Cells were th en  w ashed a n d  
perm eabilised for 5m in in  Perm eabilisation  buffer (2% FCS, 2mM EDTA, 
0.1% w/v saponin in  PBS) and incubated w ith  l |X g  of th e  re lev an t p rim a ry  
antibody (30min, 4°C). Bone m arrow  cells were sta ined  for Ig kappa c h a in  
prior to fixation.
For detection of in trace llu la r  s ta in ing  by flow cytom etry W EHI-231 cells 
were fu rth e r w ashed and sim ilarly  sta ined  w ith  an  appropria te  FITC- 
conjugated secondary antibody.
For im m unohistochem istry , the  cells were fu rth e r w ashed  and s ta in e d  
w ith  the appropria te  biotinylated antibody. Cells were th e n  
sim ultaneously  sta ined  w ith  streptavid in-T exas Red and 50nM  
Rhodam ine 123 or 200nM M itoTracker G reen (for m itochond ria  
detection). In  some experim ents, anti-ANT (adenine nucleotide  
transferase) antibody (and anti-rabbit-FITC  secondary) w as used to 
detect m itochondria. Fluorescence microscopy w as perform ed using  a n  
Axioskop microscope (Zeiss), CCD cam era and digital cap tu re  p rogram m e 
(IPlab, S ignalanalytics, V ienna, VA, USA).
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2.3.14 Q ualitative analysis of intem ucleosom al DNA  
fragm entation by agarose gel electrophoresis
WEHI-231 cells were centrifuged a t 430g for 5m in a t 20°C. Cell pellets 
were mixed w ith  0.5ml TTE buffer (lOmM TRIS, Im M  EDTA, 0.2% T riton  
X-100) and centrifuged a t 19,800g for lOmin a t 4°C. The s u p e rn a ta n ts  
were mixed w ith  0.1ml ice-cold 5M NaCl and 0.7ml ice-cold iso-propanol 
and kept overnight a t -20°C before centrifuged a t 19,800g for lOmin a t  
4°C. The DNA pellet was left to dry and w ashed w ith  70% ethanol and  
centrifuged again. The pellet was a ir dried for 3h a t room  tem p era tu re ,
and th en  incubated  overnight w ith  20-50]il TE buffer (lOmM  TRIS, Im M
EDTA). The sam ples (lOql) were mixed w ith  lOxloading buffer and  th e n
resolved on a 1% agarose gel. F ragm ented  DNA released  from the  nucle i 
of cells undergoing apoptosis was analysed by e th id ium  brom ide s ta in in g  
of DNA ladders (visible under UV light).
2.3.15 Preparation o f m itochondria-hree extracts
Cells (10^ per sample) were washed in PBS and resuspended  in  ex trac tio n  
buffer (50mM Pipes-KOH (pH 7.4), 50mM KCl, 5mM EGTA, 2mM MgCl^, 
220mM m annitol, 68mM sucrose, Im M  DTT, lOpM cytochalasin  B an d  
protease inhibitors). Cells were left a t 4"C for 30m in and  th e n  lysed w ith  
a glass hom ogeniser, w ith  40 strokes of the  glass dounce. F inally , cells 
were centrifuged a t 14,000g for 15min and th e  m itochondria-free  
su p e rn a ta n t and  m itochondrial pellets were tak en  for W estern  blot 
analysis of cytochrome C release. The pu rity  w as de term ined  by w e s te rn  
blotting for the  m itochondrial protein  ANT.
2.3.16 Isolation of m itochondria
Cells (10  ^ per sam ple) were w ashed in  PBS and th en  resuspended  in  1m l 
of MI buffer (200mM m annitol, 70mM sucrose, Im M  EGTA, lOmM 
HEPES (pH 7.5)) and left for 5min on ice. Cells w ere lysed w ith  a  g lass 
Dounce hom ogeniser, w ith  20 strokes of the  glass dounce. Sam ples w ere 
centrifuged a t 700g for 5min a t 4°C, and  the  su p e rn a ta n t w as re ta in e d  
(the pellet contains the nucleus and non-lysed cells). The s u p e rn a ta n t
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was centrifuged a t 10,000g, for 5m in a t  4°C, and resuspended  in 0.5ml of 
MI buffer (non-functional, for size de te rm ina tion  or stain ing) or 
M itochondrial Physiological buffer (250mM sucrose, Im M  EGTA, 20mM 
HEPES, 5mM succinate, 3mM KH^PO^, 1.5mM MgCl^, lOmM KCl, 3pM  
Rotenone; for functional assays such as cPLA^ assay).
2.3.17 ATP determ inations
ATP levels were m easured  using  a  com m ercial luciferase kit, V iaL ight 
HS, according to the  m an u fac tu re r 's  in struc tions and  using  a  T u rn e r 
TD-20e lum inom eter. The k it determ ines the  ATP concen tra tion  using  its  
reaction w ith  luciferin in  the  presence of luciferase (both included in th e  
k it buffer) which produces lum inescence a t 590nm.
2.3.18 Cytosolic Phospholipase Ag assay
Cytosolic phospholipase A  ^ (cPLA^) activ ity  in  whole cell lysates or 
m itochondrial fractions w as determ ined  using  a com m ercial cPLAg assay  
k it based on spectrophotom etric detection (A^ ^^ ,^ )^ of free thiol by E llm a n ’s 
reagent (5,5’-dithiobis(2-nitrobenzoic acid); DTNB) following hydrolysis of 
the  arachidonyl th ioester bond a t the  sn-2  position of the  cPLAg 
substra te , arachidonyl thio-phosphatidylcholine.
2.3.19 Protease activity  assays
Cell lysates were p repared  as described in section 2.3.6 (5x10® cells per 
sample). However, only the  serine  protease inh ib ito r PM SF and  
phosphatase inh ib ito r sodium orthovanadate  were used. E ach sam ple 
(lOOpl) was incubated for 30m in a t RT w ith  100|iM of e ith er C athepsin  B 
substra te , zRR-pNA or Caspase 3 su b s tra te  Ac-DEVD-pNa. The cleaved 
substra te  was m easured  a t 405nm  on a  Dynex MRXII p late  reader u s in g  
Revelation software.
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2.4 Company and distributor addresses
BioMol 
c/o Affinity 
M am head C astle 
M am head, E xetér EX6 8HD
A lexis/C aym an 
3 Moorbridge C ourt 
Moorbridge Road E as t 
Bingham , N ottingham  NG13 8QG
A m ersham  
A m ersham  Place 
L ittle Chalfont HP7 9NA
Aventis P asteu r MSD (formely Rhone Mérieux) 
Clivemont House 
M aidenhead SL6 7BU
P harM in  gen/Tr ans due tio n  L aboratories 
c/o Beckton D ickinson 
Between Towns Road 
Cowley, Oxford 0X 4 3LY
Bio-Rad
M aylands Avenue 
Hemel H em pstead H P2 7TD
The B inding Site 
POB 4073
B irm ingham  B29 6AT
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c  albio chem /One o gene 
c/o Calbiochem Novabiochem 
Boulevard In d u stria l P a rk  
Padge Road
Beeston, N ottingham  NG9 2JR
M olecular Probes 
c/o Cam bridge Bioscience 
24-25 Signet C ourt 
N ew m arket Road 
Cam bridge CB5 8LA
Alza
c/o Charles River 
M anston Road 
M argate CT9 4LT
DAKO 
Angel Drove 
Ely CB7 4ET
Diagnostics Scotland (formely SAPU)
Law H ospital 
Carluke ML8 5ES
ECACC
C entre for Applied Microbiology & Reaserch 
Salisbury SP4 OJG
GibcoBRL
c/o Life Technologies 
3 F oun ta in  Drive 
Paisley PA4 9RF
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S an ta  Cruz/Zymed L aboratories 
c/o Insigh t Biotechonology 
POB 520
W embley HA9 7YN 
L um itech
N ottingham  B usiness P a rk  
City Link
N ottingham  NG2 4LA
M iltenyi Biotech 
Church Lane 
Bisley GU24 9DR
New E ngland BioLabs 
Knowl Place 
W ilbury Road 
H itchin  SG4 OTY
Pierce & W arriner 
44 U pper N orthgate  S tree t 
C hester C H I 4EF
Roche D iagnostics 
Bell Lane 
Lewes BN7 ILG^
Serotec
S ta tion  A pproach 
Kidlington, Oxford 0X5 IJE
Sigm a-A ldrich 
The Old Brickyard 
New Road
Gillingham  SP8 4BR
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Jackson  Im m unoR easerch L aboratories 
c /o 'S tra tech  Scientific 
61-63 Dudley S tree t 
Luton LU2 ONP
C altag  Laboratories 
c/o TCS Biologicals 
Botolpb Claydon 
B uckingham  MK18 2LR
Vector Laboratories 
3 Accent P ark  
Bakewell Road
O rton Southgate, Peterborough PE2 6XS
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Sam ple ID: stp-APC alone
Marker Left, Right % Total Mean Median
All 1, 9910 100 .00 1.58 1.30
kappa+ 3. 9910 0 .86 19.63 3 .73
Sam ple ID: 1/10
Marker Left. Right % Total Mean Median
All 1, 9910 100 .00 36 .78 1 .84
kappa+ 3, 9910 34.11 104 .89 11.65
Sam ple ID; 1/20
Marker Left, Right % Total Mean Median
All 1. 9910 100 .00 2 8 .72 2 .53
kappa+ 3, 9910 4 6 .18 60.41 8 .43
Sam ple ID: 1/40
Marker Left, Right % Total Mean Median
All 1, 9910 1 00 .00 8 .28 2 .02
kappa+ 3, 9910 35 .88 20.21 6 .38
Sam ple ID: 1/100
Marker Left, Right % Total Mean Median
All 1, 9910 100 .00 3 .94 1.58
kappa+ 3, 9910 16.71 15.69 4.61
Sam ple ID: 1/200
Marker Left, Right % Total Mean Median
All 1, 9910 100 .00 3 .12 1.64
kappa+ 3, 9910 14.74 11.69 4 .45
Fig. 7
F ig u re  7: A n tib od y  t itra tio n s . Whole spleen cells (10®
cells/concentration) were sta ined  for surface expression w ith  an ti-k ap p a  
chain (0 to l:?200)-biotin and  streptavidin-A PC  (1:100). As control, 
streptavidin-A PC w as used alone. As dem onstrated  in  the  upper panel, in  
th is control the  positive population w as <1%. The optim al d ilu tion  in  th is  
case was 1:20 as dem ontrated  by the  clear peak and  m axim al s ta in in g  
(46%). This m ethod w as employed for t itra tin g  all o ther antibodies used  
for im m unofluorescence.
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Fig. 8
F ig u re  8: D e te r m in a tio n  o f  m ito ch o n d r ia l p o te n tia l. W EHI-231 
im m ature  B ce?Us (10® cells) were trea ted  w ith  O-lOpg/ml anti-IgM ,
M easurem ent of m itochondrial po ten tial (A\{/ )^ by the  fluorescent dye,
DiOCg (3) is shown for control (upper histogram ) and  an ti-Ig -trea ted  
WEHI-231 cells (lower h istogram ) 24h post stim ulation . As a re su lt of 
trea tm en t the  percentage of cells w ith  low m itochondrial po ten tial h a s  
increased from 16% to 60%.
57
untreated
sub diploid
G0/G1
G 2 / M
S
o
8 0 0 10006 0 0200
anti-Ig 10p,g/ml
00 —
G 0 / G 1sub diploid
G 2 / M
o
10004 0 0 8 0 06 0 0200
FL2-H
DNA content
Fig. 9
F ig u re  9; P ro p id iu m  io d id e  in c o r p o r a tio n  as a m ea su r e  o f  DNA  
co n ten t. WEHI-231 cells (5x10^ per sample) were trea te d  w ith  O-lOpg/ml 
anti-IgM  for 2d and  subjected to PI incorporation. DNA content w as 
determ ined for indiv idual sam ples as follows: (i) the  G /G i w as identified  
and the 2N gate determ ined a t 40 fluorescence u n its  w id th  (peak±20 
un its , w hich allow an approxim ate 20% m argin); (ii) the  Gg/M gate w as 
determ ined as G/G^ peak±30 units; (iii); S gate w as determ ined as th e  
gap bew teen G /G i and Gg/M; (iv) Sub-diploid gate (<2N) w as determ ined  
as the  gap betw een 5 un its  (non-stained cells norm ally  have fluorescence 
betw een 0 and 5 units) and  G /G^ gate.
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Chapter 3. MITOCHONDRIAL AND CELL CYCLE 
RELATED EVENTS DURING BCR-INDUCED 
APOPTOSIS IN WEHI-231 IMMATURE B CELLS
3.1 Introduction
Apoptosis plays a key role in  the  regu lation  of the  im m une system . For 
example, the  irum une system  has evolved selection processes w h ich  
resu lt in  clonal deletion, by apoptosis, of au to reactive  B and T 
lymphocytes during  th e ir  developm ent in  the bone m arrow  and th y m u s 
respectively. Moreover, apoptosis provides a m ajor m olecular m echan ism  
not only for the  induction of peripheral tolerance and cytotoxic T cell 
killing b u t also for the  te rm ina tion  of norm al im m une responses [224- 
226]. W hereas cells w hich die from dam age typically swell and b u r s t  
(necrosis), apoptosis is a  rigorously controlled and h ighly  ordered process 
which is charac terised  by d ram atic  m orphological changes in the  cell 
including shrinkage, chrom atin  condensation and  cleavage and  
disassem bly into m em brane-enclosed vesicles called apoptotic bodies th a t  
are rapidly  phagocytosed by neighbouring  cells to p reven t induction of 
inflam m ation and autoim m une responses [39, 227]. This sy stem atic  
disassem bly of the  apoptotic cell appears generally  to be executed by 
Caspases, cysteinyl asparta te-specific  proteases, w hich have recen tly  
been identified as m am m alian  homologues of the  cell d ea th  protein, CED- 
3 from the  nem atode C. elegans [228, 229]. Indeed, m olecular stud ies have  
shown th a t over-expression of C aspases is sufficient to cause apoptosis 
and Caspase-deficient mice have reduced levels of apoptosis [230, 231], 
However, exam ples of C aspase-independent com m itm ent to cell death  can  
be found in  several of the  classic models of apoptosis, in c lu d in g  
glucocorticoid-induced death  of thym ocytes and lym phoid cells, death  of 
haem atopoietic eell lines induced by grow th factor w ithd raw al and Bax- 
m ediated cell death  [232-234].
It has recently  em erged th a t  m itochondrial function plays a pivotal role 
in determ in ing  cellu lar com m itm ent to survival or apoptosis [234-236].
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Thus, during  apoptotic signalling, m itochondrial changes re su lt in  
enhanced production of reactive oxygen species, calcium  cycling and  
disrup tion  of the  in n er m itochondrial po ten tial [43]. Collapse of th e  
m itochondrial po ten tial has been though t to rep resen t a “point of no 
re tu rn ” in  comm iting the  cell to apoptosis as the  resu ltin g  increase in th e  
perm eability  of the  outer m itochondrial m em brane leads to the  release of 
C aspases and factors w hich prom ote activation  of effector C aspases 
(cytochrome C) and/or induce apoptosis (apoptosis-inducing factor (AIF) 
and a  C aspase-independent endonuclease) [237-242]. M itochondrial 
in teg rity  has been proposed to be regu la ted  by pro- and  an ti-apopto tic  
m em bers of the Bcl-2 fam ily [239, 243] as these reg u la to rs  of cell su rv iv a l 
or apoptosis appear to ta rg e t a  num ber of aspects of m itochondria l 
function including m itochondrial perm eability  and  hom eostasis of 
reactive oxygen species s ta tu s  and calcium  cycling.
Cell death  receptors such as Tum our Necrosis Factor Receptor (TNF-R) 
and Fas (CD95) m ediate m uch of the  rap id  apoptotic cell death  req u ired  
by the im m une system  [244]. They in itia te  apoptosis by d irec tly  
rec ru iting  pro-C aspases belonging to the  ICE-like family, such as 
Caspase 1 or 8 to th e ir  accessory ’’death  domain" tran sd u c in g  m olecules, 
FADD, TRADDi RIP and RAIDD to induce proteolytic activation  of 
effector C aspases (Caspase-3 (CPP32)-like subfam ily) w hich have proved 
to be im portan t for the  execution of the la te r stages of apoptosis [244]. 
However, reperto ire  selection during  lym phocyte developm ent is 
m ediated via the  an tigen  receptors [224-226, 244].
The B cell line WEHI-231 was used in  th is p a rt of the  w ork as a model for 
clonal deletion of im m ature  B cells. The aim s of stud ies described in  th is  
chap ter were:
(i) To observe the  m itochondrial events dow nstream  of the  BCR signal in  
WEHI-231 cells, including changes in  the  m itochondrial po ten tia l, 
expression and  d istribu tion  of Bcl-2 fam ily proteins and  pro tease  activity.
(ii) To déterm iné the  role of cPLAg and its product, arachidonic acid, in  
BCR-induced apoptosis.
(iii) To exam ine the possible rela tionsh ip  betw een m itochondrial even ts 
and  the cell cycle m achinery.
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3.2 Ligation of the antigen receptors on the 
immature B cell line, WEHI-231 induces growth 
arrest and apoptosis
C rosslinking of the  an tigen  receptors w ith  an ti-Ig  leads to a 
concentration-dependent induction of grow th a rre s t and  apoptosis in th e  
B cell lymphomfi', W EHI-231 (fig. 10). This is a widely used  model system  
for investiga ting  the  signalling  m echanism s underly ing  clonal selection 
of norm al IgM^ IgD im m ature  B cells. Growth a rre s t w as assessed by th e  
anti-Ig-m ediated suppression of DNA synthesis in W EHI-231 B cells (fig. 
10a) w hich showed th a t  m axim al grow th inh ib ition  w as e ssen tia lly  
achieved a t concentrations of an ti-Ig  betw een 0.1-1 pg/ml. This g row th  
a rre s t w as confirmed by cell cycle analysis w hich showed the  anti-Ig- 
driven accum ulation of W EHI-231 cells in  the  G/G^ phase of the  cell cycle 
(70±7% of stim ula ted  live cells versus 47±10% for control live W EHI-231 
cells 24h post-stim ula tion  w ith  anti-Ig  (Ipg/m l), n=4 independen t 
experim ents).
Com m itm ent to kpoptosis w as also assessed by exam ining the  expression  
of phosphatidy lserine  (Annexin V binding, fig. 10b) a t the  cell surface, 
DNA laddering  (fig. 10c) and propidium  iodide-stain ing  of subdiploid 
DNA content during  cell cycle analysis (fig. 10b) . These stud ies show ed 
th a t com m itm ent to apoptosis required  h igher concen tra tions of an ti-Ig  
(1-lOpg/ml; fig. 10b and resu lts  not shown) th a n  those needed for 
induction of grow th a rre s t following crosslinking of the  a n tig en  
receptors.
Im portan tly , rescue of W EHI-231 cells, via CD40, specifically overcom es 
the tran s itio n  from grow th a rre s t to apoptosis. The in te rn a l division of 
living cells betw een the  different phases of cell cycle shows th a t  an ti-Ig  
trea tm en t blocks cells from en tering  S phase, in  addition to the  in d u ctio n  
of apoptosis. The co-stim ulatory signal transduced  from CD40 overcom es 
th is  phenom ena in  the  tim e window of 16-24h post-stim ula tion  (fig. 11). 
This move beyond the  S ta r t res tric tion  point is facilita ted  by an  in c rease  
in the Gi-cyclin cdk4 ([212] and  not shown).
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3.3 Disruption of the mitochondrial potential (A\j/„) 
plays a key role in antigen receptor-driven 
apoptosis: signals which rescue from apoptosis 
stabilise Ax|/„
D isruption  of irMtochondrial function and in teg rity  has been shown to 
play a central role not only in  the  com m itm ent to apoptosis b u t also in  th e  
in itia tion  of the  execution of the  la te r  stages of apoptosis in  m any cell 
system s [234, 235, 245]. Therefore, the  role of m itochondrial d isrup tion  in  
an tigen  receptor-driven apoptosis w as investigated  by ch arac te ris in g  th e  
effects of an ti-Ig  on the inner m itochondrial tran sm em b ran e  po ten tia l,
To do th is  quantitatively , the  incorporation of the  cationic lipophilic
dye DiOCg(3) into W EHI-231 B cells w as analysed, as th e  up take  of th is
dye into m itochondria is directly propotional to A\\f^ [246]. C rosslinking of
the  an tigen  receptors on W EHI-231 im m ature  B cells induced an early
(w ithin 5h) su b s tan tia l decrease in  A\\f^ followed by a profound
dissipation of A\|/^ which w as m axim al by 20-24h (fig. 12). In  c o n tra s t,
m atu re  splenic B cells, w hich proliferate ra th e r  th a n  apoptose following 
crosslinking of th e ir an tigen  receptors (see section 5.4), do not exh ib it
th is decrease in  A\\f^ a t e ither 3 or 24h (see fig. 79 and  not shown). T hus,
the m itochondrial depolarisation observed in  W EHI-231 cells following 
crosslinking of the  an tigen  receptors correlates w ith  the  com m itm ent 
and induction of apoptosis.
The im portance of A\{/  ^ s tab ilisa tion  to the  surv ival of W EHI-231
im m ature  B cells is fu rth e r supported by the finding th a t  costim u la tion  
via CD40, w hich has been widely shown to rescue an tigen  receptor- 
driven apoptosis (nuclear DNA loss; fig. 13) and grow th a rre s t in
(fig. 11), acts to stabilise A\|f^ (albeit a t an  in te rm ed ia te  A\|/^) and p rev en t 
the profound d issipation  of A\\f^ observed in  an ti-Ig -trea ted  cells (fig. 12).
Furtherm ore , the  m itochondrial inhib itors, an tim ycin  (an inh ib ito r of 
resp ira to ry  chain  complex III w hich blocks the  tran s fe r  of electrons to
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inhib its proton tran sp o rt back into the  m itochondria by blocking th e  
proton channel, Fq protein) which can be used to stabilise th e  
m itochondrial po tential [247], m ain ta in  ATP levels [248] and p ro tec t 
against apoptosis [249], are not only capable of m ain ta in ing  alm ost 
norm al levels even in the  presence of anti-Ig  (fig. 14) bu t are also 
able to protect against the  sig-driven com m itm ent of W EHI-231 
im m ature  B cells to apoptosis (nuclear DNA loss; fig. 13a). Like CD40- 
signalling, the m itochondrial inh ib ito r antim ycin, and oligomycin to a 
very m uch lesser extent, is also able to prevent anti-Ig-m ediated a rre s t in  
GO/Gl as indicated by its  ability  to protect en try  into S phase  (fig. 13a). 
However, unlike the CD40 rescue signals they are unable to allow cell 
cycle progression th rough  G2/M (fig. 13b). Together, these d a ta  suggest 
th a t m itochondrial function not only plays a cen tral role in  th e  
com m itm ent to death  signalling  in B cells bu t also in the  reversib le  
induction of growth a rre s t by anti-IgM  [154].
The im m unosupressant cyclosporin A (CsA) has been shown to act on th e  
cyclophilins coupled to channels on m em branes of both m itochondria and  
ER [250]. In teresting ly , nanom olar concentrations of CsA, which w ere 
suggested to block the m itochondrial perm eability  tran s itio n  pore as a 
resu lt of Aij/^ depolarisation, did not block apoptosis in WEHI-231 cells, 
a lthough more cells en tered  into the  cell cycle (fig. 15). M icrom olar 
concentrations, w hich block the  Ca^^ channels on the  ER [43] w ere 
efficient, as reported elsew here [162] in relieving BCR-induced g row th  
a rrest. This observation m ay indicate th a t the effect of CsA on apoptosis 
in W EHI-231 cells is m ediated through m odulation of Ca^^ influx from th e  
ER and is not a resu lt of direct m anipulation of the  m itochondrial FTP.
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3.4 BCR-mediated disruption of A\|/^  results in 
cellular ATP depletion and is associated with 
induction of mitochondrial PLAg activity
Loss of m itochondrial function and  in teg rity  has been shown to 
contribute to the effector stages of apoptosis via production of reac tive  
oxygen species, ATP depletion, calcium cycling and release  of cytochrom e 
C, C aspases and apoptosis-inducing factors. Since d isrup tion  of 
m itochondrial function w as detected dow nstream  of the  BCR signal, th e  
potential dow nstream  effector m echanism s involved in  the  execution of 
an tigen  receptor-driven apoptosis of WEHI-231 im m atu re  B cells w ere 
investigated .
N itric oxide (NO) is a  source for a range of reactive oxygen species 
influencing m any cellu lar functions. It is syn thesised  by th ree  d is tin c t 
NO syn thases fNOSs) [251], one of them  being the  inducible (iNOS), 
which has been im plicated in  regu la ting  lymphocyte cell fate [252]. NO is 
though t to act dow nstream  of m itochondrial reactive oxygen species 
(ROS) [43], b u t o ther functions have been well docum ented (reviewed in  
[253]), including an essen tia l role for NO in m acrophage activa tion , 
w here it  assists cell killing [254, 255]. I t has also been suggested th a t  
apoptosis of splenic B cells can be prevented by NO th rough  a Bcl-2- 
dependent m echanism  [256], a lthough a role for NO w as ru led  out in th e  
case of thym ocyte apoptosis [42]. In  th is  sytem, inh ib ition  of n itric  oxide 
production, has been found to exacerbate BCR-induced grow th a rre s t of 
W EHI-231 cells, as dem onstra ted  by using L-NMMA, a pan-N O S 
inh ib ito r (fig. lêa). L-NIL, a specific inh ib ito r of iNOS, did not block or 
exacerbate e ither sig-induced growth a rre s t or apoptosis (fig. 16b and  n o t 
shown). In  fact, iNOS protein  was could not be detected in  these cells (not 
shown). These observations suggest th a t  during  BCR-induced apoptosis 
involves blockage of NO production by a NOS enzym e different th a n  
iNOS. If th is  enzyme is one of the  know n constitu tive  enzym es, eNOS or 
nNOS, it  is possible th a t its  regu la tion  is carried  out by other m eans 
th an  pro tein  expression levels.
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The role of ATP depletion in  an tigen-driven  apoptosis of W EHI-231 cells 
was elucidated: crosslinking of the  an tigen  receptors induces a profound 
depletion of cellu lar ATP (fig. 17a). The kinetics of ATP depletion, w h ich  
showed a lag before onset (5-lOh), are consistent w ith  ATP depletion 
resu lting  from m itochondrial d isruption. Moreover, as ATP depletion w as 
apparen t before the  appearance of DNA ladders (>16h), th is  depletion did 
not sim ply reflect cell necrosis resu ltin g  from apoptosis. Im portan tly , 
such ATP depletion and apoptosis could be blocked not only by the  CD40 
rescue signal b u t also by the  m itochondrial inh ib ito rs, an tim ycin  and  
oligom ycin (fig. 17). T aken together, these re su lts  suggest th a t  ATP 
depletion resu ltin g  from m itochondrial d isrup tion  plays a key role in  
an tigen  receptor-driven apoptosis of W EHI-231 im m atu re  B cells. 
G eneration of u n sa tu ra te d  fa tty  acids, such as arachidonic acid, by a 
m itochondrial phospholipase A  ^ activ ity  has been reported  to a lte r th e  
perm eability  of the  m itochondrial inner m em brane resu ltin g  in th e
collapse of A\(/  ^ [43, 257-259]. In teresting ly , i t  w as recen tly  shown [171]
th a t  cytosolic phospholipase Ag (cPLAg) is only expressed and coupled to 
the  an tigen  receptors on B cells under conditions of apoptotic signalling . 
Moreover, consisten t w ith  a role for cPLAg in sig-m ediated apoptosis, 
addition of exogeneous arachidonic acid induces a  dose-dependent sta te  of 
profound grow th a rre s t [171] and  apoptosis as ind icated  by DNA 
laddering (fig. 18a) and  induction of loss of nuclear DNA content (fig. 18b) 
in WEHI-231 im m ature  B cells. Therefore, it was investigated  w h e th e r
cPLAg played a role in  the sIg-m ediated collapse of A\\f^ and  ATP depletion
by determ in ing  w hether signalling  via sig  induced m itochondria- 
associated cPLAg activ ity  under conditions w hich correlated  w ith  th e
collapse of ATP depletion and com m itm ent to apoptosis: an ti-Ig  n o t
only stim ula ted  to ta l cellu lar PLAg activity  under apoptotic conditions 
bu t some 20-25% of th is  activ ity  was found in  purified isolated 
m itochondrial p rep a ra tio n s (fig. 19a). The sig-coupled PLAg activ ity  is (i) 
calcium -dependent [260], (ii) blocked by the  cPLAg/iPLAg-selective 
inhibitor, arachidonyl trifluorom ethyl ketone [260] and (iii) not in h ib ited  
by the iPLAg-selective inhibitor, bromoenol lactone (not shown) ru ling  ou t 
a ru le  for e ither iPLAg or sPLAg in  such arachidonic acid generation. In
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addition, in situ  im m unofluorescence analysis of perm eabilised cells 
indicates th a t  cPLAg translocates to the m itochondria and  the  n u c leu s 
w ith in  3h of stim ula tion  of W EHI-231 B cells via the  BCR and  th is is a t  
least p a rtia lly  reversed/prevented  by costim ulation via CD40 (fig. 20). 
Moreover, addition of exogeneous arachidonic acid elicited A\j/^ collapse in
a m anner analogous to th a t  observed w ith  anti-Ig  (fig. 18b). F u rth e rm o re , 
w hilst an ti-Ig  trea tm e n t was found to up regu la te  cPLAg mRNA (not 
shown) and pro tein  (fig. 19b; 2.25-fold basal levels a t 48h) levels, 
costim ulation w ith  anti-CD40 was found to p reven t/reverse  th is  
upregu la tion  (0.65-fold basal levels of cPLAg pro tein  a t  48h). T aken  
together, these resu lts  suggest th a t  sig-m ediated induction of 
m itochondrial cPLAg activation m ay play a key role in  th e  collapse of 
and com m itm ent to apoptosis in  W EHI-231 im m ature  B cells.
3.5 Arachidonic acid, rather than its metabolites, 
participates in BCR-induced death
A wide range of inh ib ito rs were employed to exam ine the  possibility th a t  
arachidonic acid, produced by cPLAg during  apoptosis of W EHI-231 cells, 
is m etabolised fu rth e r  to induce cell death  via the  COX or the  LOX 
pathw ays.
COX-2 is the  the  inducible form of the  COX enzym es and it has been 
shown to take  p a rt in  various in trace llu la r  signalling  cascades. For 
example, a  possible link  betw een COX-2 and apoptosis regu la tion  w as 
elucidated by a study w hich showed th a t  over-expression of COX-2 
indirectly  induces the  expression of Bcl-2 [261]. M oreover, exposure to 
dexam ethasone, a  known inducer of apoptosis [262], can lead to a  bias in  
the post-transcrip tiona l balance of COX-2, in favour of a  sho rt in s tab le  
isoform (C0X-2g g) in stead  of the  long stable isoform (C0X-2^ g) [263]. Two 
inhibitors of COX-2 activity, Niflumic Acid and NS-398, w ere found not to 
block BCR-induced grow th a rre s t of W EHI-231 cells (as m easured  by 
thym idine incorporation; fig. 21). R ather, NS-398 w as found to au g m en t 
BCR-induced apoptosis (as determ ined  by nuclear DNA loss; not shown).
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These observations support o ther evidence for the  involvem ent of PGEg in  
rescue signalling by CD40 in W EHI-231 cells^®.
Arachidonic acid can be also processed into leukotrienes by the  LOX 
enzym es [172]. H igh concentrations of 5-LOX have been found to be 
p resen t in B cells, b u t not in  T cells and several m echanism s have been 
suggested for the  activation  of such 5-LOX enzymes: (i) signa l
tran sduction  via tyrosine k inases [264]; (ii) s tim u la tion  by calcium  ions 
or ATP (neither calcium  ions nor ATP have been reported  to be req u ired  
for purified 12- and 15-LOXs although activation of these  by calcium  ions 
or o ther d ivalent ions has been reported in  crude p reparations); (iii) 5- 
LOX, the  5-LOX activa ting  pro tein  (FLAP), and  COX-2 are  also 
associated w ith  nuclear m em brane suggesting th a t  these  enzym es form a 
functional complex for the production of eicosanoids [172]. M urine 12- 
LOX is in fact more re la ted  to h u m an  leukocyte 15-LOX th a n  to h u m a n  
12-LOX [265] and 15-LOX needs to translocate  to m em branes in  order to 
be activated  [2661. In teresting ly , oxidative m odifications of m em brane  
phospholipid and low-density lipoprotein by 15-LOX have been noted in  
rela tion  to breakdow n of m itochondria during  reticulocyte m a tu ra tio n  
and developm ent of a therosclerosis respectively [172]. Thus, key 
inhibitiors were used to exam ine to role of LOX in  BCR-induced apoptosis 
in  WEHI-231 cells. The pan-LOX inhibitor, ethyl 3,4-dihydroxy- 
benzylidene-cyano-acetate, w as found to enhance BCR-induced g row th  
a rrest, in  a range of concentrations which will inh ib it all known LOX 
enzym es (fig. 22a). The more specific 12-LOX inhib itor, B aicalein had  no 
effect on BCR-induced grow th a rre s t or apoptosis (fig. 22b and no t 
shown). Therefore, it  is likely th a t  e ither 5-LOX or 15-LOX play a  s im ila r 
role to th a t  of COX-2 in  rescue signalling. A lack of inh ib ito rs specific for 
these forms of LOX prevented  fu rth e r investigation in  th is  direction.
M any studies have dem onstra ted  th a t  diverse stresses (oxidative, UV, 
ionizing rad ia tion  and others) activate  the sphingom yelin p a th w ay  
during  signalling of the  death  response in  eukaryotic system s. C eram ide 
production has been linked to arachidonic acid production by cPLAg [267] 
and its  m etabolism  by COX enzym es [201]. Ceram ide production is also
Gauld, S. B ., and M . M . Harnett, personal com m unication.
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one of the  well docum ented processes in BCR signalling, and  it w as 
suggested th a t resistance  to BCR-induced apoptosis in  a W EHI-231 
subline is due to insufficient production of ceram ide [193]. A lthough th e  
source of ceram ide production in W EHI-231 cells is still in  doubt, m ore 
recently  it w as suggested to be de novo synthesis [195]. De novo sy n th e s is  
of ceram ide occurs v ia  the  enzyme ceram ide syn thase , w hich in  
m am m alian  cells catalyses the  condensation of the  sphingoid base  
sph inganine and  fa tty  acyl-CoA to form dihydroceram ide. 
D ihydroceram ide is rap id ly  oxidised to ceramide. C eram ide syn thase  h a s  
not been charac terised  a t the  m olecular level and  its  activ ity  has been 
detected only in  the  ER and  m itochondria. Fum onisin  Bj, an inh ib ito r of 
ceram ide syn thase , w as used to exam ine w hether de novo syn thesis is 
the source for ceram ide production in  W EHI-231 cells and  w hether it  w as 
responsible for grow th a rre s t or apoptosis [195]. However, th is  in h ib ito r 
did not reverse the effects of IgM cross-linking (fig. 23), du ring  a wide 
range of incubations: -2 to +8 hours of anti-IgM  stim ula tion  (not shown).
3.6 The role of Bcl-2 family proteins in regulating 
BCR signalling
Three m ethods were employed to dissect the  regu la to ry  role of Bcl-2 
family m em bers in apoptosis and rescue in  W EHI-231 cells. F irs t, 
w estern  blotting of whole cell lysates were used to determ ine overall 
changes in pro tein  levels of Bcl-2 fam ily m em bers. Anti-IgM  tre a tm e n t 
was found to cause a su sta ined  decrease in the  pro tein  levels of the  an ti- 
apototic pro tein  Bcl-x^, Bcl-2 and  M cl-l levels (fig. 24). This effect w as 
reversed by the  addition of anti-CD40, b u t only in  the  case of Bcl-x^ and  
M cl-l.
F igure 25 shows the  effect of the  different trea tm e n ts  on levels of pro- 
apoptotic protein  expression. In con trast to w ha t have been predicted, a n  
increase in  Bad, Bak and Bax expression were all induced by CD40 
signalling, w ith  a m axim al induction achieved after 8h. In  addition, an ti-  
IgM trea tm en t alone appeared  to produce a  decrease in  the  pro tein  levels 
of Bad, Bak and Bax. In teresting ly , none of the  trea tm e n ts  appeared
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capable of inducing phosphorylation  of Bad (not shown), which could 
potentially  inactiva te  th is pro-apoptotic protein  [268]. This evidence h a s  
suggested th a t  the  role of Bcl-2 fam ily m em bers in  de te rm in ing  cell fate 
in WEHI-231 could not be defined solely in  term s of whole cell p ro te in  
levels.
A second approach has been taken  in  order to link  the  expression an d  
d istribu tion  of Bcl-2 fam ily m em bers to m itochondrial events. An e a rlie r  
tim e point of 3h w as chosen, proceeding grow th a rre s t and  m itochondria l 
po ten tial disruption, and  correlating  w ith  the  peak in  cPLAg activ ity  (not 
shown). In  agreem ent w ith  the  resu lts from w estern  b lo tting  of whole cell 
lysates, m any Bcl-2 fam ily m em bers, anti- and  pro-apoptotic, w ere 
induced by anti-Ig  trea tm e n t (figs. 26-27). U sing m itochondrial s ta in in g , 
it was possible to determ ine w hether rescue signal v ia  CD40 could 
change the  d istribu tion  of these proteins in a way w hich po ten tia lly  
favours survival. Two events were observed as re su lt of the  com bined 
trea tm en t: (i) fu rth e r induction of Bcl-x^ presum ably  b iasing  the  ba lance  
betw een all Bcl-2 pro teins into an  anti-apoptotic favour (fig. 26); (ii) 
prevention of Bad and Bid en try  to the m itochondria (fig. 27).
Finally, WEHI-231 cells stab ly  transfected  w ith  Bcl-x^, were used to 
exam ine more directly  the  influence of Bcl-x^ on BCR signalling. As 
reported previously, W EHI-23l-Bcl-x^ do not undergo apoptosis in  
response to BCR cross-linking, a lthough  th e ir grow th a rre s t re s u ltin g  
from th is  stim ulation  is not relieved ([269] and fig. 28a). In tersting ly , Bcl- 
Xl over-expression w as sufficient to block apoptosis induced by 
exogeneous arachidonic acid (fig. 28b). This novel evidence indicates a 
link  betw een the  apoptotic activ ity  of cPLA^ and its  prevention  by Bcl-x^.
3.7 BCR-mediated disruption of is not
associated with cytochrome C release from the 
mitochondria or activation of Caspase 3
To determ ine w hether the  observed an tigen  recep to r-d riven  
m itochondrial d isrup tion  also resu lts  in C aspase-dependent execution of 
apoptosis of W EHI-231 im m atu re  B cells, we investigated  w he ther th e
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loss of m itochondrial po ten tial correlated w ith  activa tion  of effector 
Caspases as evidenced by release of cytochrome C from the  m itochondria  
and cleavage of the  Caspase-3 su b stra tes , PARP and  Bc1-Xl [270, 271]. 
E xam ination  of m itochondria-free ex tracts showed th a t  an tigen  receptor- 
m ediated stim ulation  of W EHI-231 im m ature  B cells failed to induce any  
release of cytochrome C into  the  cytosol over the  48h tim e course of 
apoptosis m easurem ents (fig. 29a), resu lts consistent w ith  a  recen t rep o rt 
th a t  BCR-m ediated apoptosis in  WEHI-231 cells is independent of 
cytochrome C translocation  from the m itochondria  [78], In  co n tras t, 
cytochrome C release to such cytosolic fractions w as easily  detectab le  
w ith in  4h following trea tm e n t of J u rk a t  cells w ith  an ti-F as antibodies 
(not shown). Moreover, in situ  im m unofluorescence analysis of in ta c t  
cells showed th a t  w hilst cytochrome C rem ained  localised to th e  
m itochondria following stim ula tion  of WEHI-231 cells w ith  an ti-Ig , 
cytochrome C release to the  cytosol could be strongly  detected (fig. 30) 
following stim ula tion  w ith  the  cell perm ean t sphingolipid, Cg-ceramide 
(25 pM) which can induce apoptosis of WEHI-231 B cells via the  c lassical 
C aspase-dependent rou te  [194].
Sim ilarly, a lthongh  there  appears to be a very  low level of co n stitu tiv e  
Caspase activ ity  in  u n trea ted  W EHI-231 cells, re su ltin g  in th e  
generation  of low levels of the  cleaved form of PARP, no stim ula tion  of 
Caspase 3 activity, as evidenced by the  lack of s tim u la ted  cleavage of 
PARP (fig. 29) or Bcl-x^ (not shown) was observed following s tim u la tio n  
(for up to 48h) of these im m ature  B cells via the  an tigen  receptors. In  
contrast, PARP cleavage w as easily detectable w ith in  24h following 
cu ltu re  w ith  Cg-ceramide (25pM; fig. 29c). These resu lts  were ag a in  
confirmed by in situ  im m unofluorescence analysis w hich showed th e  
presence of cleaved PARP fragm ents in  in tac t cells s tim u la ted  w ith  Cg- 
ceram ide b u t not an ti-Ig  (fig. 30). In teresting ly , and consisten t w ith  sig- 
m ediated induction of m itochondrial PLAg activation playing a key role in  
an ti-Ig-stim ulated  apoptosis of W EHI-231 im m ature  B cells, we find th a t  
w hilst addition of exogeneous arachidonic acid (25pM) induces apoptosis 
(fig. 18), it  does not stim ula te  activation of Caspase-3 and  re su lta n t PARP 
cleavage in  these cells (fig. 29c).
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3.8 Caspase inhibitors do not relieve BCR-mediated 
growth arrest or apoptosis
The failure of an ti-Ig  to induce a PARP-cleaving C aspase activ ity  or th e  
release of cytochrome C from the m itochondria of W EHI-231 im m ature  B 
cells suggested th a t an tigen  receptor-driven apoptosis of these  cells m ay  
occur in  a C aspase-independent m anner. To investigate  th is  possib ility  
fu rther, the  effect of C aspase inh ib ito rs on the  an tigen  recep to r-d riven  
grow th a rre s t and apoptosis of W EHI-231 im m atu re  B cells w as 
exam ined. In  order to control for the  efficacy of these  reagen ts  p a ra lle l 
experim ents were conducted dem onstra ting  th e ir ability  to p ro tec t 
against the C aspase-dependent grow th a rre s t and  program m ed cell 
death  of J u rk a t  T cells re su ltin g  from stim ula tion  via the  an tig en  
receptors (anti-CD3 or PHA), T N F-a or Fas death  receptors (not show n)
in order to determ ine w hether the  an tigen  receptors on W EHI-231 
im m ature  B cells (BCR) and J u rk a t  T cells (TCR/CD3 complex) u tilised  
different apoptosis pathw ays.
The role of individual Caspase subtypes in  these models of lym phocyte 
apoptosis w as assessed by the  use of selective C aspase inhibitors: (i) 
zVAD-fmk is considered to be a pan-C aspase inh ib ito r [272] w ith  a h ig h  
affinity for the  C aspase-1-like subfam ily and a lower affinity for th e  
Caspase-3-like subfam ily [273]; (ii) Ac-DEVD-CHO shows g rea te r affin ity  
for Caspase-3 th a n  for the C aspases-1, -4 and -7; (iii) zVEID-fmk is a 
potent C aspase-6 inh ib ito r which has little  effect on Caspase-3, -4, -7 and  
-8 [73]. zVAD-fmk w as able to completely reverse Fas-m ediated g row th  
a rre s t and partia lly  overcome anti-CD3 and, to a  lesser extent, TNF-a-
induced growth ^ rre s t (fig. 31 and resu lts  not shown), findings co n sis ten t 
w ith  previously published studies [270]. However, Ac-DEVD-CHO and
zVEID-fmk were unable  to rescue e ither Fas- or TN F-a-m ediated  g row th
a rre s t (fig. 31 and resu lts  not shown). N evertheless, and  in  ag reem en t 
w ith  previous studies [238, 274], all th ree  inhib itors, a lbeit to a lesse r 
extent, zVEID-fmk, were able to prevent Fas-m ediated apoptosis of J u r k a t  
T cells (fig. 31).
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In  con trast, none of these  inh ib ito rs had  any effect on an ti-Ig -m ed iated  
grow th a rrest, Annexin V binding, cell cycle progression or nuclear DNA 
loss (subdiploid cells) of W EHI-231 im m ature  B cells (figs. 32-33 and n o t 
shown). However, zVAD-fmk (ln M -10 pM, m axim al 1 nM), Ac-DEVD- 
CHO (m aximal >100 pM) and  z-VEID-fmk (>10 pM) were able to p a rtia lly  
block Cg-ceramide induction of nuclear DNA loss (but not grow th a rre s t, 
fig. 32) in WEHI-231 B cells (fig. 33 and resu lts  not shown) and both z- 
VAD-fmk and Ac-DEVD-CHO were able to inh ib it apoptosis of G erm inal 
Centre (PNA^) B cells (see section 5.4), re su lts  dem onstra ting  the  efficacy 
of these inh ib ito rs in  B cell system s. In addition, w h ilst tre a tm e n t of 
W EHI-231 cells w ith  Cg-ceramide can induce activa tion  of a  Caspase 3- 
like activity, which can be blocked by the  Caspase 3 inh ib ito r, Ac-DEVD- 
CHO, crosslinking of the  BCR for up to 24h (2, 5, 8 and  24h) does n o t 
induce activation of th is C aspase (fig. 33 and not shown).
3.9 Non-paspase proteases involved in the 
execution phase of BCR-induced apoptosis
A wide range of protease inh ib ito rs were employed in  a search  for th e  
specific protease involved in  the  proteolytic activ ities w hich are p a rt of 
any proliferative and apoptotic responses. While h igh  concentra tions of 
zVAD-fmk, TLCK and chy mo s ta tin  had  some effect on grow th a r r e s t  
and/or DNA degradation, th e ir lack of specificity a t these  levels p rev en ts  
a conclusive explanation  about the  n a tu re  of these  proteases. Table 2 
sum m arises the  effects of m ost protease inh ib ito rs tested . S u rp ris in g ly , 
in m ost cases, the  inh ib ito rs were effective in relieving grow th a rre s t. 
This evidence supports rela tively  early  involvem ent of pro tease  ac tiv ity  
in BCR-signalling of W EHI-231 cells, as suggested by o thers [78].
The cathepsin  B inhibitor, EST [275] was capable of inh ib iting  sig- 
m ediated apoptosis, b u t not grow th arrest, of W EHI-231 cells (as 
indicated by loss of nuclear DNA content, fig. 34a). In  addition, w h ils t 
crosslinking of the  BCR does no t induce activation  of Caspase-3 activ ity , 
it does stim ulate  the  cleavage of the  C athepsin  B su b stra te , zRR-pNA (z- 
Arg-Arg-pNA; fig. 34b). Moreover, a lthough  inh ib ition  of sig -m ediated
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apoptosis by EST w as m axim al by InM , the  percentage of subdiploid cells 
resu ltin g  from stim ula tion  w ith  Cg-ceramide was not reduced by th is  
reagen t a t concentrations of EST <10pM (fig. 34a), providing fu r th e r  
evidence th a t  an ti-Ig  and  Cg-ceramide stim ula te  apoptosis of W EHI-231 
cells by distinct^ m echanism s. D espite p reven ting  BCR-driven apoptosis, 
EST did not block an ti-Ig -stim u lated  grow th a rre s t (fig. 35a) nor did it
p reven t an ti-Ig  driven collapse of A\\f^ (fig. 35b). In  con trast, zVAD-fmk
(InM-lOOpM) w as able to block Cg-ceramide, b u t no t an ti-Ig -m ediated
d isrup tion  of A\|/^ in W EHI-231 cells. Taken together, these  re s u lts
suggest th a t  the  execution phase of BCR-driven apoptosis is m ediated by 
C athepsin  B (or sim ilar pro teases) ra th e r  th an  by effector Caspases.
3.10 The nature of the involvement of p53 and 
related proteins in proliferation and apoptosis of 
WEHI-231 cells
Exogenous p53 can be recru ited  w ith in  hours during  BCR-induced cell 
death  of WEHI-231 cells [114]. Only very low levels of endogenous p53 a re  
detectable in  W EHI-231 cells [213]. An increase above basal levels in p53 
has been observed for both proliferative and apoptotic stim uli, w ith o u t 
su b s tan tia l a lte ra tion  of phosphorylation levels (fig. 36a). However, a 
su b s tan tia l increase in  Mdm2 levels w as observed in response to an ti-Ig  
trea tm en t, suggesting th a t  th e  BCR signal is reg u la tin g  p53 levels, a t  
least in part, by ta rg e tin g  it for degradation  (fig. 36b). A lthough d irec t 
in terac tion  of  ^p53 and M dm2 is hard  to investiga te  by co- 
im m unopercipitation, because of blockage of m ost epitopes by th e  
antibody in te rac tion  itself, in  some cases cleaved p53 or M dm2:p53 
complexes are  detectable even following resolution by SDS-PAGE (fig. 
36b: upper band). One of m ost im portan t m ediator of p53 activ ity  a t th e  
S ta rt restric tion  point appears to be p l 6 [89]. This pro tein  is b a re ly  
detectable in  W EHI-231 cells, although it  m ay slightly induced by an ti-Ig  
trea tm en t and abolished by anti-CD40 and IL-4 tre a tm e n ts  (fig. 36c), 
suggesting th a t  it m ay be involved in  BCR-induced apoptosis.
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An im portan t factor of p53 signalling  in grow th a rre s t  and  apoptosis 
pathw ays, appears to be the  involvem ent of the  pro tein  Rb. This p ro tein , 
however, appea ls  to be hard ly  affected by any of the  stim uli in  th is  
system. I t displays a  cyclic behaviour in w hich levels peak  a t 24 h o u rs  
regard less of trea tm e n t {n~3). In  exam ining th is  tim e point, Rb is 
dephosphorylated in response to an ti-Ig  trea tm e n t and co-incubation  
w ith anti-CD40 induced a m iddle band, which m ay reflect sufficien t 
phosphorylation of Rb to enable en try  to the  cell cycle (fig. 36d). No 
association of Rb w ith  one of its m ain  dow nstream  m ediators, the  h istone  
deacetylase HD AC-1 [103], which is expressed in low levels in W EHI-231 
cells, could be detected, under any of the  conditions tested . In te re s tin g ly , 
p l30 , a  Rb fam ily m em ber [276], was induced a t 24h by the  rescue signa l 
and it  m ay be th a t th is  is more im portan t th an  Rb in  the  re tu rn  of W EHI- 
231 into the  cel^ cycle (fig. 36e). Sim ilarly, p l3 0  w as induced by AA p lus 
anti-CD40, in  com parison to AA trea tm en t.
3.11 Discussion
Com m itm ent to an tigen  receptor-driven apoptosis of the  B cell lym phom a, 
WEHI-231 correlates w ith  m itochondrial phospholipase Ag ac tiv a tio n  
leading to d isrup tion  of m itochondrial function and  ATP depletion. 
R a ther surprising ly , however, such apoptosis is executed independen tly  
of Caspase activation  and instead , the  executioner phase appears to 
involve the  BCR-driven, post-m itochondrial activation  of the  p ro tease  
cathepsin  B. This novel m echanism  of B cell apoptosis is supported by 
several lines of evidence: firstly, it  w as dem onstra ted  a  pivotal role for 
m itochondrial function in  determ in ing  com m itm ent to B cell surv ival or 
apoptosis by showing th a t  cPLAg expression and m itochondrial activity  is 
upregu la ted  under conditions of sig-driven  apoptosis and  dow nregu la ted
during  CD40-m ediated rescue (figs. 18-19 and 29). Secondly, the  A\\f^ is
d isrup ted  resu ltin g  in  depletion of cellu lar ATP un d er conditions of 
apoptotic, b u t not proliferative, signalling via th e  BCR (fig. 17).
Im portan tly , such collapse of A\\f^ can be m im icked by addition of 
exogeneous arachidonic acid w hilst d isrup tion  of Axj/ ,^ ATP-depletion an d
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apoptosis can be blocked by rescue signals v ia CD40 or by A\|/^ s tab ilise rs
&
such as antim ycin or oligomycin (figs. 13-14). Thirdly, i t  w as shown th a t  
activation of C aspases is no t essen tia l for com m itm ent and post- 
m itochondrial execution of BCR-m ediated apoptosis by d e m o n s tra tin g  
th a t  apoptotic signalling via the  BCR or following addition of exogeneous 
arachidonic acid does not induce e ither the  release of cytochrome C from 
m itochondria which is requ ired  for the  activation of the  C aspase-3 
cascade [72, 277] nor does it cause cleavage of PARP (figs. 19 and 29) or 
Bc1-Xl (resu lts not shown) w hich have been reported  to be su itab le  
m arkers of Caspase-3-like effector activity in  various cell types [270, 271]. 
Indeed, apoptotic signalling  via  the  BCR in W EHI-231 B cells does no t 
appear to stim u la te  the  activation  of Caspase-3 (fig. 33). C onsisten t w ith
this, BCR-m ediated d isruption  of A\\r^ and  com m itm ent to apoptosis takes 
place in  the  presence of C aspase inh ib ito rs (figs. 32-33) ind icating  th a t  
none of the  known in itia to r or effector C aspases are  essen tia l for th e  
com m itm ent or execution of BCR-induced apoptosis of W EHI-231 
im m ature  B cells. R ather, apoptotic signalling  via the  BCR stim u la te s  
the  post-m itochondrial activation  of the  protease, ca thesp in  B (figs. 34- 
35) which has previously been shown to be a key executioner pro tease  in  
a lternative  m echanism s of apoptosis w hich have recen tly  been described  
[74]. T hat th is PLA^-dependent m echanism  of m itochondrial function is 
likely to be a key checkpoint of antigen-driven cell fate  is evidenced by th e  
dow nregulation  ^of PLAg activation  and expression, and  protection of 
m itochondrial function, resu lting  from signalling via CD40 w hich effects 
rescue from BCR-m ediated apoptosis in these W EHI-231 im m ature  B 
cells.
ATP depletion resu ltin g  from oxidant-induced calcium  release from 
m itochondria followed by excessive calcium  cycling and collapse of A\]/  ^
has been proposed to be a  h a llm ark  of apoptosis [43]. In te re s tin g ly , 
production of ROS been previously been shown to increase following 
apoptotic signalling  via sIg on WEHI-231 im m atu re  B cells [269]. 
Moreover, CD40 signalling, w hich rescues these cells from apoptosis, 
leads to an  increase in  the  expression of Bcl-x^ ([158] and  figs. 24 and 26) 
w hich preven ts accum ulation  of in trace llu la r oxidants [158, 269], blocks
75
thapsigarg in -induced  in trace llu la r  m obilisation of calcium  from th e
endoplasm ic reticu lum  [278] and  stabilises and  m itochondria l
hom eostasis [243]. However, observations th a t  the  m itochondria l 
inhibitors, antim ycin and oligomycin, which will induce the  production of 
ROS [42], protect again st sig-m ediated ATP depletion and  apotosis (fig.
13), argue against a role for ROS in  BCR-driven collapse of Ai;/^ in  W EHI-
231 B cells. C onsistent w ith  th is, it  has recently  been show n th a t  r a th e r  
th a n  induce apoptosis, low levels of ROS appear to exert m itogenic or 
anti-apoptotic effects [279, 280].
An a lte rna tive  candidate apoptotic pa thw ay  for the  collapse of Aij/m and  
ATP depletion involves the  stim ulation  of m itochondrial phospholipase Ag 
activ ity  resu ltin g  in  the  accum ulation of u n sa tu ra te d  fa tty  acids 
(arachidonic acid) w hich have been reported to a lte r  the  perm eability  of 
the m itochondrial inner m em brane resu ltin g  in the  collapse of A\\f^ [43,
257-259], Indeed, w hereas apoptotic signalling via sig  up regu la tes cPLAg 
expression, induces its translocation  to the m itochondria and  s tro n g ly  
stim ula tes cPLAg activity (figs. 18, 19, 29 and re su lts  no t shown), rescue  
from BCR-m ediated apotosis by co-stim ulation via CD40 dow nregu la tes 
cPLAg expression and uncouples sig  from cPLAg translocation  an d  
signalling in  W EHI-231 im m ature  B cells (figs. 18, 19, 29 and resu lts  no t 
shown). In  addition, and  consisten t w ith  a role for cPLAg in  th is  sig- 
m ediated, m itochondrial-dependent m echanism  of apoptosis, addition of
exogeneous arachidonic acid induces a profound collapse of Aij/^ and  
re su lta n t induction of grow th a rre s t [171] and apoptosis (fig. 18) in  
W EHI-231 im m ature  B cells. T aken together, these re su lts  suggest t h a t  
sig-m ediated induction of m itochondrial PLAg and  generation  of
arachidonic acid m ay play a key role in  the collapse of A\j/^ and  
com m itm ent to apoptosis in  W EHI-231 im m ature  B cells.
The Bcl-2 fam ily proteins are d ifferentially  expressed during  B cell 
developm ent [281, 282]. W hereas Bcl-x^ is expressed in  im m atu re  and  
tran s itio n a l B cells, Bcl-2 appears to be the  p redom inan t fam ily m em ber 
expressed in m atu re  cells [8]. Recently, o ther an ti-apoptotic m em bers, 
such as M cl-l, have been suggested to play an  im p o rtan t role in  su rv iv a l
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a t different stages of B cell developm ent [282]. M any m em bers of the  Bcl-2 
fam ily have been shown to ta rg e t calcium and/or m itochondria l 
responses [65, 76, 283]. However, the  lack of evidence for a d ifferent mode 
of action betw een anti-apoptotic Bcl-2 proteins [284], for exam ple, m akes 
it  h a rd  to assess w hat role plays induction of Bcl-x^ and  A1 by anti-C D 40 
trea tm en t of B cells [269, 278, 285, 286], N onetheless, over-expression of 
either Bcl-2 or Bcl-x^ were shown to a lte r B cell developm ent 
considerably. Perhaps m ost im portan tly , w hilst over-expression of Bcl-x^ 
is sufficient to enable self-reactive B cells to escape negative selection in  
the bone m arrow  [287], no such correlation has been found w ith  Bcl-2 
expression [288], which, by con trast can rescue GC B cells from apoptosis 
[289, 290].
The Bcl-2 family, w hich has been proposed control the  effector C aspase 
cascade (i.e. the  m em bers of Caspase-3-like subfamily), appears to act in  a 
non-conventional m anner in  W EHI-231 cells. For exam ple, an ti-IgM  
trea tm en t causes a  decrease in  the  expression of m ost of the  Bcl-2 fam ily 
m em bers, regard less of th e ir  known function. M oreover, anti-C D 40 
trea tm en t alone appears to provoke a tra n s ie n t increase  in  pro-apoptotic 
protein  levels. Therefore, long-term  induction of Bcl-x^ expression in th e  
m itochondria is essen tia l for the  rescue of W EHI-231 cells (fig. 26) and  
probably blocks BCR-induced Bid and  Bad pro-apoptotic activ ities th e re  
(fig. 27), F u rth e r  experim ents in W EHI-231 cells overexpressing Bcl-x^ 
can elucidate more about the  modes of action of Bcl-x^ in  re la tion  to o th er 
pa rts  of the  apoptotic pa thw ay  described here, especially cPLAg 
activation and ATP depletion. P re lim inary  resu lts  in  th is d irec tion  
already show th a t  Bcl-x^ over-expression can override BCR-induced 
m itochondrial cPLAg activation^\
C aspases are  u sually  regarded  as essen tia l to the  induction  of cell d ea th  
in the im m une system  (for review see [50, 69]). N evertheless, there  is 
increasing evidence th a t  apoptotic stim uli which differ from the  TN F/Fas 
cascades m ay not necessarily  u tilise  effector (Caspase-3-like) C aspase 
cascade [291]. The m echanism s dow nstream  of m itochondrial m em brane  
depolarisation and ATP depletion have not, as yet, been delineated.
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However, the  failure of an ti-Ig  to induce a PARP-cleaving C aspase 
activ ity  or the  release of cytochrome C from the m itochondria  of W EHI- 
231 im m ature  B cells (figs. 19-20 and 29-30) suggested th a t  B C R -driven 
apoptosis of these cells is no t dependent on Caspase activation. This 
suggestion is supported by findings here th a t signalling  via sig  does n o t 
induce Caspase-3 activation and  th a t  Caspase inh ib ito rs did not p rev en t 
BCR-m ediated grow th a rre s t and  apoptosis in  such cells (fig. 33). A t f irs t  
sight therefore, these resu lts  appear to conflict w ith  previously pub lished  
reports which showed th a t  sig  w as coupled to the  activa tion  of C aspases 
and th a t  such Caspase activation played a role in  sig-m ediated  apoptosis 
of W EHI-231 [194, 2921. However, by using  z-VAD-fmk a t h ig h  
concentrations (>100pM) we have been able to reproduce some of th e  
effects of C aspase inh ib ito rs on sig-m ediated apoptosis p resen ted  in th e  
earlier papers: these  ap p aren t differences m ay therefore sim ply reflect 
the  use of high concentrations (>20pM) of C aspase inh ib ito rs in  th e  
earlie r studies as it  is now widely recognised th a t  a t co n cen tra tio n s 
>10pM, z-VAD-fpk will inh ib it o ther cysteine pro teases such as C alpa in  
[78] and C athepsin  B [74]. C onsisten t w ith  th is, apoptotic signalling  v ia  
the BCR stim u la tes cathepsin  B activity  (fig. 34) and the  post- 
m itochondrial stages of an tigen  receptor-driven apoptosis in  W EHI-231 
im m ature  B cells are  blocked by the cathepsin  B inh ib ito r EST (fig. 34). 
S im ilarly, BCR-m ediated apoptosis can  also be preven ted  by the  se rin e  
and cysteine protease-selective, C aspase-independent inhib itor, TLCK 
[73, 293] and p a rtia lly  by the  calpain and/or cathepsin -selec tive  
inhib itors, leupeptin , an tip a in  and  pepsta tin  (table 2) [293-295].
In teresting ly , recen t evidence now suggests th a t  ATP depletion can lead 
to the induction of DNA fragm en ta tion  and consequent apoptosis in  a 
C aspase-independent, b u t TLCK or TPCK-sensitive, p ro tease-dependen t 
m anner [296]. T aken together, these  findings suggest th a t, in  addition to 
an  inability  to drive the  energetically  unfavourable reactions involved in  
the  metabolic, b iosynthetic and signal tran sd u ctio n  processes req u ired  
for cell survival and cell cycle progression [234, 236, 279, 297, 298], ATP 
depletion can trigger the  post-m itochondrial activation  of a cathepsin-B -
Lord, C. And M , M . Harnett, personal com m unication .
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like protease-dependent m echanism  of DNA fragm en ta tion  and apoptosis 
in W EHI-231 B cells stim ulated  via the  BCR.
Finally, C aspase inhibitors w ere found to block sig-m ediated  apoptosis of 
G erm inal C entre (PNA"^) B cells suggesting th a t  B cells m ay employ 
d istinct m a tu ra tio n  stage-specific m echanism s of apoptosis. However, 
th is rescue by Caspase inh ib ito rs is only p a rtia l and  m ay reflect th e  
resu lts  of a recen t study  w hich show th a t  apoptosis of h u m an  G erm inal 
C entre B cells requ ires the  activation  of both C aspase and C a th ep sin  
activities, the  C athepsin  activ ity  being dow nstream  of C aspase 3 and  
responsible for exonuclease activ ity  and execution of apoptosis [275]. 
Taken together w ith  C aspase-dependent processes of apoptosis observed 
in  Ju rk a t  T cells therefore, these  resu lts  m ay suggest th a t  there  is a 
fundam ental difference in  the  w ay th a t  the  an tigen  receptors on B and T 
cells signal com m itm ent to grow th a rre s t and  apoptosis and  th is  proposal 
could reflect recen t reports th a t  w hilst Caspase-deficient mice exhib ited  
ab e rran t T cell developm ent, they  did not appear to have s ig n ifican t 
defects in  B cell selection and developm ent [230, 231, 299].
3.12 Summary
C rosslinking of the  an tigen  receptors on the  im m atu re  B cell 
lym phom a,W EHI-231, leads to grow th a rre s t and  apoptosis. C om m itm ent 
to such BCR-m ediated apoptosis has been found here  to include two 
im portan t cellu lar aspects:
• Induction of specific m itochondrial-associated activities: m itochondria l 
phospholipase Ag activation, arachidonic acid-m ediated collapse of
and ATP depletion.
• C athepsins, and not C aspases, are the  active k iller proteases. T his
apoptotic signal also does not induce release of cytochrome C.
D isruption  of ATP-depletion and apoptosis can be prevented  by
rescue signals v ia  CD40 or by A\\f^ stab ilisers. CD40 also causes a n  
increase in of Bcl-x^ pro tein  levels and p reven ts the  pro-apoptotic 
proteins from the  Bcl-2 family, Bad and Bid from en te ring  th e  
m itochondria .
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Fig. 10
F ig u re  10: L ig a tio n  o f  th e  BCR in d u c e s  g r o w th  a rrest a n d  
a p o p to s is  o f  WEHI-231 im m atu re  B cells. G row th a rre s t w as 
assessed by m easu rem en t of anti-Ig-m ediated  suppression  of DNA 
synthesis by WIj<HI-231 B cells (a). W EHI-231 B cells w ere trea ted  for 48 
hours w ith  O-lOmg/ml of anti-IgM  and levels of [^H]-Thymidine 
incorporation into DNA m easured. D ata  are expressed as m eans ± SD 
{n-3) from a single experim ent. Apoptosis w as also analysed  by A nnex in  
V (open bars, y-axis) binding to cell surface phospha tidy lse rine , 
propidium  iodide sta in ing  (panel b, filled bars), of subdiploid DNA (panel 
b, open bars; lOpg/ml anti-Ig), and  DNA laddering  (c) a t 48h post­
stim ulation  w ith the  indicated concentration of anti-Ig. All d a ta  are  from 
single experim ents rep resen ta tive  of a t least two o ther independen t 
experim ents.
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F ig u re  11: T he t im in g  o f  CD40 m ed ia ted  r e sc u e  from  BCR- 
in d u ced  a p o p to sis . W EHI-231 cells were trea te d  w ith  an ti-IgM  
(lOvig/ml) and/or anti-CD40 (lOpg/ml) for 48h. DNA content w as 
m easured  by PI incorporation. Subpopulations w ere determ ined as 
described in  M aterials and  M ethods  and  % of cells calculated  from th e  
to ta l >2N DNA population.
81
a.
■ Ill ii^ ii ili|
109
c.
1250  »
7 5 0  "
5 0 0  " □
o
2 5 0  “
1510 2 0  250 5
Tim e (h)
Tim e (h)
70
I
Cl
6 0 -
I
Q §  4 0 -
g
I  3 0 -
O
S 20-1
1
• v P 10 -
20 2515100 5
□  N o n e
B  anti-Ig
0 an ti-C D 40
#  anti-Ig + 
an ti-C D 40
Fig. 12
F ig u re  12: A n ti-Ig -m d u ees  a  d ec re a se  in  th e  A\{/^  o f  W EHI-231 
im m atu re  B ce lls . W EHI-231 im m atu re  B cells (10® cells) were tre a te d  
w ith  O-lOpg/ml anti-IgM  and/or anti-CD 40. In  panel a, com m itm ent to 
apoptosis was assessed by m easurem ent of m itochondrial po ten tial (A\j/^) 
by the fluorescent dye, DiOCg (3) in  control (upper h istogram ) and  an ti- 
Ig-treated  W EHI-231 cells (lower histogram ) 24h post stim ulation . A
decrease in  A\|/^ is indicated  by decrease in  m ean fluroescence in te n s ity
(MFI) of DiOCg (3) stain ing . In  panel b, the d a ta  are  rep resen ted  as th e  
m ean fluorescence in ten sity  of DiOCg (3) s ta in ing  to dem onstra te  th e  
extent of depolarisation w hereas in panel c th is d a ta  is p resen ted  as % 
cells of low m itochondrial potential. All d a ta  are  from single experim en ts 
rep resen ta tive  of a t least two o ther independent experim ents.
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F ig u re  13: An^i-CD40 an d  m ito ch o n d r ia l in h ib ito r s  p r e v en t BCR- 
d r iv en  a p o p to s is  an d  c e ll c y c le  arrest in  G /G i. In  panel a, an ti-Ig  
(10pg/m l)-m ediated apoptosis of W EHI-231 cells w as blocked by 
costim ulation w ith  anti-CD40 (lOpg/ml) or the  m itochondrial in h ib ito rs , 
antim ycin (50ng/ml) or oligomycin (8ng/ml). In  panel b, an ti-Ig  (lOpg/ml)- 
m ediated grow th a rre s t of W EHI-231 cells was blocked by costim u la tion  
w ith  anti-CD40 (lOpg/ml) or the  m itochondrial inh ib ito rs, an tim y cin  
(50ng/ml) or oligomycin (8ng/ml). Apoptosis and cell cycle p rogression  
was m easured  by PI sta in in g  of DNA content as decribed in M ateria ls  
and  M ethods.
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F ig u re  14: M ito ch o n d r ia l in h ib ito r s  b lo ck  m ito c h o n d r ia l
p o te n tia l d e p o la r isa tio n . W EHI-231 im m ature  B cells were tre a te d  
w ith  O-lOpg/ml anti-IgM  w ith  or w ithout an tim ycin  (50ng/ml) or
oligomycin (8ng/ml). M itochondrial po ten tial (A\)/^) w as assessed  by th e
fluorescent dye, DiOCg (3). A decrease in  A\\f^ is ind icated  by decrease in
m ean fluorescence in ten sity  (MFI) of DiOCg (3) s ta in in g  (open bars) or 
the percentage of cells w ith  low m itochondrial po ten tial (close bars). All 
da ta  are from single experim ents rep resen ta tive  of a t least two o th e r 
independent experim ents.
85
8 □ sub-diploid 
O Go/G,
0 0.001 0.01
Cyclosporin A (pM)
Fig. 15
F ig u re  15; T he e ffe c t  o f  c y c lo sp o r in  A  on  a p o p to s is  an d  g r o w th  
arrest, W EHI-231 cells were trea ted  w ith  anti-IgM  (lOpg/ml) an d  
cyclosporin A (O-lOpM) for 48h. DNA content w as m easured  by PI 
incorporation. % of sub-diploid cells w as determ ined as the  <2N DNA 
population, % of cells in  Gq/Gj are  shown as calcu lated  from the  >2N 
("living") DNA population.
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F ig u re  16; E ffec t o f  N itr ic  O xid e S y n th a se  in h ib ito r s  o n  BCR - 
in d u c ed  gro w th  arrest. G row th a rre s t was assessed by m easu rem en t 
of anti-Ig-m ediated suppression  of DNA synthesis by W EHI-231 B cells. 
WEHI-231 B cells (5x10^ per well) w ere trea ted  for 48h w ith  O-lOmg/ml of 
anti-IgM  and (a) 0-40pM L-NMMA or (b) 0-40pM L-NIL. Levels of [^H] 
thym idine incorporation into DNA were m easured  a fte r fu rth e r 4h. D a ta  
are expressed as m eans ± SD (n=3) from a single experim ent, 
rep resen ta tive  of a t least two o ther independent experim ents.
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F ig u re  17: A n ti-Ig  in d u c e s  ATP d e p le tio n  in  W EHI-231 B ce lls  
w h ic h  ca n  b e  r e sc u e d  b y  anti-C D 40 or m ito c h o n d r ia l in h ib ito r s .
W EHI-231 cells were trea ted  w ith  anti-IgM  (lOpg/ml) and/or anti-C D 40 
(lOpg/ml) for up to 30h and ATP content assessed  as indicated  in  
M aterials and  M ethods  (panel a). A nti-Ig -stim ulated  depletion of ATP in  
WEHI-231 B cells was blocked (panel b) by costim ulation  w ith  th e  
m itochondrial inhib itors, an tim ycin  (50ng/ml) or oligomycin (8ng/ml). 
D ata are  presen ted  as m eans ± SD (n=3) from single experim ents. All 
da ta  are from single experim ents rep resen ta tive  of a t least two o ther 
independen t experim ents.
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F ig u re  18: A n ti-Ig  in d u c e s  m ito c h o n d r ia l tr a n s lo c a tio n  a n d  
a c tiv a t io n  o f  c y to so lic  p h o sp h o lip a se  Ag r e su lt in g  in  
a r a c h id o n ic  a c id  g e n e r a tio n , d isru p tio n  o f  m ito c h o n d r ia l  
p o te n tia l an d  a p o p to sis . A nti-Ig (10 pg/ml) and  arachidonic acid (10- 
lOOpM) induce apoptosis of W EHI-231 cells as indicated  by DNA 
laddering 48b post-stim ulation  (panel a). Exogeneous arachidonic acid (5- 
lOOpM) induces collapse of m itochondrial po ten tial (as assessed  u s in g  
the  dye DiOCg (3); panel b: open bars) and induction of subdiploid DNA 
content (panel b: filled bars). All experim ents are single experim en ts 
rep resen ta tive  of a t least two o ther independent experim ents.
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F ig u re  19: A n ti-Ig  m o d u la te s  p h o sp h o lip a se  e x p r e ss io n  a n d  
a c tiv ity .
M itochondrial and  cellu lar phospholipase Ag activ ity  is induced by an ti-  
Ig (lOpg/ml) 24h post-stim ulation  (a). Expression of cPLAg p ro te in  
(W estern Blot; panel b) is m odulated during  apoptotic sina lling  in W EHI- 
231 im m ature  B cells: W EHI 231 cells were incubated  w ith  m edia (lanes 
1 and  5), lOpg/ml anti-IgM  (lanes 2 and 6), lOpg/ml anti-CD 40 (lanes 3 
and 7) or a  com bination of these stim uli (lanes 4 and  8) for 1 hour (lanes 
1-4) or 24 hours (lanes 5-8).
89
none
anti-Ig
anti-Ig+anti-CD40
%
F ig u re  20: cPLAg e x p r e ss io n  an d  m ito ch o n d r ia l tr a n s lo c a tio n .
The cell nucleus is sta ined  blue (DAPI), cPLAg (Texas red) and  
m itochondria (green). In  u n stim u la ted  W EHI-231 cells, th e re  is little  or 
no cPLAg expression (red) in  e ither the  nucleus, cytoplasm  (panel a; 
underestim ated  here  due to the  loss of soluble cPLAg during  sta in in g  (as 
reported  in [300]) or m itochondria (panel c). In  co n trast in  an ti-Ig-cells 
there  is indication of upregu la tion  of cPLA2 expression (panel a) and  
strong and diffuse nuc lear (purple, panels a, c & d) and  m itochondria l 
(yellow, panels c & d) translocation  by 3h. A lthough in  cells costim ulated  
w ith  anti-CD40 th ere  is still evidence of m itochondrial and  to a  lesse r 
extent, nuclear cPLAg localisation, th is  is more discrete (panels a, c & d) 
and there  is strong red cytoplasm ic sta in ing  (panels a, c & d). 
D ow nregulation of cPLAg by anti-CD 40 is not seen a t  3 h. panel a: 
sta in ing  of nucleus (DAPI; blue) and  cPLAg (Texas red); panel b: n u c leu s  
(blue) and m itochondria (anti-A N T+anti-rabbit-FITC ); panel c; nuc leus, 
cPLAg and m itochondria & panel d: as panel c4- brigh t field.
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F ig u re  21: E ffect o f  COX-2 in h ib ito r s  on  B C R -in d u ced  g r o w th  
arrest. Growth .arrest w as assessed by m easu rem en t of an ti-Ig -m ediated  
suppression of DNA synthesis by W EHI-231 B cells. W EHI-231 B cells 
(5x10^ per well) were trea ted  for 48h w ith  O-lOpg/ml of anti-IgM  and (a) 0- 
IpM  niflum ic acid or (b) O-lOpM NS-398. Levels of pH] thym id ine  
incorporation into DNA were m easured  after fu rth e r  4h. D ata  a re  
expressed as m eans ± SD {n-3)  from a single experim ent, rep re se n ta tiv e  
of a t least two other independent experim ents.
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F ig u re  22: E ffect o f  LOX in h ib ito r s  on  B C R -in d u ced  g r o w th  
arrest. Growth a rre s t w as assessed  by m easu rem en t of an ti-Ig -m ediated  
suppression of DNA syn thesis by W EHI-231 B cells. W EHI-231 B cells 
(5x10^ per well) were trea ted  for 48h w ith  O-lOpg/ml of anti-IgM  and (a) 0- 
lOpM pan-LOX inhib itor or (b) 0-lpM  Baicalein. Levels of pH] thym id ine  
incorporation into DNA w ere m easured  after fu rth e r 4h. D ata  a re  
expressed as m eans ± SD (n=3) from a single experim ent, rep re se n ta tiv e  
of a t least two o ther independent experim ents.
The pan-LOX inh ib ito r IC5Q values, according to the  m an u fac tu rer, a re  
estim ated  as follows: 12-LOX ~ O.lpM, 15-LOX ~ IpM , 5-LOX ~ lOpM.
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F ig u re  23: E ffec ts  o f  cera m id e  sy n th a se  in h ib ito r  on  BCR- 
in d u c ed  g ro w th  arrest. G row th a rre s t was assessed  by m easu rem en t 
of an ti-Ig-m ediated suppression  of DNA synthesis by W EHI-231 B cells. 
W EHI-231 B cells (5x10^ per well) w ere trea ted  for 48b w ith  O-lOpg/ml of 
anti-IgM  and 0-lpM  Fum onisin  B .^ Levels of pH] thym id ine  
incorporation into DNA were m easured  after fu rth e r  4h. D ata  a re  
expressed as m eans ± SD (ji-3 )  from a single experim ent, rep re se n ta tiv e  
of a t least two other independent experim ents.
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F ig u re  24: E x p ress io n  o f  a n ti-a p o p to tie  B cl-2 p r o te in s  in  
a p o p to s is  an d  su rv iv a l o f  W EHI-231 cells. W EHI-231 cells (10^ p er 
sample) were stim ula ted  as follows - 1: none 0; 2: an ti-Ig  (5pg/ml) 8h; 3; 
anti-CD40 (lOpg/ml) 8h; 4: anti-Ig+anti-C D 40 8h; 5: an ti-Ig  16h; 6: an ti-  
CD40 16h; 7: anti-Ig+anti-C D 40 16h; 8: an ti-Ig  24h; 9: anti-CD 40 24h; 
10: anti-Ig+anti-C D 40 24h; 11: an ti-Ig  48h; 12: anti-CD 40 48h; 13: an ti-  
Ig+anti-CD40 48h; 14: none 48h. At the  end of the  s tim u la tion  cells w ere 
lysed and W estern  b lo tting  w as preform ed w ith  the  ap p ro p ria te  
antibodies as descibed in  M aterials and  M ethods.
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F ig u re  25: E x p ress io n  o f  p ro -a p o p to tic  B cl-2 p r o te in s  in
a p o p to s is  an d  su r v iv a l o f  WEHI-231 cells. W EHI-231 cells (10^ per 
sample) were stim u la ted  as follows - 1: none 0; 2: an ti-Ig  (5pg/ml) 8h; 3: 
anti-CD40 (lOpg/ml) 8h; 4; anti-Ig+anti-C D 40 8h; 5; an ti-Ig  16h; 6: an ti- 
CD40 16h; 7: anti-Ig+anti-C D 40 16h; 8 : an ti-Ig  24h; 9: anti-CD 40 24h; 
10: anti-Ig+anti-C D 40 24h; 11: an ti-Ig  48h; 12: anti-CD 40 48h; 13: an ti- 
Ig+anti-CD40 48h; 14: none 48h. A t the  end of the  stim u la tion  cells w ere 
lysed and W estern b lotting w as preform ed w ith  the  ap p ro p ria te  
antibodies as descibed in  M aterials and  M ethods.
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F ig u re  26: E x p ress io n  an d  m ito ch o n d r ia l tr a n s lo c a tio n  o f  a n ti-  
a p o p to tic  B cl-2 p ro te in s . W EHI-231 cells (10® per sam ple) w ere 
stim ulated  w ith  media, an ti-Ig  (lOpg/ml) or anti-Ig+anti-C D 40 (lOpg/ml) 
for 3h and th en  were subjected to in trace llu la r s ta in in g  as described in  
M aterials and  M ethods, For the  detection of A l, an ti-goat-b io tin  and  
streptavid in-T exas Red were used. For the detection of Bcl-2, M cl-l or 
Bcl-x^, anti-m ouse-gam m a-chain-biotin  and strep tav id in -T exas Red w ere  
used. For m itochondria sta in in g  in  A l, Bcl-2 and M cl-l sam ples 
M itoTracker G reen w as used. For Bcl-x^ sam ples, R hodam ine 123 w as 
used for m itochondria stain ing.
In  each set of panels, the  cell nucleus is sta ined  blue (DAPI), the  p ro te in  
(Al, Bcl-2, M cl-l or B cl-xJ in  red and m itochondria is green. The left 
panel shows nucleus plus protein, the  middle panel m itochondria  p lus 
protein  and the  righ t panel all colours superim posed.
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F ig u re  27: E x p re ss io n  an d  m ito ch o n d r ia l tr a n s lo c a tio n  o f  pro- 
a p o p to tic  Bcl-2 p ro te in s . W EHI-231 cells (10® per sam ple) w ere 
stim ula ted  w ith  media, an ti-Ig  (lOpg/ml) or anti-Ig+anti-C D 40 (lOpg/ml) 
for 3h and th en  were subjected to in trace llu la r s ta in in g  as described in  
M aterials and  M ethods. For the  detection of Bid or Bad, an ti-goat-b io tin  
and streptav id in-T exas Red were used. For the  detection of Bax or Bak, 
anti-m ouse-gam & na-chain-biotin and streptav id in-T exas Red were used. 
For m itochondria sta in ing  in  Bad and  Bak sam ples M itoTracker G reen  
was used. For Bid and Bax sam ples, anti-ANT and anti-rabbit-F IT C  w ere 
used for m itochondria stain ing.
In  each set of panels, the  cell nucleus is sta ined  blue (DAPI), the  p ro te in  
(Bad, Bak, Bax or Bid) in  red  and m itochondria is green. The left panel 
shows nucleus plus protein, the  m iddle panel m itochondria  plus p ro te in  
and the  righ t panel all colours superim posed.
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F ig u re  28: Bcl-x^ o v e r -ex p re ss io n  b lock s BCR- a n d  A A -in d u ced  
a p o p to s is  in  WEHI-231 ce lls . WEHI-231-neo and  W EHI-23 l-Bcl-x^ 
cells w ere trea ted  w ith  m edia, anti-IgM  (lOpg/ml) or AA (lOOpM) for 48h. 
DNA content was m easured  by P I incorporation, (a) % of sub-diploid cells 
was determ ined as the  <2N DNA population, (b) % of cells in  Gq/Gj a re  
shown as calculated from the  >2N DNA population.
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F ig u re  29: A n ti-Ig  d o es  n o t in d u c e  m ito c h o n d r ia l r e le a se  o f  
cy to ch ro m e C n o r  PA R P c le a v a g e  in  W EHI-231 B ce lls
M itochondrial release of cytochrome C w as assessed  by W estern  Blot 
analysis of whole cell lysate  and m itochondria-free fractions of W EHI-231 
B cells (panel a). W EHI 231 cells were incubated  w ith  m edia (lanes 5 and  
9), lOpg/ml anti-IgM  (lanes 2, 6 and 10), lOpg/ml anti-CD 40 (lanes 3, 7 
and 11) or a com bination of these stim uli (lanes 4, 8 and  12) for 8 h o u rs  
(lanes 2-4), 24 hours (lanes 5-8) or 48 hours (lanes 9-12). Lanes 1 and 13 
are whole cell lysates of u n trea te d  W EHI 231 cells a t 0 and 48 hours, 
respectively. Lanes 2-12 are m itochondria-free ex trac ts  p repared  as 
described in  M aterials and  M ethods, (lane +) rep resen ts  purified  
cytochrome C (from chicken). Effector Caspase activation  as assessed by 
PARP cleavage w as determ ined W EHI 231 cells (b and c). In  panel b, 
WEHI-231 B cells were incubated  w ith  lOpg/ml anti-IgM  (lanes 2 and 5), 
lOpg/ml anti-CD40 (lanes 3 and 6) or a  com bination of these stim u li 
(lanes 4 and 7) for 24 hours (lanes 2-4) or 48 hours (lanes 5-7). Lanes 1 
and 8 are u n trea ted  W EHI 231 cells a t 0 and 48 hours, respectively. In  
panel c, W EHI-231 cells were trea ted  for 48 h  w ith  m edia (lane 1), an ti-Ig  
(lOpg/ml; lane 2), anti-CD40 (lOpg/ml; lane 3), an ti-Ig  plus anti-C D 40 
(lane 4), Cg-ceramide (25pM; lane 5) and  arachidonic acid (25pM; lane 6). 
All experim ents are single experim ents rep resen ta tive  of a t least two 
o ther independent experim ents.
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None 24 h Ceramide 24 h anti-Ig 24 h
Ceramide 5 h Ceramide 24 h anti-Ig 24 h
F ig u re  30: In  s i tu  a n a ly s is  o f  m ito c h o n d r ia l r e le a se  o f  
c y to ch ro m e C an d  c o n se q u e n t PARP c le a v a g e . The cell nucleus is 
sta ined  blue (DAPI), cytochrome C is red  (panels a-c), cleaved PARP is red  
(panels d-f & j-1) and  m itochondria are green (rhodam ine 123). 
Cvtochrome C : In  u n stim u la ted  (panel a) or an ti-Ig  (panel c)-treated  
WEHI-231 cells, th ere  is little  or no release of cytochrome C from th e  
m itochondria (yellow) even w hen com m itm ent to apoptosis h a s  
progressed sufficiently to generate  apoptotic nuclei (panel c). In  c o n tra s t, 
trea tm e n t w ith  ceram ide induces strong release (red) of cytochrome C. 
Cleaved PA RP: In  u n stim u la ted  (panel d) or an ti-Ig  (panel f) W EHI-231 
cells, there  is little  or no cleaved PARP (red) p resen t. In  co n tra s t, 
trea tm en t w ith ceram ide induces strong cleavage (red; panel e) of PARP. 
B right field v isua lisa tion  of these  cells is given in  panels g-i. A tim e 
course (panels i-1) shows th a t  there  is no PARP cleavage induced by 
ceram ide w ith in  5 h  (panel j) and  no PARP cleavage can be seen in  an ti- 
Ig-treated  cells even w hen com m itm ent to apotosis has progressed as far 
as the  generation  of apoptotic nuclei (panel 1). In  con trast, in  ceram ide- 
trea ted  cells cleaved PARP (red) is easily  detected in such cells (panel k). 
panels a-c: sta in ing  of nucleus (DAPI; blue), cytochrome C (texas red) an d  
m itochondria (rhodam ine 123, green); panel d-f: nucleus (blue) an d  
cleaved PARP (Texas red) ; panels g-h: b righ t field; panels j-1: s ta in in g  of 
nucleus (DAPI; blue), cleaved PARP (Texas red) and m itochondria  
(rhodam ine 123, green).
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F ig u re  31: C asp ase  in h ib ito r s  r e lie v e  a n ti-F a s-in d u c ed  g r o w th  
arrest and a p o p to sis  in  J u r k a t T ce lls . J u rk a t T cells w ere induced to 
undergo grow th a rre s t by the  an ti-F as (62.5 ng/ml) in  the  presence or 
absence of C aspase inh ib ito rs and  levels of [®H]-Thymidine inco rpo ra tion  
m easured. The d a ta  (m eans ± SD, n=3) in  panel a  have been no rm alised  
w ith  control u n stim u la ted  cells expressed as 100%. In  panel b, J u r k a t  
cells were trea ted  w ith  C aspase inh ib ito rs w ith  or w ithou t an ti-F as and  
apoptosis (subdiploid DNA content) assessed by propidium  iodide 
stain ing. All d a ta  are from single experim ents rep resen ta tiv e  of a t lea s t 
two other independent experim ents.
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F ig u re  32: C asp ase  in h ib ito r s  do  n o t b lo ck  a n t i- lg -m e d ia te d  
g ro w th  arrest in  WEHI-231 ce lls . WEHI-231 im m atu re  B cells w ere 
induced to undergo grow th a rre s t by anti-Ig  (lOpg/ml) or Cg-ceramide 
(25pM) in  the  presence or absence of Caspase inhib itors and  levels of PHj- 
Thym idine incorporation m easured  (m eans ± SD, n=3) ng/ml).
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F ig u re  33: C asp ase  in h ib ito r s  do n o t b lo ck  a n ti-Ig -m e d ia te d  
a p o p to s is  b u t do r e lie v e  cer a m id e-in d u c ed  a p o p to s is  in  WEHI- 
231 B ce lls . In  panels a  & b, W EHI-231 B cells were cu ltu red  w ith  m edia 
or an ti-Ig  (lOpg/ml) or ceram ide (25pM) for 48h in  the  presence and  
absence of the  indicated  concentration  of z-VAD-fmk (panel a) or lOOpM 
Ac-DEVD-CHO or lOpM z-VEID-fmk (panel b) before assessing  DNA 
content (PI sta in ing , panels a & b). In  panel c, W EHI-231 B cells w ere 
cu ltu red  w ith  m edia or an ti-Ig  (lOpg/ml) for 48h in the  presence and  
absence of of lOpM z-VAD-fmk or 2nM  Ac-DEVD-CHO or lOOnM z-VEID- 
fmk (panel b) before sta in ing  w ith  A nnexin V. In  panel d, W EHI-231 B 
cells were incubated w ith  m edia, an ti-Ig  (lOpg/ml) or ceram ide (25pM) in  
the presence or absence of the  Caspase 3 inhibitor, Ac-DEVD-CHO (In M  
or lOpM) for 24h and  cell lysates prepared. C aspase 3 activ ity  as 
evidenced by the  cleavage of the  Caspase-3 su b stra te , Ac-DEVD-pNa (N- 
Acetyl-Asp-Glu-Val-Asp-pNA) w as th en  assayed as described in  
M aterials a n d  M ethods. All d a ta  are from single experim en ts 
rep resen tative of a t lea s t two o ther independent experim ents.
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T able 2: S u m m ary o f  th e  e ffe c ts  o f  d ifferen t p r o tea se  in h ib ito r s  
on  th e  p ro g ress  o f  a p o p to s is  in  WEHI-231 cells . <=> - incdicates no
change observed; ft - a  reduction; ft - an  increase; and  ND - not done. In
values, an  increase m eans proportionaly  less cells in low 
m itochondrial po tential.
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F ig u re  34: A n ti-Ig -stim u la tes  th e  p o s t-m ito c h o n d r ia l a c t iv a t io n  
o f  c a th e p s in  B an d  th e  c a th e p s in  B in h ib ito r , EST b lo ck s B C R  
d r iv en  a p o p to s is  in  WEHI-231 B cells . W EHI-231 im m atu re  B cells 
were induced to undergo apoptosis by anti-Ig  (lOpg/ml) or Cg-ceramide 
(25pM) in  the presence or absence of the  indicated concentra tions of EST 
and the levels of subdiploid DNA content m easured  (panel a). In  panel b, 
W EHI-231 B cells were incubated  w ith  anti-Ig  (lOpg/ml) for 24h and cell 
lysates prepared. Caspase-3 and  C athepsin  B activ ity  as evidenced by 
cleavage of the  C aspase-3  su b stra te , Ac-DEVD-pNa (N-Acetyl-Asp-Glu- 
Val-Asp- pNA) or the  cathepsin  B su b stra te , zRR-pNA (z-Arg-Arg- pNA) 
was th en  assayed as described in  M aterials and  M ethods.
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F ig u re  35: T he c a th e p s in  B in h ib ito r , EST d o e s  n o t B C R -d riven  
grow th  arrest or m ito ch o n d r ia l p o te n tia l d e p o la r isa t io n  in  
WEHI-231 B cells. In  panel a, W EHI-231 B cells were cu ltu red  w ith  
m edia or anti-Ig  (10 pg/ml) or Cg-ceramide (25pM) for 48h in  the  presence 
and absence of the  indicated concentrations of EST before assess in g  
growth a rre s t as indicated by the  level of l^H]thymidine uptake. In  panel 
b, W EHI-231 B cells were cu ltu red  w ith  media, an ti-Ig  (lOpg/ml) or Cg- 
ceram ide (25pM) for 48h in  the  presence and absence of the ind icated  
concentrations of EST or z-VAD-fmk before assessing  the  resu ltin g  level 
of m itochondrial po ten tial by DiOCg sta in ing  as described in  M ethods.
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F ig u re  36: T he p53 n e tw o rk  in  a p o p to s is  an d  r e sc u e  o f  W EHI-231 
ce lls . W EHI-231 cells (10^ per sam ple) w ere s tim u la ted  as follows for 24h  
w ith  the  following trea tm en ts: none; anti-CD40 (lOpg/ml); IL-4 (lOU/ml); 
anti-Ig  (5pg/ml); anti-Ig+anti-C D 40; anti-Ig+IL-4; AA (25pM); A A +anti- 
CD40; +: positive (m acrophage lysate). At the  end of the  stim u la tion  cells 
were lysed and W estern  b lo tting  was preform ed as descibed in  M ateria l 
and M ethodsw iih  the  appropria te  antibodies: (a) anti-p53; (b) anti-M dm 2; 
(c) a n ti-p l6; (d) anti-Rb; (e) an ti-p l30 . Arrows in  panels a and  d ind ica te  
the m ultip le phosphorylation sta te s  of p53 and Rb. Lower arrow  in  panel 
b indicate M dm2 and upper arrow  indicate possible Mdm2:p53 complexes.
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Chapter 4. E X  VIVO  DEVELOPMENT OF WHOLE 
BONE MARROW CULTURES
4.1 Introduction
The question of how im m atu re  B cells are selected in  the  bone m arrow  
has been addressed in  m any different ways, using  both  cell line m odels 
[286, 301] and  by observing w h a t happens in vivo [8 , 12]. To date, there  is 
no agreem ent how th is  selection proceeds and w h a t are  the  lim itin g  
factors of the  selection process (reviewed in  [6, 11, 135]). The discovery of 
a tran s itio n a l s ta te  betw een im m atu re  and m atu re  B cells [8] h a s  
suggested th a t  these  are  in  fact th e  cells in  w hich selection occurs. 
Again, th is aspect of B cell developm ent is unc lear and  there  is some 
evidence th a t  the  m ajority  of tran sitio n a l B cells m igrate  to the  p erip h ery  
before th e ir selection [12].
Previous studies have employed several biochem ical and genetic  
approaches in  order to investigate  different fea tu res of the  c ru c ia l 
selection steps of B cell development.
Biochemical approaches have been taken  m ainly  w here it  has been 
possible to employ model system s. The m ost commonly used models are:
(i) Cell lines, such as W EHI-231 cells, which are  of an  im m atu re  (IgM^ 
IgD ) B cell phenotype. This approach has achieved m any  insigh ts in to  
the  signals involved in  the  deletion and  rescue of im m atu re  B cells, as 
discussed in  chap ter 1. Cell line models are unsa tisfac to ry , though, in  
some ways. For example, there  is difficulty in te rp re tin g  the  role of cell 
cycle re la ted  events as these  m ay be different from the  situa tion  in vivo, 
due to the  constan t cell proliferation of the  cell lines. M oreover, these  cell 
lines are  usually  fixed a t a  p a rticu la r stage of m a tu ra tio n  w ith  no ab ility  
to develop further.
(ii) Repopulation studies w here spleens of sub-lethally  irrad ia ted  mice 
were used to exam ine rela tively  im m ature  tran s itio n a l B cells in  la rge  
num bers. This is essen tia lly  an  artific ial process to gain access to 
tran s itio n a l B cells, th rough  the  g radual repopulation  of the  p erip h ery  
w ith  newly produced B cells, a process which occurs n a tu ra lly  in  th e
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neonatal anim al. This technique has been very sucessful in  iden tify ing  
different types of tran s itio n a l cells and  th e ir suscep tab ility  to cell d ea th  
(see for example: [12]).
Com pleting these model system s, two genetic approaches have been 
widely used to identify the  key molecules involved in  B cell selection:
(i) C onstruction  of tran sgen ic  mice which bear a rela tive ly  h ig h e r 
proportion of B cells specific to a  know n antigen. S tudies in  specific BCR 
transgen ic  mice have contribu ted  to the u n d e rs tan d in g  of the  ba lance  
betw een deletion, anergy and receptor editing of im m atu re /tran s itio n a l B 
cells in  the  bone m arrow  [3].
(ii) A varie ty  of knock-out mice and n a tu ra lly  occuring im m unodefic ien t 
mice. These mice have enabled genetic analysis of B cell recep to r 
signalling  during  developm ent and  have estab lished  role for ty rosine
kinases (Btk, Syk) and o ther factors such as Iga , in  tran s itio n a l B cell
selection (reviewed in [37]).
There were two m ain  reasons to devise an a lte rn a tiv e  in vitrolex vivo 
model system  for B cell developm ent in  the  bone m arrow : (i) to find a w ay  
to investigate  the  signals requ ired  for B cell developm ent in  a n  
environm ent closely resem bling the  bone m arrow  in vivo; (ii) to g a in  
in sigh t into the  n a tu re  of BCR signals involved in  bone m arrow  derived 
cells, w ithout the  compromises involved in  w orking w ith  cell lines.
In  the  system  devised, the  stim u la ted  cu ltu res included all th e  
haem opoietic and  strom al cells in  the  bone m arrow , allowing the  no rm al 
m icro-environm ent to be kep t as close as possible to the  situa tion  in vivo. 
Subsequent observations showed th a t a lthough  m any cells die w ith in  a 
few hours of cu lture, the  rem ain ing  population is stab le  for a t least 3 
days. Even after 48h in  cu ltu re  about 75% of these  cells survive, a 
percentage w hich exceeds the  ra te  of survival of o ther p rim ary  B cell 
populations cu ltu red  in vitro. This stab ility  is p resum ably  achieved by 
cell-cell in terac tions and  continuing  secretion of IL-7 by different cell 
types, such as strom al cells [302, 303]. Im portan tly , in  th is  ex vivo 
experim ental system , im m ature  B cells do not seem to die of neglect. In  
fact, a sm all proportion (~5%) of these  cells spontaneously  develop in to  
tran s itio n a l cells. U sing ex vivo whole bone m arrow  cu ltu res it  is show n
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here th a t  polyclonal stim ula tion  of the  BCR using  an ti-Ig  is sufficient to 
drive positive selection of im m atu re  B cell into phenotypically  m a tu re  
(kappa^* delta^“) B cells.
4.2 Polyclonal activation of immature B cells leads 
to positive selection and development of mature B 
cells
The bone m arrow  population of mice contains few kappa  chain  positive B 
cells. However, the  m ost ab u n d an t kappa* B cell population, w h ich  
consists typically  of around 5-15% of the whole bone m arrow  cell 
population, is th a t  of im m ature  B cells (kappa^ de lta  ). In  some m ouse 
stra in s , the tran s itio n a l B cell population (kappa^° delta^°) is also 
apparen t. In  Balb/c mice, w hich were used in m ost of the  experim en ts 
described below, th is  population usually  comprises not m ore th a n  5% of 
the  whole bone m arrow. In  some cases, a  sm all population (<1%) of 
m atu re  cells (kappa^' delta^^) could be also detected. Some p lasm a B cells 
are also p resen t in the  bone m arrow  [304]. Due to th e ir very low 
percentage and  obscure role in  B cell development, it  w as decided not to 
investigate  these cells.
Two concentrations of an ti-Ig  were chosen to stim u la te  the  BCR of 
im m ature  and tran s itio n a l cells ex vivo. In  pe riphera l B cells, a 
concentration  of 5pg/ml functions as a  survival signal, w hilst high dose 
of 50pg/ml s tim u la tes m atu re  B cells to proliferate (see section 5.4). 
Furtherm ore , it was previously suggested th a t  the  s tren g th  of BCR 
signal can determ ine which cell fate decision will be tak en  [138].
As B220 expression w as reported to be up regu la ted  gradually  in  th e  
progression of B cells from im m ature  to tran s itio n a l to m atu re  cells, in  
in itia l experim ents B220 expression was used to identify B cell 
phenotype. Previous reports d ifferentiated  betw een these  popu lations 
according to B220 expression and  cell size [8]. In  practice, though, only 
B220*° and B220*"‘ populations could be clearly d iscrim inated  (fig. 37a). 
This p relim inary  experim ent showed, th a t  as reported  elsew here [8], 
th a t the B220^° population (which contains pre-B, pro-B and  im m ature  B
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cells) can undergo apoptosis in  response to BCR stim u la tion  (fig. 37b). 
The B220^^ population, in  con trast, appears to expand th rough  enhanced  
proliferation (cf. 17% of u n trea ted  cells in  S, Gg and M phases, 29% w ith  
5pg/ml anti-Ig  and 21% w ith  50pg/ml anti-Ig). This detection m ethod 
could not d istingu ish  betw een tran s itio n a l B cells and  other su b ­
populations. Hence, it  was h a rd  to resolve which B cell population w as 
being selected and allowed to proliferate. Therefore, a  different approach  
for distinction of the  B cell populations had  to be established.
In order to d iscrim inate b e tte r betw een the im m ature , tran s itio n a l and  
m atu re  B cells, double sta in ing  for kappa (for both IgM and IgD) and  
delta  (for IgD) chains w as employed. K appa chain  w as chosen because its  
expression is restric ted  to B cell populations from the  im m atu re  B cell 
stage onwards, while the  m u chain  is already expressed as p a rt of th e  
pre-BCR [305].
Using th is s ta in ing  m ethod it  w as observed th a t  h igh  concen tra tion  
(50pg/ml) of anti-Ig  clearly drives cells from the im m ature  sta te  (kappa* 
de lta  ) to m atu re  cells (kappa^' delta^'; fig. 38) [6]. The lower dose of an ti-Ig  
(5pg/ml) was sufficient to drive developm ent to tran s itio n a l B cells, b u t 
not to m atu re  cells, suggesting th a t  th is process is dose dependent. U sing  
flow cytom etry sta in ing  together w ith  cell counting a t the  end of th e  
stim ulation, it w as possible to estim ate  how m any cells survive the  BCR 
stim ulation  and develop and/or proliferate (fig. 39). W ith both doses of 
anti-Ig, the kappa* B cell population was reduced alm ost to the  sam e 
extent: -40%  of control a t 5pg/ml and about 30% a t 50pg/ml.
Furtherm ore, the  num ber of im m ature  B cells w as reduced su b s ta n tia lly  
as well; they  were about 25% of control in 5pg/ml an ti-Ig  and -15%  of 
control in  50pg/ml anti-Ig. In  both cases, the  expansion of tra n s it io n a l 
cells w as sim ilar in  response to both doses of anti-Ig: 2.5- to 3-fold. T aken 
together, these da ta  suggest th a t  even a low dose of an ti-Ig  is sufficient to 
drive im m ature B cells into tran s itio n a l state. This m ight be m ost easily  
explained by the  change in  the  ratio  of im m ature  to tran s itio n a l cells: in  
a typical experim ent th is  ratio  stands a t approxim ately 17:1 in  cells 
which have simply been cu ltu red  w ith  media. A low dose of an ti-Ig  
improves th is ratio  ten-fold (to about 2:1) and a high dose alm ost 
equalises the  num bers of im m ature  and tran s itio n a l B cells in th e
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culture. The identification of kappa^° delta^“ cells as tran s itio n a l cells w as 
supported by para lle l experim ents w here the  induction  of tran s itio n a l B 
cells alone (i.e., 5pg/ml an ti-Ig  trea tm en t) produced the  h ighest n u m b ers  
of kappa* CD44^^ (fig. 40) and kappa* Fas* cells (see below). These d a ta  
correlate w ith  earlie r observations w hich docum ented the  tran s itio n a l B 
cells as uniquely  expressing these m arkers, w ith in  the  kappa* B cell 
population [8]. F u rtherm ore , an  increase in RAG-1 expression in  kappa+  
B cells w as detectable w ith in  4h of an ti-Ig  (50pg/ml) tre a tm e n t, 
indicating, th a t  ex vivo stim ualtion  can also induce receptor editing (fig. 
41).
N egative selection of B cells is proposed to occur du ring  th e  developm ent 
of tran sitional B cells to m atu re  cells [8]. C onsistent w ith  th is, a m assive 
increase in the  num ber of apoptotic cells w as observed following 
trea tm e n t w ith  50pg/ml anti-Ig, as m easured  by DNA conten t (fig. 42). 
N onetheless, the  surv iv ing  cells developed into m atu re  B cells, to 
comprise about 15% of the  kappa* population (n -5), in  com parison to less 
th a n  5% in control and  5pg/ml an ti-Ig  trea ted  bone m arrow  cu ltu res . 
Depletion of IgD^' cells (m ature B cells) on a  m agnetic colum n did no t 
affect the  phenom ena described here (not shown). Hence, th is  IgD 
depletion excluded the  form al possibility of em ergence of m atu re  B cell 
population solely due to its  p ro liferation  in  cu ltu re  in  response to an ti-Ig  
stim u la tion .
T cell help in thb periphery, as dem onstra ted  here  by CD40 ligation, can  
not overcome the  checkpoint b a rrie r  in  the developm ent of tran s itio n a l B 
cells. At all stages checked, 5pg/ml anti-Ig  plus lOpg/ml anti-C D 40 
trea tm en t, which is co-mitogenic in  m atu re  B cells, did not enhance B cell 
developm ent fu rth e r th a n  5pg/ml anti-Ig  alone, w hich caused  
progression into tran s itio n a l B cells. Moreover, anti-CD 40 tre a tm e n t 
alone has no positive effect on these  bone m arrow  cu ltu res and for 
unknow n reasons causes w ide-spread death  in  all populations (not 
shown). The observation th a t m atu re  B cells, w hich developed in the  ex- 
vivo bone m arrow  set-up, undergo apoptosis (fig. 43), m ay suggest th a t  T 
cell help is needed a t th is stage for m atu re  B cell survival. G ain of IgD is 
widely acknowledged to enable B cells to m igrate  to the  periphery  [17] 
and therefore it  m ay not be su rp ris ing  th a t  m atu re  B cells were not able
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to proliferate in  an  ex vivo bone m arrow  to the  sam e ex ten t as in th e  
periphery  in vivo (fig. 44). This m ay indicate a lim ita tion  of tissue- 
restric ted  cu ltures, a lthough the  precise reason for th is  is unknow n.
4.3 Fas participates in transitional but not 
immature B cell deletion
Previous observations suggested th a t  Fas-induced death  w as im p o rta n t 
for the regu la tion  of m atu ra tio n  of B cells in the  bone m arrow  [8, 302], 
a lthough direct deletion by FasL  w as not reported. In  order to verify th e  
role of Fas using the  ex vivo system , two approaches w ere used.
Firstly , cells were sta ined  for both kappa chain and Fas sim ultaneously . 
The num bers of Fas* kappa* cells were reduced considerably w ith  an ti-Ig  
trea tm en t, in  a dose dependent m anner. N onetheless, the  prevalence of 
Fas expression w ith in  the  kappa* B cell population correlated  w ith  th e  
induction of tran s itio n a l B cells, by 5pg/ml anti-Ig  tre a tm e n t (fig. 45). 
Susceptibility to Fas w as suggested as a  unique fea tu re  of tran s itio n a l B 
cells [8], bu t it  is only in th is  model system  th a t  it  h as  been shown, for th e  
first tim e, th a t  they  can be deleted in vitro by an ti-F as tre a tm e n t (fig. 46). 
Moreover, the  num bers of kappa^ Fas* cells w ere reduced w ith  50pg/m l 
anti-Ig  trea tm en t to a  lesser ex ten t th a n  5pg/ml an ti-Ig  (cf. 73% and 26% 
of control, respectively). The preferen tial deletion of kappa^° cells suggests  
th a t  BCR stim ula tion  causes indirect Fas-induced cell d ea th  of these  
cells.
Secondly, the  significance of Fas during  B cell developm ent w as 
exam ined by u tilising  Ipr transgenic  mice. These mice are  Fas'^‘ and have  
widely reported  defects in  th e ir im m une system , including  B cell 
development, resu ltin g  in  the  production of au toan tibodies [306, 307]. 
However, in  the  ex vivo bone m arrow  cultures, a t firs t sight, an ti-Ig  
trea tm en t induced a sim ilar profile of m atu ra tio n  to th a t  observed in  WT 
stra in s  (fig. 47). The overall surv ival ra te  of kappa chain  positive B cells 
after trea tm e n t w ith  anti-Ig  w as sim ilar to the  WT average (73% of 
kappa* cells in  control) and  a sim ilar proportion of kappa* cells w as found 
to m atu re  (14% of kappa* B cells). N onetheless, a  closer exam ina tion
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revealed some im portan t differences. W hen com paring th is  an ti-Ig  d riv en  
developm ent to observations in  norm al cells, i t  w as a p p aren t th a t  Fas 
deficient kappa* B cells have a h igher ra te  of developm ent to m atu re  cells 
(fig. 48). This enhanced selection process in  the  absence of Fas is n o t 
apparen t overall because in  para lle l to accum ulation  of cells a t th e  
tran s itio n a l stage, apoptosis in  im m atu re  B cells is augm ented  (fig. 49). 
This enhancem ent in  the  apoptosis of im m ature  B cells did not occur 
un til the second day of stim u la tion  and m ay reflect com petition on a n  
unidentified  resource (such as IL-7). Combined tre a tm e n t of an ti-Ig  p lus 
anti-CD40 had  different effects on Ipr m ice-drived bone m arrow  c u ltu re  
from norm al cultures. In  WT cu ltu res th is  trea tm en t leads to an  increase  
in  apoptosis ra te  of all cells, and  especially tran s itio n a l B cells (cf. 17% in  
trea ted  cells and  9% in  u n stim u la ted  tran s itio n a l cells) and to a 
su b s tan tia l increase in  Fas expression on kappa* B cells (not shown). 
Surprisingly , in  Ipr cu ltures, the  combined tre a tm e n t resu lts  in  th e  
recovery of more im m ature  and m atu re  cells w hilst the  num ber of 
transitional B cells is kept as in  control (fig. 50). This suggests th a t  a Fas 
deficiency enables more cells to m atu re  w ith  an ti-Ig  plus anti-C D 40. 
A lthough th is trea tm e n t is still not as effective as h igh doses of an ti-Ig , 
th is  m ay reflect a  rescue scenario in  w hich absence/blockage of Fas is 
needed for successful CD40 co-stim ulation.
4.4 Deletion of immature and transitional B cells by 
self-antigen
In  the  bone m arrow  ex vivo model, a  high dose of an ti-Ig  can drive 
im m ature  B cells to develop into m atu re  B cells. HEL-BCR tra n sg e n ic  
mice were used to observe the  response of im m ature  B cells to a specific 
antigen. A large proportion of the  B cells (50-70%) in  these  mice a re  
specific for the  chicken egg lysosyme (HEL) and they  have been w idely 
employed as a model system  for investigating  B cell to lerance in  th e  
periphery  [15]. Here, these  tran sgen ic  mice w ere used to te s t how 
exposure to soluble self an tigen  influences m atu ra tio n  of im m atu re  B 
cells in  a ex vivo bone m arrow  cultures. The ex ten t of response to self
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antigen  w as suggested to determ ine w hether B cell selection is 
essentially  positive or negative. Exposure to polyclonal an ti-Ig  w as 
effective in driving im m ature  B cells into m atu ra tio n  in  th is  system  and  
the num ber of HEL* B cells was increased following th is trea tm e n t, 
particu la rly  w ith  low dose of anti-Ig  (fig. 51). Polyclonal an ti-Ig  
stim ulation  sim ulation may, therefore, rep resen t positive selection of B 
cells via a  w eak or low affinity signal, as suggested in  o ther models [138]. 
In  accordance w ith  th is  theory, exposure to h igh  concentra tions of h ig h  
affinity self-antigen (i.e. HEL) caused deletion and m atu ra tio n  of B cells. 
The low affinity self-antigen, the  duck egg lysosyme (DEL) w as even m ore 
effective th an  anti-Ig  in  driving B cells into m atu ra tion , sim ilarly  to low 
anti-Ig  (fig. 52). I t is im portan t to note th a t th is is not necessarily  due to 
receptor editing, because absolute num bers of HEL* cells did not decrease 
due to DEL trea tm en t (fig. 53). Fas expression correlated well w ith  th e  
extent of BCR stim ulation , a lthough  num bers of apoptotic tran s itio n a l B 
cells for high doses of e ither HEL or DEL were sim ilar (fig. 54), possibly 
suggesting induction of anergy.
This evidence suggests th a t  the  crucial selection step  m ay be in  th e  
tran sitio n a l B qell stage, w hen a very strong BCR signal (such as th e  
signal induced by HEL here) will lead to deletion. In order to verify th is  
possibility, fu rth er experim ents of two kinds are needed: first,
determ ination  of the  num ber of cells in each kappa* B cell population  
after trea tm en t w ith  anti-Ig, HEL and DEL in  a wide range of a n tig en  
concentrations. Second, determ ination  of the  num ber and  n a tu re  
(im m ature or tran sitiona l) of cells under these trea tm en ts  w hich  
undergo receptor editing or apoptosis. This evidence can help in  
unders tand ing  to w hat ex ten t B cell selection is dependent on an tig en  
affinity and concentration.
4.5 Role for Btk in B cell selection
The tyrosine kinase B tk is an  im portan t m ediator of BCR signalling. I t is 
well docum ented th a t  the  X id  phenotype, w hich is deficient in  Btk, h a s  
reduced num bers of B cells in  the  periphery  and poor responses to BCR
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stim ulation [147]. Bone m arrow  cu ltures were used to exam ine the  role of 
B tk in the  m atu ra tio n  of B cells ex vivo. The B tk deficient phenotype is 
exclusive to the  m ale population of these mice and  therefore a d irec t 
comparison to wildtype (female) mice is possible.
The kappa* B cell population from Xid cu ltu res showed su rp ris in g ly  
be tter ra te s  of survival, relative to WT cultures, e ither w hen u n tre a te d
or trea ted  w ith  50pg/ml anti-Ig  (-25%  more kappa* cells in  Xid c u ltu re s
■>
w ith  e ither stim ulus, th a n  in  wildtype cultures). Therefore the  da ta  is 
p resented  as fold change after 50pg/ml anti-Ig  trea tm en t, in  com parison 
to the  appropriate  control (fig. 55). The absolute num ber of Btk^ 
tran s itio n a l B cells, as induced by anti-Ig, w as also approxim ately 2 
tim es the num ber in  WT cells. This p a tte rn  in  induction of th e  
tran s itio n a l stage, correlates w ith  accum ulation of Fas* cells (cf. 16% 
kappa* Fas* in  Xid and 12% in  litte rm ates after 50pg/ml an ti-Ig  
trea tm en t), although w ithou t any significant increase in  the  apoptosis of 
these cells. In  con trast and as expected, the num ber of m atu re  cells w as 
reduced by 3-fold in  com parison to wild-type culture.
In conclusion, it  seems th a t im m ature  B cells a re  able to develop 
norm ally into tran s itio n a l cells in  the  absence of Btk. N onetheless, B tk 
appears to be essential for the  development of tran sitiona l B cells into full 
m atu rity , as previously reported [308].
4.6 Involvement of the mitochondria in the 
selection of immature and transitional B cells
One of the  m ost im portan t events in the  apoptotic cascade is th e  
depolarisation of the  m itochondrial potential. As discussed above in th e  
WEHI-231 cell line model (section 3.3), th is event is likely to be crucial for 
the generation of BCR apoptotic signal in im m ature  B cells. Indeed, 
m easurem ent of the  m itochondrial potential has shown th a t  it  is reduced 
substan tia lly  by anti-Ig  trea tm e n t (fig. 56). Furtherm ore , th is  reduc tion  
was specific for the  kappa^“ population which reflects the  im m ature  and  
tran sitiona l B cells.
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Changes in the  m itochondrial po ten tial are  closely linked in m any cases 
to in itia tion  of the  effector Caspase cascade. Therefore, it  was of in te re s t  
to determ ine the  role of C aspases in BCR-induced apoptosis of im m atu re  
B cells in  the  bone m arrow , using  the  broad inh ib ito r Ac-DEVD-CHO, 
which blocks the  activation of effector C aspases such as Caspase-3, -6 
and -9. A lthough the  addition of Ac-DEVD-CHO alone im proved th e  
overall surv ivah  of kappa* B cells in cu lture (not shown), inhib ition  of 
Caspase activ ity  did not improve the  ability of im m atu re  B cells to 
develop to m atu re  cells (fig. 57a). Moreover, there  w as no reduction in  th e  
ra tes of cell death  w hen cells trea ted  w ith  both an ti-Ig  and the  in h ib ito r 
(fig. 57b). These resu lts  are  in agreem ent w ith  the  observations in th e  
WEHI-231 model, which suggest th a t  o ther proteases such as C ath ep sin s 
m ay substitu te  for C aspases in  im m ature  B cell death  (sections 3.8-9). In  
addition, Caspase inhibition  alone did not cause a specific increase in th e  
num ber of tran sitio n a l B cells and  th is observation m ay suggest th a t  
Caspase activation in  these cells is linked to the ir Fas susceptib ility  a fte r 
BCR stim ulation.
O ther m itochoiidria-related events were described by others to be 
im portan t for the  selection of B cells in vivo. The anti-apoptotic p ro te in  
Bc1-Xl is regarded as necessary  for the  rescue of im m atu re  B cells from 
cell death  [309] and its close homologue, Bcl-2, appears to be im p o rtan t 
for the m ain tainance of m atu re  B cells [310]. Both pro teins were found to 
be upregu la ted  w ith in  4h of an ti-Ig  (50pg/ml) trea tm e n t as m easured  by 
in trace llu la r sta in ing  of all kappa* cells. The pro-apoptotic pro tein  p53 
was, in con trast, dow nregulated  (fig. 58). Taken together, these find ings 
suggest th a t the  surviving cells after an ti-Ig  trea tm e n t exhibit a 
protective profile of proteins.
4.7 A specific role for IgM in the selection of 
transitional B cells
Deletion of the transm em brane dom ain of the m u chain (pm(TM)) leads to 
a full blockage in B cell developm ent and  to absolute loss of peripheral B 
cells [4]. In  an  a lterna tive  knock-out system , a deletion of the  Cp reg ion
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and the p-ô in tron  caused a rep lacem ent of the m u chain  region by de lta
chain, a change th a t  has been reported to allow norm al B cell 
developm ent [5]. This report of apparen tly  norm al selection an d  
d istribu tion  is su rp ris in g  regard ing  the  well docum ented differences 
betw een surface IgM and IgD signalling [14]. Therefore, it  was of in te re s t  
to exam ine w hether norm al B cell developm ent occurs in  these  mice ex 
vivo.
Upon sacrifice the  percentage of IgD^“ (delta^°) cells in  IgM"^ mice is 
comparable to the  kappa^“ cells in WT litte rm ates (21% vs. 22%), a lth o u g h  
the  absolute num ber of these cells w as significantly  h igher (cf. 2.3x10*^ 
and 1,5x10^ cells, respectively). However, bone m arrow  from knock-out 
mice contained more apoptotic B cells (about 2.5-fold the  percentage in  
litterm ate). As a  whole, the  cell cycle profile of IgD* IgM   ^ B cells 
compromised an  appearance slightly  closer to IgM*^* tran s itio n a l B cells 
th a n  to im m ature  cells (fig. 59). The profile of m itochondrial po ten tial w as 
different in IgM  bone m arrow , w here more cells had  a h igher po ten tia l 
(fig. 60). Taken together, th is  is the  first evidence th a t  IgM^' bone m arrow  
consists of delta* B cells, w hich are not en tirely  identical to im m ature  B 
cells in  th e  wild-type mice, due to the  different BCR they  carry.
Responses to ex vivo stim uli were in m ost cases sim ilar. N otably, 
however, the  expansion of bone m arrow  IgD^° B cells in  response to 
50pg/ml an ti-Ig  w as less ap p aren t (fig. 61). In norm al bone m arrow , th e  
C aspase inhibitor Ac-DEVD-CHO is able to synergise w ith  a h igh  dose of 
an ti-Ig  in  push ing  more IgD*° cells into the  IgD^' stage (on background of 
more death  in the  IgD^° population). This was not observed in KG cells 
and therefore points to dependency of norm al tran s itio n a l B cells upon  
signalling from IgM (fig. 62). This unique IgM signal m ay be C aspase- 
regulated  and cannot be substitu ted  by delta  chain usage.
4.8 ES-62 can enhance maturation of B cells in v i tro  
and in  v ivo
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ES-62 is a  phosphorylcholine-contain ing  parasite-derived  glycoprotein  
which is capable of inducing Th2-type responses in vivo, an d  
desensitising BCR-induced proliferation of peripheral B cells [311]. ES-62 
has a significant effect on BCR signalling, p redom inantly  v ia  
m anipulation  ofithe MAPK cascade [311]. Therefore, I t  w as of in te re s t to 
exam ine w hether th is  molecule is able to subvert BCR signalling  in  
earlie r stages of B cell developm ent, w hich rely heavily  on s igna ls  
transduced  v ia  the  BCR.
ES-62 was found to be capable of su b stan tia lly  decreasing  the death  of 
kappa* B cells in  bone m arrow  cu ltu res (from 29% in  u n tre a te d  cells to 
20% in  ES-62 treated). Increased  survival is evident across all su b ­
populations of B cells, bu t is especially significant in  tran s itio n a l B cells, 
w here th e ir  num bers increase by 138% (fig. 63). M oreover, w hen tre a te d  
sim ultaneously  w ith  ES-62 and 50pg/ml anti-Ig, num bers of im m a tu re  
and m atu re  cells a re  considerably h igher th a n  w ith  an ti-Ig  alone (fig. 64). 
These d a ta  probably reflect an  increase in the m a tu ra tio n  ra te  since th e  
ratio  of tran s itio n a l cells to m atu re  is 1.6:1 (cf. 3:1 in  anti-Ig  alone). 
Indeed, a possible explanation  for the  increase in  the  num ber of m a tu re  
cells arises from exam ination  of changes in  m itochondrial po ten tial due 
to addition of ES-62. U sing DiOCg(3) stain ing, it is ap p aren t th a t  ES-62 is 
inducing an  alm ost 6-fold increase  in  the  m itochondrial po ten tia l of 
kappa* B cells (fig. 65a). Together w ith  anti-Ig  tre a tm e n t it  is in c re a s in g  
the  po ten tial of kappa^^ cells, hence giving them  a b e tte r  chance of 
survival against apoptosis (fig. 65b).
Fas-induced cell death  is a know n pathw ay u tilis ing  m itochondrial pore 
tran s itio n  (as reflected by a decrease in m itochondrial potential). 
Therefore Fas/kappa chain  double sta in ing  w as preform ed to check th e  
possibility th a t  protection of kappa^' cells by ES-62 is achieved by 
blocking the F as pathw ay. ES-62 alone did not change the  overall 
num ber of kappa* Fas* cells, although it  appears to p referen tially  sup p o rt 
survival of the  kappa^° Fas* population. Together w ith  50pg/ml an ti-Ig , 
ES-62 continues to pro tect them  and th e ir num bers are  increased  by 22% 
in comparison to anti-Ig  alone (fig. 66). N evertheless, th is  is only a m inor 
phenom enon - m ost kappa* Fas* cells d isappear w ith  an ti-Ig  tre a tm e n t 
w ith  or w ithout ES-62 (22% of kappa* Fas* cells in  control a t 50pg/m l
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anti-Ig, 25% a t 50pg/ml anti-Ig+ES-62), In  conclusion, it  seem s un like ly  
th a t  blocking Fas-induced cell death  is a m echanism  u tilised  by th is  
p a rasite  product.
To exam ine w hether the  effects of ES-62 could be reproduced in vivo, 
cu ltu res from mice which were continously exposed to ES-62 by osm otic 
m ini-pum ps for two weeks were used (see M aterials and  M ethods for 
fu rth er details). The observation th a t  ES-62 is capable of increasing  th e  
num ber of B cells w hich m atu re  w ith  anti-Ig  tre a tm e n t ex vivo could be 
reproduced in mice exposed to ES-62 in vivo (fig. 67). The rise in  th e  
num ber of tran s itio n a l B cells did not en tirely  correlate w ith  the  rise in  
m atu re  cells, ind icating  th a t ES-62 has a lim ited ability  to help 
tran s itio n a l B cells. The m olecular basis to th is  observation is s till 
obscure. However, a t the  firs t 24h of an ti-Ig  stim u la tion  it is clear th a t  
ES-62 reduces su b s tan tia lly  the  num ber of tran s itio n a l B cells w h ich  
undergo apoptosis and  induces proliferation (fig. 68), sim ilarly  to w hat is 
observed in vitro (not shown).
4.9 Discussion
The developm ent of B cells from th e ir  progenitors in  the  bone m arrow  
into m atu re  B cells en te ring  the  naive pool in  the  periphery  has been a 
centre of a tten tio n  for m any years in  the  field of B cell biology. U sing  
m any approaches, num erous stud ies have tried  to address the  issue of 
selection of non-self-reactive B cells (reviewed in  [3, 9, 11]). In  the p a s t 
few years, some key observations have altered  the  classical model of B cell 
development. Now it  is well estab lished  th a t  some in te rm ed ia te  s tag es 
exist betw een im m ature  (IgM* IgD ) and  m atu re  B cells (IgM* IgD*), 
although the  precise num ber of "transitional" s ta tes  is still unc lear [9]. I t  
has also became ap p aren t th a t  the  selection process is not abso lu te ly  
restric ted  to the  bone m arrow  and a secondary selection process m u s t 
exist in  the periphery. This secondary selection in  the  periphery  seems to 
con trast w ith  the  concept of m atu ra tio n  of B cells as an  in s tru c tiv e  
process. The classical model has predicted th a t  im m atu re  B cells will be 
negatively selected based on th e ir affinity. According to th is  model, a self­
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reactive B cell will be deleted [7], anergised [312] or undergo recep to r 
editing [11], according to the  stren g th  of signal tran sd u ced  from its  BCR. 
If, indeed, some tran s itio n a l B cells leave the bone m arrow  to th e  
periphery, they  will encounter non-self an tigens and  therefore it  is n o t 
feasible th a t  all of them  will be deleted th is  way. This scenario p red ic ts  
some level of positive selection in  the  periphery. Therefore B cell selection 
in  the  bone m arrow  would not be necessarily  dependent on BCR 
specificity and m ay be stochastic, i.e. based on p a ram ete rs  such as cell 
density .
This study has tried  to address the  questions underly ing  B cell selection 
by u tilising  a d ifferent approach for track ing  the  signals required  for th is  
process. The usage of ex vivo bone m arrow  cu ltu res enabled in v es tig a tio n  
of w hat happens to im m atu re  and tran s itio n a l B cells upon s tim u la tio n  
via th e ir surface Ig. About 4% of im m ature  cells upon sacrifice were lead 
to m atu re  after 2d stim ula tion  w ith  anti-Ig, a num ber sim ilar to 
estim ates derived from other system s [6]. S tim ulation of im m ature  B cells 
under conditions w hich mimic signalling  a t a  low th resho ld  induces th e  
developm ent of tran sitiona l B cells (kappa^° delta^®). S trong stim u la tion  of 
the BCR of transitional B cells leads to th e ir negative selection - deletion 
of m ost cells together w ith  developm ent of a sm all num ber into m a tu re  
cells (kappa^' delta^'^) (fig. 38).
Strong stim ula tion  of the  BCR, as observed by others, enhanced cell 
death  [11, 12]: while u n trea te d  kappa* B cells have around  75% su rv iv a l 
ra te  after 48h, only 30% of them  survive w ith  5pg/ml an ti-Ig  and  25% 
w ith  50pg/ml. N onetheless, only tran s itio n a l B cells were found to 
undergo su b stan tia l grow th a rre s t in  G /G i. This m ay be consisten t w ith  
the  studies of Nem azee et al. w hich suggested th a t  w eak stim u la tion  of 
the  BCR would causes grow th a rre s t and  allow receptor ed iting  [7]. 
Therefore, it  is feasible th a t  receptor editing happens, in  fact, du ring  th e  
tran s itio n a l s ta te .
This ex vivo model enabled exam ination  of the role of Fas in  selection 
processes during  B cell m atu ra tion . I t w as show n th a t  Fas is be ing  
up regu la ted  in  correlation to the  induction of tran s itio n a l B cells and  
dow nregulated ^ i t h  th e ir  developm ent to m atu re  cells, in ag reem en t 
w ith  previous reports [8]. A nti-Fas trea tm e n t also selectively deleted
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tran s itio n a l B cells w hich developed following BCR stim u la tion  (fig. 46). 
F u rtherm ore , developm ent in  cu ltu res derived from th e  F as deficient Ipr 
mice, showed a considerable increase in  the num ber of tran s itio n a l B 
cells (fig. 48), providing fu rth e r evidence th a t these cells are  deleted in  
Fas-dependent m anner. N evertheless, the ability  to count and com pare 
precentage of surv iv ing  cells enhances our knowledge of Fas function  
during  th is  developm ental process. I t  is clear from th e  d a ta  p resen ted  
here th a t  the  m ain role of Fas is to lim it the num ber of tran s itio n a l B 
cells. W hen Fas is absent, more tran sitiona l cells survive and  m atu re  and  
th is defective selection m ay be linked to the au to im m unity  p revailing  in  
Ipr mice [306]. ./^though the  proportions of tran s itio n a l to m atu re  B cells 
are kept, de facto more B cells reach the  naive pool and  some of them  m ay  
be self-reactive due to inappropriate  selection. This im plies again  th a t  th e  
selection of B cells in the bone m arrow  is, to a certa in  extent, s to ch astic  
and not necessarily  dependent on the  BCR specifity of the  cell. If  th e  
selection of B cells is purely  in stru ctive  - i.e, dependent only on deletion 
by self-antigen - th en  the  num ber of m atu re  B cells should not in c rease  
w hen Fas is om itted. In  th is  type of selection, B cells will selected only on 
the  basis of th e ir BCR specificity. An a lte rna tive  view is th a t  Fas* 
tran s itio n a l B cells rep resen t a population w hich failed to re a r ra n g e  
th e ir BCR after its ligation and therefore is designated  to die. In  th is  
scenario, Fas deficiency will enable self-reactive B cell to avoid positive 
selection in the  tran sitiona l stage and  to become m atu re  B cells.
In  agreem ent w ith  the  stochastic model, it w as show n using  HEL-BCR 
mice, th a t  there  is no complete deletion by self-reactive an tigens and, in  
fact, w eak stim ula tion  via the  BCR using  the  p a rtia l agonist DEL, 
promotes B cell m a tu ra tio n  (figs. 52-53). F u rtherm ore , in  wild-type mice, 
changes th a t  favour survival could be detected in  some cells shortly  a fte r 
BCR stim ula tion  (fig. 58), suggesting  th a t  a  proportion of im m atu re  B 
cells m ay be genetically predisposed to have the  r ig h t com bination of 
protein  expression to develop further.
In terestingly , th is ex vivo model has not identified the  m atu ra tio n  con tex t 
of CD40-m ediated rescue signal. As discussed by M onroe [9], th is  s ig n a l 
can lead potentially  to auto im m unity  and  therefore its  physiological 
context is ambiguous. In ex vivo bone m arrow  cu ltu res described here, no
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role b u t m ain ta in in g  h igher num bers of im m atu re  B cells can be 
a ttrib u ted  for CD40. This is in  agreem ent w ith  M onroe's suggestion th a t  
CD40 ligation in vivo leads only to im m ature  B cell activation, bu t does 
not support th e ir m atu ra tion . The resu lts  p resen ted  here  for Fas'^" bone 
m arrow  cu ltu re  m ay ass is t in resolving th is issue (fig. F as.5). In  c o n ta s t 
to the full rescue by CD40 in  W EHI-231 cells, a th ird  signal, w hich blocks 
Fas-induced apoptosis, m ay be required  in  tran s itio n a l B cells in  order to 
ensure  th e ir development. Such a signal m ay be tran sd u ced  by MHC 
class II or B7.2 [313].
The s tren g th s of th is  ex vivo model were dem onstra ted  in  a few m ore 
ways. For example, it  w as possible to exam ine how different surface Ig 
isotypes determ ine B cell m atu ra tion . Replacem ent of IgM by IgD w as 
sufficient for tran s itio n a l B cell form ation bu t not for th e ir  full po ten tia l 
of m atu ra tion  (fig. 61).
O ther exam ples included estab lish ing  an unique role for B tk  in  d ifferen t 
signalling situa tions (fig. 55). F irstly , the  dysfunctional B cell 
developm ent observed in  Btk^ Xid mice was reproduced in  th is  ex vivo 
model, as reported previously, tran sitiona l B cells accum ulated w ith  little  
fu rth er m atu ra tio n  [314]. In teresting ly , cells from Btk^ bone m arro w  
cultures m ain tained  th e ir m itochondrial po ten tial responses (not shown). 
Therefore, i t  is ‘possible th a t  the  B tk-sensitive pa thw ay  is seg rega ted  
from the m itochondrial b ranch  of BCR signalling. This segregation  m ay  
explain how tran s itio n a l B cells reduce th e ir  m itochondrial po ten tial in  
response to BCR crosslinking, b u t a t the  sam e tim e are  unab le  to m atu re. 
M anipulation  of B cell m a tu ra tio n  by n a tu ra lly  occuring pathogens w as 
dem onstrated  by u tilising  the  parasite-derived  molecule, ES-62 (figs. 64 
and 67). These effects were evident not only by d irect addition of 
exogenous ES-62 to the  bone m arrow  cultures, b u t also by using  mice 
th a t  were p re-trea ted  in  advance w ith  ES-62 in  vivo. I t  is unknow n how  
the ES-62 molecule is brought into the  bone m arrow. ES-62 affects a wide 
varie ty  of cells rang ing  from m atu re  lym phocytes to m acrophages. I t is 
therefore possible th a t it  is tran spo rted  to the bone m arrow  by any of th e  
rec ircu la ting  cells who pass there . Im portan tly , th ere  are  reports of 
m atu re  B cells re tu rn in g  to the  bone m arrow  and influencing B cell 
m atu ra tion  [315]. Again, the  m echanism  of th is influence is not clear.
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In  sum m ary, the  ex vivo system  described here  offers an  u n iq u e  
opportunity to observe changes in  different B cell populations in  the bone 
m arrow . C ultu res derived from different knock out mice or those 
m anipu lated  in vitro give a powerful tool to exam ine th e  im portance of 
d istinc t com ponents of signalling  pathw ays. S tudies using  cells iso lated  
after stim ula tion  could prove even more potent in  enhancing  ou r 
u n d ers tan d in g  of the  signals underly ing  B cell developm ent in  the  bone 
m arrow .
4.10 Summary
In th is chap ter a  physiologically re levan t model of bone m arrow  B cell 
developm ent is described. In  th is  model, polyclonal stim u la tion  of th e  
BCR leads to both selection and m atu ra tio n  of im m atu re  B cells. The 
m ain  observations in  th is  model were:
• T ransitional B cells depend on Fas, IgM and B tk for progression in to  
the  m atu re  B cell pool.
• D uring the  anti-Ig  response, kappa* B cells reduce also th e ir  
m itochondria^m em brane potential, sim ilarly  to W EHI-231 cells.
• I t was investigated  how an tigen  specificity/affinity influences th e  
selection of B cells in  the  bone m arrow , using a soluble an tigen  (HEL 
and DEL).
• B cell m atu ra tio n  is m an ipu la ted  by ex ternal factors, such as th e  
pathogen product ES-62, even in  th e  bone m arrow.
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F igu re  37: B220*“ B c e lls  u n d erg o  a p o p to sis  in  r e sp o n se  to  a n t i-Ig  
w h ils t  th e  B220^  ^ p o p u la tio n  ex p a n d s, (a) B220 expression in  whole 
bone m arrow  cultures. The cells w ere incubated  w ith  B220-APC (1:50) 
and analysed by flow cytom etry. The background fluorescence (using  
streptavidin-A PC , 1:100) is shown in  the  dotted line. The B220  ^
population w as of <1% w ith  the  background sta in ing  (a sh ift in  th e  
overall fluorescence is also ap p aren t due to unspecific b inding  of th e  
B220 antibody), (b) Whole bone m arrow  cu ltu red  w ith  0-50pg/ml an ti-Ig  
for Id. Cells th en  were sta ined  w ith  B220-APC as in  (a) and w ere 
subjected to PI incorporation to determ ine DNA content.
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Fig. 38
F igu re  38: B ce ll d ev e lo p m en t in  th e  b on e  m arrow  ex  v ivo . Whole 
bone m arrow  cu ltu res (10® cells/sample) were stim u la ted  w ith  0-50pg/ml 
anti-Ig  for 2d and sta ined  for surface expression w ith  an ti-delta  ch a in  
(l:50)+anti-rat-IgG -FITC  (1:100) and an ti-kappa chain  (l:50)-biotin  
+streptavidin-A FC (1:100). For negative sta in ing  control, only th e  
secondary antibodies were used and all gates consisted of <1% of the  cell 
population.
126
Absolute cell number
to LnOl oo o oo o o
? ? ?
o oo
o
Ul
o
Uj
F ig u re  39: Im m atu re B c e lls  are se lec ted  b y  BCR s t im u la t io n  ex  
v ivo . Whole bone m arrow  cu ltu res (10® cells/sample) were s tim u la ted  
w ith 0-50pg/ml an ti-Ig  for 2d. The to ta l cell num ber of bone m arrow  
cu ltu res was determ ined by counting after stim ulation . Cells w ere 
stained  for surface expression w ith  an ti-delta  chain  ( 1:50)+anti-rat-IgG - 
FITC (1:100) and an ti-kappa chain ( 1:50)-biotin+streptavidin-A PC  
(1:100). Im m ature  B cells were kappa^ delta ', tran s itio n a l cells: kappa^” 
delta^°, m atu re  cells: kappa^ delta'^'. For negative s ta in in g  control, only 
the  secondary antibodies were used and all gates consisted of <1% of th e  
cell population.
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F ig u re  40: In d u ctio n  o f  CD44 e x p r ess io n  co rre la tes  w ith  
in d u c tio n  o f tr a n s it io n a l B  cells . Whole bone m arrow  cu ltu res (10® 
cells/sample) were stim ulated  w ith  0-50pg/ml anti-Ig  for 2d. The to ta l cell 
num ber of bone m arrow  cu ltu res was determ ined by counting a fte r 
stim ulation. Cells were sta ined  for surface expression w ith  anti-C D 44- 
FITC (1:200), an ti-kappa chain (l:50)-b io tin+ strep tav id in-PerC P  (1:100) 
and an ti-delta  (l:50)+anti-rat-A PC  (1:20). Im m ature  B cells were kappa^ 
delta  and tran s itio n a l cells were kappa^° delta^°. For negative s ta in in g  
control, only the secondary antibodies were used and  all gates consisted  
of <1% of the  cell population.
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F ig u re  41; In d u c tio n  o f  RAG-1 p r o te in  e x p r e ss io n  in  kappa+ B 
c e lls  a fter  s t im u la tio n  o f  b o n e  m arrow  cu ltu res . Whole bone 
m arrow  cu ltu res (10® cells/sam ple) were stim u la ted  w ith  0-50pg/ml an ti- 
Ig for 4h. Cells were sta ined  for surface expression w ith  an ti-kappa  ch a in  
(l:50)-b io tin+ strep tav id in-PerC P  (1:100). Cell surface sta in in g  w as 
followed by in trace llu la r  s ta in in g  for RAG-1 of the  whole population (see 
M aterials and M ethods for full details). For negative s ta in in g  control, 
only the  secondary antibodies were used and all gates consisted of <1% of 
the cell population. R esults a re  shown for kappa+ cells only.
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F ig u re  42: T r a n sit io n a l B c e lls  u n d erg o  g r o w th  arrest a n d  
a p o p to sis  in  resp o n se  to  stro n g  an ti-Ig  s t im u la tio n  e x  v iv o .
Whole bone m arrow  cu ltu res (10® cells/sample) were stim ula ted  w ith  0- 
50pg/ml anti-Ig  for 2d. The to ta l cell num ber of bone m arrow  c u ltu re s  
was determ ined by counting after stim ulation. Cells were sta ined  for 
surface expression w ith  an ti-de lta  chain (l:50)+anti-rat-IgG -FITC  (1:100) 
and anti-kappa chain (l:50)-biotin+streptavidin-A PC  (1:100). S ta in in g  
was followed by PI incorporation to determ ine DNA content. T ran s itio n a l 
B cells were kappa^° delta^°. For negative sta in ing  control, only th e  
secondary antibodies w ere used and all gates consisted of <1% of the  cell 
population.
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F ig u re  43: C h ron ic  a n ti-Ig  s t im u la tio n  lea d s  to  a p o p to s is  o f
m ature B c e lls  in  th e  b on e  m arrow . Whole bone m arrow  cultu res (10® 
cells/sample) were stim ula ted  w ith  0-50pg/ml an ti-Ig  for 2d. The to ta l cell 
num ber of bone m arrow  cu ltu res w as determ ined  by counting a fte r 
stim ulation. Cells were sta ined  for surface expression w ith  an ti-d e lta  
chain (l:50)+anti-rat-IgG -FIT C  (1:100) and an ti-kappa  chain  (1:50)- 
biotin+streptavidin-A PC  (1:100). Im m atu re  B cells w ere kappa^ delta ', 
tran s itio n a l cells: kappa^” delta^% m atu re  cells: kappa^* delta^\ S ta in in g  
w as followed by ,PI incorporation to determ ine DNA content.
For negative sta in ing  control, only the  secondary antibodies were used  
and all gates consisted of <1% of the  cell population. Sub-diploid cells 
were the  <2N DNA population.
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F ig u re  44; R e stim u la tio n  o f  c e lls  from  b o n e  m arrow  cu ltu res .
Whole bone m arrow  cu ltu res (10® cells/sample) were stim u la ted  w ith  0- 
50pg/ml anti-Ig  for 2d and th en  for a fu rth er 2d w ith  0-50pg/ml an ti-Ig  
w ith  or w ithout lOpg/ml anti-CD40. The to ta l cell num ber of bone 
m arrow  cu ltu res w as determ ined by counting after stim ulation . Cells 
were stained  for surface expression w ith  an ti-delta  chain  (l:5 0 )+ an ti-ra t-  
IgG-FITC (1:100) and an ti-kappa chain (l:50)-b io tin+ strep tav id in-A FC  
(1:100). M ature p  cells were kappa^ delta^\ For negative sta in in g  control, 
only the secondary antibodies were used and all gates consisted of <1% of 
the  cell population.
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F ig u re  45: S tro n g  BCR st im u la tio n  su p p orts th e  d ev e lo p m en t o f  
Fas^ IgD% n o t k ap p a  , B ce lls . Whole bone m arrow  cu ltu res (10® 
cells/sample) were stim ula ted  w ith  0-50pg/ml anti-Ig  for 2d and detected 
for co-expression of Fas w ith  e ither kappa chain (a) or de lta  chain (b). The 
to tal cell num ber of bone m arrow  cu ltu res was determ ined by coun ting  
a fter stim ulation. Cells were sta ined  for surface expression w ith  (a) a n ti­
kappa chain /1 :50)-biotin+streptavidin-A PC (1:100) and an ti-F as  
( 1:100)4-anti-mouse Ig-FITC (1:100); or (b) an ti-delta  chain  (1:50)4-an ti- 
rat-IgG-FITC (1:100) and anti-Fas-b io tin  (l:100)4-streptavidin-A PC  
(1:100). For negative sta in ing  control, only the  secondary antibodies w ere 
used and all gates consisted of <1% of the  cell population.
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F ig u re  46; D e le tio n  v ia  F as is  sp e c if ic  to  tr a n s it io n a l B  cells .
Whole bone m arrow  cu ltu res (10® cells/sample) w ere s tim u la ted  w ith  0- 
50pg/ml anti-Ig  for 2d and th en  for a  fu rther 4h w ith  O-O.lpg/ml an ti-F as. 
The to ta l cell num ber of bone m arrow  cu ltu res w as determ ined by 
counting after stim ulation . Cells were sta ined  for surface expression  
w ith  an ti-delta  chain (l:50)+anti-rat-IgG -FIT C  (1:100) and an ti-k ap p a
k.
chain (l:50)-biotin+streptavidin-A PC  (1:100). Im m atu re  B cells w ere 
kappa^ delta* and tran s itio n a l cells: kappa^° delta^”. For negative s ta in in g  
control, only the  secondary antibodies were used and all gates consisted  
of <1% of the cell population.
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F ig u re  47: B  c e ll d ev e lo p m en t in  Ipr (F a s ‘^ ) m ice  ex  v ivo . W hole 
bone m arrow  cu ltu res (10® cells/sam ple) from e ither WT BALB/c or Ipr 
mice were stim u la ted  w ith  0-50pg/ml anti-Ig  for 2d and sta ined  for 
surface expression w ith  an ti-de lta  chain (1:50)+anti-rat-IgG -FIT C  (1:100) 
and an ti-kappa chain (l:50)-biotin+streptavidin-A PC  (1:100). For 
negative sta in ing  control, only the secondary antibodies were used and  
all gates consisted of <1% of the  cell population.
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F ig u re  48: E n h a n ced  e x p a n s io n  o f  m atu re B c e lls  in  F a s  b o n e  
m arrow  cu ltu res . Whole bone m arrow  cu ltu res (10® cells/sam ple) from  
either WT BALB/c or Ipr mice were stim ulated  w ith  0-50pg/ml anti-Ig  for 
2d. The to tal cell num ber of bone m arrow  cu ltu res w as determ ined by 
counting after stim ulation . Cells were sta ined  for surface expression  
w ith  an ti-delta  chain (l:50)+anti-rat-IgG -FITC  (1:100) and an ti-kappa  
chain (l:50)-biotin+streptavidin-A PC  (1:100). Im m atu re  B cells w ere 
kappa^ delta ', tran s itio n a l cells: kappa^° delta^°, m atu re  cells: kappa^' 
delta^\ For negative sta in ing  control, only the secondary antibodies w ere 
used and all gates consisted of <1% of the  cell population. P ercen tages 
calculated from to ta l kappa^ cells in  u n trea ted  cu ltures of each cell type.
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F ig u re  49: E n h a n ced  an ti-Ig  in d u c ed  ex p a n s io n  an d  a p o p to s is  o f  
tr a n s it io n a l B c e lls  in  Ipr  m ice. Whole bone m arrow  cu ltu res (10® 
cells/sample) from either WT BALB/c or Ipr mice were stim u la ted  w ith  0- 
50pg/ml anti-Ig  for 2d. The to ta l cell num ber of bone m arrow  c u ltu re s  
was determ ined by counting after stim ulation. Cells were sta ined  for 
surface expression w ith  an ti-de lta  chain (l:50)+anti-rat-IgG -FITC  (1:100) 
and an ti-kappa chain (l:50)-biotin+streptavidin-A PC  (1:100). S ta in in g  
was followed by P I incorporation.
Im m ature  B cells were kappa^ delta", tran s itio n a l cells: kappa^° delta^°, 
m atu re  cells: kappa^' delta^*. For negative s ta in ing  control, only th e  
secondary antibodies were used and all gates consisted of <1% of the  cell 
population. Sub-diploidity was determ ined by DNA content (<2N) of th e  
im m ature  and tran sitiona l B cells.
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F ig u re  50: C o-stim u la tion  w ith  anti-C D 40 is  m ore e ffe c t iv e  in  Ipr  
m ice. Whole bone m arrow  cu ltu res (10® cells/sample) from e ither WT 
BALB/c or Ipr mice were stim u la ted  w ith  0-50pg/ml anti-Ig  w ith  or 
w ithout lOpg/ml anti-CD40 for 2d, The to ta l cell num ber of bone m arrow  
cu ltu res was determ ined by counting after stim ulation . Cells w ere 
stained  for surface expression w ith  an ti-delta  chain (l:50 )+ an ti-ra t-IgG - 
FITC (1:100) and an ti-kappa chain (l:50)-b io tin+ streptavid in-A PC  
(1:100). Im m ature  B cells were kappa^ delta", tran s itio n a l cells: kappa^° 
delta^°, m atu re  cells: kappa^ delta^ . For negative sta in in g  control, only 
the secondary antibodies were used and all gates consisted of <1% of th e  
cell population.
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F ig u re  51: B c e ll  m a tu ra tio n  in  HEL-BCR m ice . Whole bone m arrow  
cu ltu res (10® cells/sample) from MD4 mice were s tim u la ted  w ith  0- 
50pg/ml anti-Ig  for 2d. The to ta l cell num ber of bone m arrow  c u ltu re s  
was determ ined by counting after stim ulation. Cells were sta ined  for 
surface expression w ith  an ti-kappa chain  (l:50)-b io tin+ streptavid in-A PC  
(1:100) and (a) an ti-delta  chain (l:50)+anti-rat-IgG -FIT C  (1:100), or (b) 
HEL-FITC (1:20). For negative sta in ing  control, only the secondary  
antibodies were used and all gates consisted of <1% of the  cell population. 
In  (a) m atu re  B cells were the  kappa^' delta^“ cells. In  (b), kappa^ HEL^ 
cells are shown.
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F ig u re  52: L ow  a ff in ity  se lf-a n tig en  p rom otes m a tu r a tio n  o f  B 
cells . Whole bone m arrow  cu ltu res (10® cells/sam ple) from MD4 mice 
were stim ulated  w ith 0-lpg/m l HEL or 0-lpg/m l DEL for 2d. The to ta l cell 
num ber of bone m arrow  cu ltu res w as determ ined by counting a fte r 
stim ulation. Cells were sta ined  for surface expression w ith  an ti-d e lta  
chain (l:50)+anti-rat-IgG -FITC  (1:100) and an ti-kappa chain (1:50)- 
b iotin+streptavidin-A PC  (1:100). M ature B cells w ere the  kappa^" delta^* 
cells. For negative sta in ing  control, only the  secondary antibodies w ere 
used and all gates consisted of <1% of the  cell population.
140
PQ
+
200000
O  150000-
§  100000- H  HEL+
<D
% 50000-
Antigen (gg/ml)
Fig. 53
F ig u re  53: L im ited  d e le tio n  o f  se lf-rea c tiv e  B  c e lls  b y  se lf­
an tig en . Whole bone m arrow  cu ltu res (10® cells/sam ple) from MD4 mice 
were stim ulated  w ith  0-lpg/m l HEL or 0-lpg/m l DEL for 2d. The to tal cell 
num ber of bone m arrow  cu ltu res was determ ined by counting a fte r 
stim ulation. Cells were sta ined  for surface expression w ith  an ti-kappa  
chain (l:50)-biotin+streptavidin-A PC  (1:100) and HEL-FITC (1:20). For 
negative sta in ing  control, only the  secondary antibodies were used an d  
all gates consisted of <1% of the  cell population. Only kappa^ HEL^ cells 
are shown.
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F ig u re  54: C o rre la tio n  b e tw e e n  F a s e x p r ess io n  an d  d e le t io n  o f  
tr a n s it io n a l B cells . Whole bone m arrow  cu ltu res (10® cells/sam ple) 
from MD4 mice were stim ula ted  w ith  0-lpg/m l HEL or 0 -lpg/m l DEL for 
2d. The to tal cell num ber of bone m arrow  cu ltu res w as determ ined  by 
counting after stim ulation. Cells were sta ined  for surface expression  
w ith  an ti-kappa chain (l:50)-biotin+streptavidin-A PC  (1:100) and an ti- 
Fas ( l :100)+anti-m ouse Ig-FITC (1:100). After sta in ing , cells w ere 
subjected to PI incorporation. For negative sta in ing  control, only th e  
secondary antibodies w ere used and  all gates consisted of <1% of the  cell 
population. Fas^ B cells were the kappa* Fas* population. Sub-diploidity 
was determ ined by DNA content (<2N).
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F ig u re  55: B tk  d e fic ie n c y  b lo ck s m a tu ra tio n  o f  tr a n s it io n a l B 
c e lls  in  resp o n se  to  a n ti-Ig  trea tm en t. Whole bone m arrow  c u ltu re s  
(10® cells/sample) from either female (WT) or m ale {Xid ) CBA/N mice w ere 
stim ulated  w ith  0-50pg/ml an ti-Ig  for 2d. The to ta l cell num ber of bone 
m arrow  cu ltu res w as determ ined by counting after stim ulation . Cells 
were stained  for surface expression w ith  an ti-delta  chain  (l:5 0 )+ an ti-ra t-  
IgG-FITC (1:100) and an ti-kappa chain  (l:50)-b io tin+ strep tavid in-A FC  
(1:100). Im m ature  B cells were kappa* delta', tran s itio n a l cells: kappa^° 
delta '”, m atu re  cells: kappa'"' delta'". For negative sta in in g  control, only 
the  secondary antibodies were used and all gates consisted of <1% of th e  
cell population. Changes in  B cell populations w ere determ ined as fold 
change in comparison to u n trea ted  cells from the sam e origin.
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F ig u re  56; a n ti- lg  trea tm en t lea d s to  a sp e c if ic  r e d u c tio n  in  th e  
m ito ch o n d r ia l p o te n tia l o f  kappa'" B cells . Whole bone m arrow  
cultures (10® cells/sample) were stim ulated  w ith  0-50pg/ml anti-Ig  for 2d. 
Cells were sta ined  w ith  anti-kappa-chain-biotin  (1:50)+ strep tav id in-A P C  
(1:100) and th en  w ith  50nM of the  m itochondrial dye DiOCg(3). The 
m itochondrial potential was determ ined by the m ean fluorescence of th e  
dye of each cell population.
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F ig u re  57: T he e ffe c t  o f  C asp ase  in h ib it io n  o n  B c e ll m a tu r a tio n .
Whole bone m arrow  cu ltu res (10® cells/sample) were stim u la ted  w ith  0- 
50pg/ml anti-Ig  w ith  or w ithout lOpM Ac-DEVD-CHO for 2d. The to ta l 
cell num ber of bone m arrow  cu ltu res was determ ined by counting a fte r 
stim ulation. Cells were sta ined  for surface expression w ith  an ti-d e lta  
chain (l:50)+anti-rat-IgG -FIT C  (1:100) and an ti-kappa chain  (1:50)- 
biotin+streptavidin-A PC (1:100). After staining, cells w ere subjected to PI 
incorporation. For negative sta in ing  control, only the  secondary  
antibodies were used and all gates consisted of <1% of the  cell population, 
(a) Im m ature B cells were kappa* delta ', tran s itio n a l cells: kappa'” delta '”, 
m atu re  cells: kappa'" delta'", (b) Sub-diploidity was determ ined by DNA 
content (<2N).
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F ig u re  58: C h an ges in  p r o te in  e x p r ess io n  o f  Bcl-x^, Bcl-2 an d  p53  
in  kappa* B c e lls  a fter  s t im u la tio n  o f  b on e  m arrow  cu ltu res .
Whole bone m arrow  cu ltu res (10® cells/sample) were stim ula ted  w ith  0- 
50pg/ml anti-Ig  for 4h. Cells were sta ined  for surface expression w ith  
anti-kappa chain (l:50)-biotin+streptavidin-A PC  (1:100). Cell su rface  
sta in ing  was followed by in trace llu la r  sta in ing  of the  whole population  
(see M aterials and M ethods for full details). For negative s ta in in g  
control, only the secondary antibodies were used and  all gates consisted  
of <1% of the  cell population. Results are  shown for kappa* cells only.
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F ig u re  59: B on e m arrow  o f  WT and  IgM   ^ B alb /c  m ice . B cell 
populations from e ither WT or BALB/c mice were determ ined upon
sacrifice by sta in ing  for surface expression w ith  an ti-delta  ch a in  
(l:50)+anti-rat-IgG -FITC  (1:100) and an ti-kappa chain  (1:50)- 
biotin+streptavidin-A PO  (1:100). A fter staining, cells were subjected to PI 
incorporation. For negative sta in ing  control, only the  secondary  
antibodies were used and all gates consisted of < 1% of the  cell population. 
WT im m ature  B cells were kappa* delta ', WT tran s itio n a l cells: kappa'” 
delta '”, IgM^ IgD* cells: kappa* delta*. Cell cycle phases w ere determ ined  
by DNA content.
147
o _
I g M
o _
I s  -
o _
FL1-H
DiOCg (3)
Fig. 60
F ig u re  60: T he m ito ch o n d r ia l p o te n tia l o f  kappa^ B c e lls  d u r in g  
d ev e lo p m en t in  th e  a b sen ce  o f  IgM. Bone m arrow  cells (10® 
cells/sample) from e ither WT or IgM''" BALB/c mice sta ined  upon sacrifice 
w ith  an ti-kappa chain (l:50)-biotin+streptavidin-A PC  (1:100) and th e n  
w ith  50nM of the m itochondrial dye DiOCg(3). The m itochondria l 
potential was determ ined by the  m ean fluorescence of the  dye.
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F ig u re  62: E ffec ts  o f  C asp ase  in h ib it io n  on  r ec o v er y  from  B C R  
s tim u la tio n . Whole bone m arrow  cu ltu res (10® cells/sam ple) from e ith e r  
WT or IgM BALB/c mice were stim ula ted  w ith  0-50pg/ml an ti-Ig  w ith  
or w ithout lOpM Ac-DEVD-CHO for 2d. Cells were sta ined  for su rface  
expression w ith  an ti-delta  chain (l;50)+anti-rat-IgG -FIT C  (1:100) and  
anti-B220-APC (1:50). S ta in ing  was followed by PI incorporation . 
Percentages are of the  to ta l bone m arrow  population, (a) M ature B cells 
were B220^ IgD^‘ cells, (b) Sub-diploidity of m atu re  B cells w as 
determ ined by DNA content (<2N). For negative sta in in g  control, only 
the  secondary antibodies were used and all gates consisted of <1% of th e  
cell population.
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F ig u re  61: B ce ll d ev e lo p m en t in  IgM  B alb /c m ice  ex  v ivo . Whole 
bone m arrow  cultures (10® cells/sample) from e ither WT or IgM  ^ BALB/c 
mice were stim ulated  w ith 0-50pg/ml anti-Ig  for 2d. Cells were sta ined  for 
surface expression w ith  an ti-de lta  chain  (l:50)+anti-rat-IgG -FITC  (1:100) 
and anti-B220-APC (1:50). IgD^° cells were B220^ IgD^" ; m atu re  B cells 
were B220^ IgD^' cells. Percentages are of the  to ta l bone m arrow  
population. For negative sta in ing  control, only the secondary an tibodies 
were used and all gates consisted of <1% of the  cell population.
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F ig u re  63: ES-62 su p p orts  th e  m a in te n a n c e  o f  a ll kappa^ B ce lls  
in  th e  b on e  m arrow . Whole bone m arrow  cu ltu res (10® cells/sam ple) 
were stim ulated  w ith  0-2pg/ml ES-62 for 2d. The to ta l cell num ber of bone 
m arrow  cultu res w as determ ined by counting after stim ulation . Cells 
were stained  for, surface expression w ith  anti-delta  chain  (l:5 0 )+ an ti-ra t-  
IgG-FITC (1:100) and an ti-kappa chain  (l:50)-b io tin+ strep tavid in-A PC  
(1:100). For negative sta in ing  control, only the  secondary antibodies w ere 
used and all gates consisted of <1% of the  cell population.
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F ig u re  64: ES-62 sy n e r g ise s  w ith  a n ti- lg  to  d r iv e  im m atu re  B  
c e lls  in to  m atu rity . Whole bone m arrow  cu ltu res (10® cells/sam ple) 
were stim ulated  w ith  50pg/ml anti-Ig  w ith  or w ithout 2pg/ml ES-62 for 
2d. The to tal ceil num ber of bone m arrow  cu ltu res w as determ ined by 
counting after stim ulation. Cells were sta ined  for surface expression  
w ith an ti-delta  chain (l:50)+anti-rat-IgG -FIT C  (1:100) and an ti-kappa  
chain (l:50)-biotin+streptavidin-A PC  (1:100). For negative s ta in in g  
control, only the  secondary antibodies were used and all gates consisted  
of <1% of the cell population.
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F igu re  65: ES-62 in c re a se s  th e  m ito ch o n d r ia l p o te n tia l o f  kappa^  
B cells . Bone m arrow  cells (10® cells/sample) were stim u la ted  w ith  0- 
50pg/ml anti-Ig  ' w ith or w ithout 2pg/ml ES-62 for 2d. Cells were s ta in ed  
w ith  an ti-kappa chain  (l:50)-biotin+streptavidin-A PC  (1:100) and th e n  
w ith 50nM of the m itochondrial dye DiOCg(3). The m itochondria l 
po tential was determ ined by the  m ean fluorescence of the  dye and it is 
shown for (a) the whole kappa^ population, or (b) for kappa^' cells.
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F ig u re  66: ES-62 h a s  n o  e ffec t on  F as e x p r e ss io n  in  kappa^ B  
cells . Whole bone m arrow  cu ltu res (10® cells/sample) were s tim u la ted  
w ith  0-50pg/ml anti-Ig  w ith  or w ithout 2pg/ml ES-62 for 2d. The to tal cell 
num ber of bone m arrow  cu ltu res was determ ined by counting a fte r 
stim ulation. Cells were sta ined  for surface expression w ith  an ti-kappa  
chain (l:50)-biotin-t-streptavidin-APC (1:100) and an ti-F as (l:100)-f-anti- 
mouse Ig-FITC (1:100). For negative sta in ing  control, only the  secondary  
antibodies were used and all gates consisted of <1% of the  cell population.
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F ig u re  67: R eco v ery  from  a n ti-Ig  trea tm en t o f  b o n e  m arrow  
cu ltu res  from  ES-62 e x p o sed  m ice . Whole bone m arrow  cu ltu res (10® 
cells/sample) from mice trea te d  continuously w ith  ES-62 (0-0.2pg/h) w ere 
stim ulated  w ith  50pg/ml anti-Ig  for 2d. The to ta l cell num ber of bone 
m arrow  cu ltu res w as determ ined by counting after stim ulation . Cells 
were sta ined  for surface expression w ith  an ti-delta  chain  (l:5 0 )+ an ti-ra t-  
IgG-FITC (1:100) and an ti-kappa chain (l:50)-b io tin+ strep tavid in-A PC  
(1:100). Im m ature  B cells were kappa* d e lta , tran s itio n a l cells: kappa^'' 
delta^®, m atu re  cells: kappa^^ delta^*. For negative sta in in g  control, only 
the  secondary antibodies were used and all gates consisted of < 1% of th e  
cell population.
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F ig u re  68: D ea th  an d  p r o life ra tio n  o f  tr a n s it io n a l B ce lls  from  
ES-62 ex p o sed  m ice  in  resp o n se  to  an ti-Ig  trea tm en t. Whole bone 
m arrow  cu ltu res (10® cells/sample) from mice exposed continuously w ith  
ES-62 (0-0.2pg/h) were stim ula ted  w ith  50pg/ml an ti-Ig  for 2d. The to ta l 
cell num ber of bone m arrow  cu ltu res w as determ ined by counting a fte r 
stim ulation. Cells were sta ined  for surface expression w ith  an ti-d e lta  
chain (l:50)+anti-rat-IgG -FIT C  (1:100) and an ti-kappa ch a in -b io  tin  
(l:50)+streptavidin-A PC  (1:100). After stain ing, cells were subjected for 
PI incorporation. For negative sta in ing  control, only the secondary  
antibodies were used and all gates consisted of <1% of the  cell population. 
Sub-diploidity and hyper-ploidity was determ ined by DNA content of 
kappa* delta^” (transitional B) cells.
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C h a p t e r  5 .  S I T E - S P E C I F I C  E F F E C T S  O F  B  C E L L  
S T I M U L I  O N  C E L L  F A T E
5 .1  I n t r o d u c t i o n
In  peripheral lymphoid tissues (e.g., the  spleen and the  lym ph nodes), th e  
population of B lym phocytes is dynam ically m ain tained . A balance is 
achieved betw een the  continuous output of B cells from the  bone m arrow  
and th e ir proliferation in  response to an tigen  and  the  te rm in a l 
differentiation and death  of effector B cells. The choices betw een th e  
a lterna tive  fates of proliferation, differentiation and d ea th  are la rge ly  
determ ined by in trace llu la r signalling  cascades triggered  by receptor- 
ligand in teractions, w ith the B cell receptor being a cen tral regu la to r of B 
cell fate. BCR signalling is required  for survival and  rec ircu lation  of 
naive B cells as well as for antigen-specific im m une responses [15, 23, 29]. 
Ligation of the BCR by an tigen  can have various outcomes in  d ifferent 
contexts, including proliferation, differentiation, anergy or apoptosis 
(reviewed in  [11. 17, 302]). There are a t least th ree  d istinc t m echan ism s 
by which BCR ligation can lead to such different consequences:
(i) The affinity and valency of the  an tigen  can affect the  response by 
leading to different degrees of receptor aggregation and consequen tly  
differences in  signal quan tity  and  perhaps quality.
(ii) The im m unological context of an tigen  encounter can influence th e  
outcome by differential engagem ent of B cell co-receptors such as CD 19 
and CD40. These co-receptors can act by directly modifying events in  
BCR signalling  pathw ays or by activating  additional s ig n a llin g  
pathw ays which influence the  outcome of BCR signalling. Such a 
situation  is exemplified by T cell help during  the  G erm inal C en tre  
reaction.
(iii) The outcome of BCR ligation m ay be regu la ted  by activation  or 
differentiation stage-specific changes in the expression or cross-talk  of 
signalling cascades.
The significance of the  regu la to ry  m echanism s controlling B cell 
responses is illu stra ted  by findings th a t  dysregulation of B cell ac tiv a tio n
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pathw ays can lead to imm unodeficiency, au to im m une an d  
lym phoproliferative disorders, leukem ias or lym phom as [146]. The scope 
of th is  chapter was to extend the  ex vivo model of developm ent outlined in  
chapter 4 and to explore both sim ilarities and differences betw een th e  
responses of m atu re  B cells in  various developm ental and  im m unological 
contexts.
T raditionally , the  m easu rem en t of B cell activation  is perform ed by [®H] 
thym idine incorporation of p rim ary  cells in response to in vitro 
stim ulation. This m ethod has several lim itations: (i) it  does not take in to  
account the  fact th a t  m any B cells a re  dying im m ediately upon ac tiv a tio n  
(see below); (2) DNA synthesis of the whole population could no t 
d iscrim inate betw een a varie ty  of B cells, m ost notably, those in th e  
G erm inal C entre (GC) and those outside of the  GCs, w hich exh ib it 
d ifferential responses to an tigen  [22]; (3) The widely used tim e point for 
incorporation m easurem ents is a t its  peak  (around 48h, including in  th is  
study), an  obvious restric tion  in  the  understand ing  of activation  k inetics. 
To address thes&9 lim itations, w here possible, different aspects of the  B 
cell response in  the  periphery  were exam ined. Flow cytom etry w as used  
to d iscrim inate betw een d istinc t B cell populations, w hen CD 19 is u sed  
as a  pan-B cell m arker in  m ost of the  experim ents. The o ther widely used  
pan-B cell m arker, B220 (CD45R), proved in  m any cases to be un re liab le , 
presum ably  due to the phenom enon of B220 dow nregulation  in c e r ta in  
types of peripheral B cells, as reported  very recently  [316].
The aim s of the  studies described in  th is  chapter w ere as follows:
(i) To charac terise  the  differences in  response to BCR stim u la tio n  
betw een different populations of peripheral B cells - in  the  spleen, th e  
lym ph nodes and the  peritoneal cavity.
(ii) To estab lish  the  n a tu re  of the  p rim ary  and secondary responses to 
an tigen  and to compare the  behaviour of G erm inal C enter and  non- 
G erm inal C enter B cells.
(iii) To define the  role of some signalling components (IgM, B tk  etc.) in  th e  
processes described above.
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5 .2  C h a r a c t e r i s a t i o n  o f  p e r i p h e r a l  B  c e l l  
p o p u l a t i o n s
Using flow cytom etry it  is clear th a t, post-sacrifice, splenic and lym ph 
node B cells differ in  th e ir proliferation ra te  - more B cells in  the  lym ph 
nodes are pro liferating  w ithout any exogenous s tim u la tion  (fig. 69). T his 
phenom enon can be explained by the  fact th a t  the  mice used in  th is w ork 
were not kept in  a  pathogen-free anim al house and the  G erm inal C en tre  
content of the  lym ph nodes w as rare ly  below 5% of the  B cell population  
and alw ays h igher th a n  th a t  observed in the spleen. I t  is possible th a t  
differences in  an tigen  circulation resu lt in g rea te r exposure of B cells in  
the lym ph nodes to an tigen  and  therefore resu lts in  more pro lifera tion  
and generation of GCs th an  in the  spleen.
A ctivation of peripheral B cells, e ither purified B cells or the  whole 
population of splenocytes, can be easily dem onstra ted  in vitro following 
stim ulation  w ith  Ffab^g fragm ents of anti-Ig  antibodies, w ith  or w ith o u t 
anti-CD40 and recom binant IL-4, using [®H] thym idine incorporation (fig. 
70) or cell cycle analysis (fig. 71) after 48h stim ulation . These re su lts  
show the benefit outlined above of using  these two m ethods in parallel - 
relatively  subtle change in  the  percentage of pro liferating  cells (i.e. in  S, 
Gg and M phases) is reflected by a  6-7-fold increase in [®H] thym id ine  
incorporation. The differences betw een splenic and  lym ph node B cells 
are also apparen t w hen exam ining the cell cycle profile of these cells in  
response to 24h anti-Ig  stim ulation  in vitro (fig. 72).
Moreover, the G erm inal C entre B cell population behaves differently in  
its response to an tigen  challenge th an  the re s t of follicular B cells, 
presum ably due to the  process of affinity m atu ra tion  [22]. D isc rim in a tio n  
betw een G erm inal C entre B cells and  non-GC B cells is essen tia l in o rder 
to study th e ir unique responses. GC B cells express a m arker w hich can  
be sta ined  specifically by peanu t agglutin in  (PNA), a m ark er widely used 
to identify them  [20]. In  fig. 73, it is shown how th roughou t studies of 
prim ary  and secondary responses, GC B cells were identified as CD 19*
159
PNA* and were com pared to the  non-GC population (CD 19* PNA ) in  
applications such as determ ination  of cell cycle profiles.
M ature peripheral B cells are IgM* IgD^' [6] and they lose th e ir surface Ig 
expression while en tering  the  G erm inal C entre to become cen tro b las ts  
[22]. The expansion of the  IgD^' population w ith in  isolated B cells is easily  
detectable w ith in  48h (fig. 74). In teresting ly , a t firs t sight, T cell co­
stim ulation  as mimicked by anti-CD40 or IL-4 does not appear as 
effective as an ti-Ig  trea tm e n t in  inducing IgD^' B cells. I t is possible, 
though, th a t  these cells had  expanded faster th a n  B cells trea ted  only 
w ith  anti-Ig  and already  lost th e ir surface IgD to become G erm inal 
Centre B cells [317]. A lthough in vitro s tim ulation  of G erm inal C entre B 
cells triggers th e ir expansion (fig. 75), th is response is accom panied by 
enhanced cell death  (fig. 76).
5 .3  T h e  p r i m a r y  r e s p o n s e  t o  a n t i g e n  i n  t h e  
p e r i p h e r y
The transgenic mice model MD4 has been proved useful in  in v es tig a tin g  
a varie ty  of responses of peripheral B cells [318, 319]. In  these mice a 
large percentage of B cells are specific for an  epitope from the  chicken egg 
lysozyme (HEL) [320]. Fig. 77 shows how whole spleen and  lym ph nodes 
cu ltu res from these mice respond to anti-Ig  trea tm en t. A lthough B cells 
from both sites have m axim um  proliferation a t 50pg/ml anti-Ig, lym ph 
node B cells can be stim u la ted  even by the  lowest concen tra tions of an ti- 
Ig tested  (0.5-5pg/ml). Furtherm ore , the  ex ten t of BCR-induced 
proliferation of]3 cells from the  lym ph nodes is alw ays g rea te r th a n  in  
splenic B cells {n-3\ typically ~20-Fold vs. Control in  the  lym ph nodes 
and only up to 10-fold in  the  spleen).
Responses to specific/partially-specific an tigen  also vary  betw een th e  
spleen and lym ph nodes. In  the  spleen, specific stim u la tion  w ith  HEL 
achieves m axim al levels of DNA synthesis around Ipg/m l HEL and  
p lateaus over the  range of 1-lOOpg/ml HEL (fig. 77a). An alm ost as 
effective stim ulation  can be achieved using the  duck egg lysozyme (DEL) 
- an  an tigen  w ith  predicted 2000-fold less affinity to the  transgen ic  BCR
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in these mice [321]. The peak of the  response to DEL in  the  spleen is 
around lOpg/ml, su rp rising ly  close to the HEL concentration. Cell cycle 
analysis allowed to determ ine w hich type of B cells w ere pro liferating  in  
response to these different antigens. Almost all tre a tm e n ts  induced  
proliferation in  both non-GC and GC B cells, although anti-Ig  was best in  
inducing GC B cell num bers (fig. 78a). Due to th is proliferation in both B 
cell populations, all trea tm en ts  had  a lim ited success in  ra is ing  th e  
proportion of GC B cells (cf. 21% GC B cells, out of to ta l B cells, in  control 
and 29-36% in o ther trea tm en ts),
A different dose response to specific an tigens w as revealed in the  lym ph 
nodes (fig. 77b). Here, the  response to HEL peaks a t 1-lOpg/ml and  
declines a t h igher concentrations. A sim ilar stim ulation  by DEL req u ire s  
a t least ten-fold h igher concentration (lOOpg/ml), b u t it  is not as effective 
as is in  the  spleen (cf. 70±6% of HEL peak response in  lym ph nodes an d  
88±2% of response in the  spleen). Cell cycle profiles together w ith  
CD19/PNA sta in ing  were used to show a d istinct response in the  lym ph 
nodes, for both non-GC and GC B cells. The expansion of lym ph node GC 
B cells in response to HEL is m uch more su b s tan tia l th a n  in the  sp leen  
(cf. 3.6-fold of control in  lymph nodes and 1.3-fold in  the  spleen). DEL w as, 
a t least, as effective as HEL in  inducing to tal B cell num bers and GC B 
cell num bers (fig. 78b). Nonetheless, non-GC B cells proliferated less th a n  
control by 48h post-stim ulation w ith  HEL and DEL (17% of control cells 
in S, Gg and M phases, 20-22% of anti-Ig  trea ted  cells and  6-11% in  HEL 
or DEL trea ted  cells).
Taken together, these resu lts  show th a t peripheral B cells, non-GC and  
GC, differ in  th e ir responses in  the spleen and the  lym ph nodes. 
Therefore, the  possibility th a t differences in the  responses of peripheral B 
cells a t these sites is solely a function of the  GC B cell content in th e  
whole population of the  tissue, is excluded.
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5.4 Molecular features of Germinal Centre B cells
5.4.1 Changes in  the m itcæhondrial potential in  response to BCR 
stim ulation
Resting splenic B cells elevate th e ir m itochondrial po ten tial in  response 
to various stim uli (fig. 79). This elevation, which reflects an  increase in  
ATP production, is necessary  for the  enlargem ent in  cell size which is 
p a rt of lymphocyte activation [322]. One of the  m ain  fea tu res of GC B is 
th a t, in  con trast to activated naive B cells, these cells have th e ir  
m itochondrial m em brane potential reduced in  response to BCR 
stim ulation, sim ilarly  to the  im m ature  B cell line, W EHI-231 (fig. 80). In  
addition and in con trast to im m ature  B cells, IL-4 or Caspase in h ib ition
can block in  GC B cells the  reduction in  I t  is now well e stab lished
th a t  BCR-induced apoptosis in  G erm inal Centre B cells is m itochondria- 
and C aspase-dependent [275].
5.4.2 CD19 surface expression
Induction of B cell expansion by polyclonal an ti-Ig  trea tm en t is para lle led  
by induction of the  B cell m arker CD19. This co-stim ulatory molecule is 
widely acknowledged as tak ing  p a rt in determ ining  the  th resho ld  for 
BCR signalling, presum ably by prom oting cell activation  [21]. As show n 
in figure 81, CD19 surface expression is enhanced by anti-Ig  trea tm e n t of 
B cells in  lymph node and spleen. This increase is su rp ris in g  because 
over-expression of CD 19 expression has been reported  to lead to 
autoantibody production [318]. The difference in CD19 expression is even 
more s trik ing  w hen com paring GC and non-GC B cells, w here th e  
increase in CD 19 surface expression is more profound in  GC B cells th a n  
in th e ir coun terparts  in  both spleen (fig. 82) and lym ph nodes (sim ilar 
resu lts  not shown).
5.4.3 The role o f B tk
The tyrosine kinase B tk  has been suggested as an  im portan t in teg ra to r of 
proliferative signals dow nstream  of both the  BCR and CD19 [146]. Xid
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mice are therefore a  useful model for estim ating  the  role of B tk in BCR 
stim ulation. In  these mice, m ales are  B tk deficient w hilst females, w h ich  
carry a dom inant norm al allele and  a defective allele, a re  healthy . Hence, 
these mice enable direct com parison of B cell responses on the  sam e 
genetic background. Upon sacrifice, male Xid mice were found, as 
expected, to have reduced num bers of B cells (15.5x10® per spleen of B tk   ^
m ales in  com parison to 19.4x10® cells in Btk*^* females) and  v irtu a lly  no 
GC B cells (1.5% of to ta l splenic B cells in  m ales vs. 9% in  females). In  
proliferation assays, as previously published, spleen cu ltu res from Xid 
mice show a very lim ited response to BCR stim ula tion  (fig. 83 and no t 
shown). W hen exam ining the  responses to an ti-Ig  stim ulation , a lbe it 
absolute num bers were still about 60% less, it  is clear th a t  GC B cell 
expansion (50pg/ml anti-Ig  vs. un trea ted ) has increased  slightly  in  B tk 
deficient mice (cf. 6 .2-fold in cells derived from Xid m ale mice and 5.2-fold 
increase in cells from female mice; fig. 83). In  con trast, non-GC B cells 
expanded su b stan tia lly  less in cu ltu res from m ale mice th a n  in  female 
litte rm ates  (2.3-fold and 3.7-fold, respectively). Absolute num bers of non- 
GC Btk'^' B cells a fter trea tm en t w ith  anti-Ig  were ~50% of the  num ber in  
cu ltu res derived from female mice. Taken together, B tk   ^ derived splenic 
B cells exhibit dysfunctional responses to BCR stim u la tion  w hen as a 
whole they  expand to a lesser ex tent th an  th e ir Btk*^* co u n te rp arts . 
Nonetheless, th is  overall phenom enon can be carefully dissected into two 
trends: (i) non-GC Btk'^" B cells respond poorly to antigen; and (ii) the few 
existing Btk'^' GC cells respond be tte r th a n  wild type cells. Therefore, it  is 
feasible th a t  the  sm all num ber of GC cells p resen t in  Xid mice is sim ply 
due to low cellu larity  of the  follicular com partm ent as a whole. Hence, 
Btk m ay play a restric tive  role in  GC B cell responses, sim ilar to th a t  
observed for im m ature  B cells in  section 4.6. In  both cases, h y p e r­
responsiveness to BCR cross-linking is observed in the  B tk  deficient cells. 
Im portantly , th is  role for B tk m ay be independent of CD 19 su rface  
expression. The expression profiles of CD19, before and after BCR 
stim ulation, for both non-GC and GC B cells of Xid mice were sim ilar to 
those of w ildtype mice (not shown). Therefore, B tk m ay p a rt of an  
a lternative  pathw ay, CD 19-independent, which detem ines the  th resh o ld  
for BCR activation.
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5.5 Role for Fas in the Germinal Centre reaction
The m echanism s th a t  underly  selection of B cells du ring  the  G erm inal 
C entre reaction are poorly understood. One suggestion, is th a t  B cells 
are undergoing activation-induced cell death  (AICD) sim ilar to th a t  
observed w ith  T cells [25, 323]. Moreover, about h a lf  of GC B cells express 
Fas on th e ir surface (not shown) and therefore are  susceptible for 
induction of apoptosis by FasL  expressed on activated T cells [18].
Lymph node cultures from Ipr (Fas'^') mouse were u tilised  to exam ine th e  
possibility of A*ICR in  B cells, in  ligh t of the  conceivable FasL -Fas 
in teractions betw een T and B cells. In  Ipr cultures, a  h igher dose of BCR 
stim ulation  (50pg/ml instead  of 5pg/ml) was needed in  o rder to effectively 
increase the rela tive  proportion of GC B cells in  the  B cell population  
relative to th a t  seen in  WT B cells (fig. 84; see also fig. 75). In  addition, for 
as yet unknow n reason, the  response to anti-Ig  stim u la tion  in  non-GC 
cells from Ipr mice is also im paired  (fig. 84). However, trea tm e n t w ith  
anti-Ig  plus anti-CD40 induced stronger proliferation of GC B cells in  
F as '^ cu ltures th an  in  wildtype B cells (not shown).
Fas expression m ay also be linked to the  observed m itochondrial even ts 
in  GC B cells [324]. Fas could th u s  a lte r  B cell surv ival in  the  G erm inal 
Centres, in  order to te rm in a te  activation. This possiblity w as supported  
by the  fact th a t a  long tim e w as needed for reduction in  the  m itochondria l 
potential in  response to BCR stim ulation  in  GC B cells, enabling  changes 
in  Fas expression. If  Fas plays a p a rt in  such a scenario, th en  C aspase 
inhibition  m ay no t enhance GC B cell survival.
The Caspase inh ib ito r Ac-DEVD-CHO, in  synergy w ith  an ti-Ig  
trea tm en t, w as capable of enhancing  GC B cells expantion  in repense to 
BCR stim ula tion  (fig. 84). Therefore, it  is likely th a t  Fas-induced  
apoptosis of GC B cells does not u tilise  a  m itochondria -dependen t 
pathw ay, as described in  o ther cells [299].
164
5.6 The role of IgM in Germinal Centre formation
In  certa in  IgM '' mice, a  deletion of the  Cp region and th e  p -8 in tro n
enforces the  expression of IgD instead  of IgM (see also section 4.7), a 
change reported to allow norm al B cell developm ent [5]. These tran sg en ic  
mice were used to exam ine if  IgM expression is absolutely essen tia l for B 
cell activation or w hether developm ent driven by IgM can be fully 
substitu ted  by expression of IgD.
5.6.1 The IgM  Spleen
Although the  to ta l cellu larity  of spleens from both IgM*^* and IgM  ^ mice 
has been found to be sim ilar, B cell num bers are reduced by about 40%. 
The cell cycle profiles of all the  B cell sub-populations exam ined could no t 
provide a  full explanation to these differences (fig. 85). However, it  c lear 
th a t there  is a g rea ter ratio  of apoptosis of both non-GC and GC B cells 
and more GC B cells are found in  Gq/Gj in  IgM^ mice, com pared to B cells 
derived from WT mice. Moreover, the  p a tte rn  of expansion of IgD B cells, 
which presum ably rep resen t GC B cells, was quite different th a n  th a t  
observed w ith  norm al B cells. F irstly , it  required  a h igher dose of an ti-Ig  
(50pg/ml) in order to achieve a short-lived 64% expansion of B cells from 
IgM  ^ mice, in  com parison to u n trea ted  cells, a fter 24h. Moreover, th is  
exapansion w as abolished after 48h. In  comparison, IgM*^* cells needed 
less BCR stim ulation  (5pg/ml anti-Ig) and after 48h showed 143% 
expansion in the  IgD sub-population. In teresting ly , in both spleen and  
lym ph nodes, a  notable expansion in  IgD* cells is observed as well (not 
shown). These d a ta  were supported by analysis of DNA synthesis, w h ich  
was largely reduced, relative to WT cells (fig. 86a). Indeed, in both spleen 
and lym ph nodes p reparations, no proliferation w as observed in response 
to anti-Ig. However, proliferation w as observed in  response to anti-Ig  p lus 
anti-CD40, LPS (spleen and lym ph nodes) and also to an ti-Ig  plus IL-4 as 
anti-CD40 alone (lymph nodes only). These resu lts  suggest th a t  IgM   ^
peripheral B cells are defective in  activation responses v ia  the  BCR.
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5.6.2 IgM  Lymph nodes
The knock-out anim als have a h igher percentage of B cells in th e ir
lymph nodes (cf. 30% in  IgM'^' mice and 20% in  wildtype), a lthough  th e  
difference in  to tal num ber of B cells (about 2% less in  KO) w as w ith in  th e  
accuracy of counting. This presum ably  because in  the  overall B 
lymphocyte population, less cell death  was ap p aren t th a n  in  wild-type. 
A lthough the  proportions of G erm inal C entre B cells to to ta l B cells w ere 
m ain tained , IgM'^' non-GC cells were found to be G/G^ a rrested  bu t w ere 
not as apoptotic as in  control litte rm ates  (fig. 87). This phenom ena w as 
presum ably com pensated by the  fact th a t  non-GC B cells were m ore 
prone to proliferate (cf. 84% of KO cells in S, Gg and M phase and 63% of 
wildtype cells). Surprisingly, a  high dose of anti-Ig, w hich drives KO cells 
to expand, seemed to encourage more proliferation in  IgD cells and more 
death  in IgD* cells (fig. 88). This observation can be explained by loss of 
IgD expression during  proliferation of IgD* B cells.
In  thym idine incorporation assays, as discussed above, the  response to 
anti-Ig  was largely im paired w ith  only 5-fold increase in  DNA sy n th esis  
(Fig. 86b), while the norm al response is in  the  range of 20-100-fold. 
Responses to co-stim ulation w ith  IL-4 and anti-CD40 (w ith or w ith o u t 
anti-Ig) trea tm eh ts  were in tact.
5 .7  T h e  s e c o n d a r y  r e s p o n s e  t o  a n t i g e n
5.7.1 Changes in  antibody specificity
HEL-BCR MD4 mice were used to exam ine how the secondary response 
to a  specific an tigen  differs from the  prim ary  response. Mice w ere 
im m unised w ith  e ither lOOpg HEL or DEL, or PBS and after 8d whole 
spleen and lym ph node cu ltu res were exam ined for in vitro p ro liferative  
response to antigens. Induction of GC reaction, as observed by flow 
cytom etry upon sacrifice, was evident only w ith  HEL im m unisation  (fig. 
89). Unexpectedly, given the  the  response to DEL observed in vivo, DEL 
im m unisation has increased the  num ber of non-GC B cells bu t not these  
of G C B  cells.
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In  the  spleen, im m unisation  w ith  e ither HEL or DEL im proved th e  
response to subsequent HEL stim ula tion  in vitro. The pro liferative  
response peaked a t O.lpg/ml HEL, ra th e r  th a n  Ipg/m l in  PBS control, 
therefore show ing the  expected lowering of th resho ld  for activation  by 
antigen  (fig. 90). In teresting ly , im m unisation w ith  DEL or HEL im proved 
the proliferative response in vitro to DEL, in com parison to PBS control. 
N onetheless, th is response has peaked a t the  sam e co n cen tra tio n  
(lOpg/ml DEL) as the  control. This was also reflected by the  d is tr ib u tio n  
of B cells (fig. 91). In teresting ly , a fte r 2d cu ltu re  w ithou t fu r th e r  
stim ulation , the  percentage of GC B cells in  the  B cell population h a s  
equalised in cu ltu res from all mice. The basis to th is  phenom enon is 
unclear, bu t m ay resu lt from apoptosis of GC B cells from the HEL 
im m unised mice.
The lym ph node response after im m unisation  differed from th a t  of th e  
spleen, in  a num ber of aspects. DEL im m unisa tion  has reduced  
d ram atically  the  proliferative response to HEL in vitro (m axim um  HEL- 
induced proliferation in  PBS: 81-fold of un trea ted , in  DEL im m unised: 7- 
fold). In  contrast, HEL im m unisation  increased the  pro liferative response  
to HEL by about 3-fold, in  com parison to PBS (236-fold increase vs. 
un treated). Taken together, these  observations suggest th a t  DEL 
im m unisation  has caused to lerance to HEL in the  lym ph nodes, 
presum ably  via affinity m a tu ra tio n  to DEL specificity in  the  G erm inal 
C entres.
HEL im m unisation  in vivo lead to a m assive induction  of GC reaction  - 
about 50% of B cells were PNA* and  CD 19 expression w as elevated (not 
shown). S im ilarly  to the  spleen, im m unisation  w ith  e ith e r HEL or DEL 
im proved the  sensitiv ity  to DEL stim ula tion  - the  pro liferative response 
peaked in lOpg/ml in com parison to lOOpg/ml in PBS, a lthough  HEL 
im m unisation  perform ed b e tte r  th a n  DEL (fig. 92). These finding w ere 
also confirmed by CD19/PNA sta in ing  (not shown). This evidence su g g est 
again, th a t  induction of affinity  m atu ra tio n  is possible here  and leads to 
changes in  secondary in  vitro stim ulations.
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5.7.2 The secondary response after ES-62 prhning
ES-62, a phosphorylcholine containing glyco-protein secreted by th e  
parasite  A  viteae, is a  useful model for the  induction  of T h2-type 
responses [311]. T rea tm en t of mice w ith  ES-62 leads to the  induction of 
G erm inal C entre reaction in vivo, in  a dose dependent m anner (fig. 93).
The proliferation of B cells from the  spleens of ES-62 trea ted  mice, in  
response to anti-Ig  stim ulation , is suppressed in com parison to mice 
trea ted  w ith  PBS (fig. 94). This effect is largely dependent on the  dose of 
ES-62 in the lym ph nodes (fig. 95). Since BCR-induced cell death  of 
G erm inal Centre B cells can be blocked by Caspase inh ib ition  (see above), 
the  w ide-range Caspase inh ib ito r zVAD-fmk was employed to determ ine  
w hether it could block the  suppression of proliferation by ES-62. 
Surprisingly , zVAD-fmk has no effect in  e ither the  spleen or the  lym ph 
nodes (figs. 94-95). These resu lts  were corroborated by cell cycle an a ly sis  
of in vitro spleen cultures. In  the  lower dose of ES-62 trea tm e n t (5pg/h) 
apoptosis was suppressed and proliferation enhanced (fig. 96), a lth o u g h  
BCR -stim ulation had  only m arg inal effects on proliferation as observed 
in the  thym idine incorporation assays (fig. 94). In  con trast, a t the  h ig h e r 
dose of ES-62 (2pg/h), apoptosis w as enhanced by an ti-Ig  trea tm e n t (fig.
96). A lthough zVAD-fmk addition did not improve pro liferation  (fig. 94), 
th is evidence suggest th a t  Caspase inhibition, a lthough  blocking GC B 
cell apoptosis, is not sufficient to overcome growth arrest.
5 .8  B  c e l l  r e s p o n s e s  i n  t h e  p e r i t o n e a l  c a v i t y
5.8.1 BCR stim ulations o f B-1 cells
The role of BCR stim ula tion  of B cells in  the  peritoneal cavity (m ostly 
Mac-1* B-1 cells) is unclear [36]. B-1 cells are thought to be self-renew ing. 
B-1 cells are thought to be especially im portan t for the  rap id  responses to 
infections in neonatals, by v irtue  of th e ir specificity to m u ltiv a len t 
an tigens such as LPS [38]. The broad specificities of B-1 cells m ay cross- 
react w ith selfantigens and are thought to contribute to the  developm ent 
of autoim m unity. Therefore, it  was of in te res t to compare the  responses of 
B-1 cells to B cells p resen t a t other lymphoid sites.
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Despite the  proposal th a t  B cells are self-renewing, w hilst u n trea ted  B-1 
cells appear to proliferate, they  do not appear to do so m ore su b s ta n tia lly  
th an  any o ther peripheral B cells (as determ ined by DNA synthesis; fig.
97). B-1 cell survival in cu lture, however, is m uch im proved in  th e  
presence of the  re s t of the  peritoneal w ash  (cf. 17% sub-diploid in  
un trea ted  cells f|fter 24h and 2% in presence of the  re s t of the  wash). T his 
observation m ay h in t a t some undocum ented support by o ther cells, m ost 
likely to be m acrophages which are by far the largest population in  th is  
cavity [186]. B-1 cells, however, do proliferate in  response to an ti-Ig  
trea tm en t, a lthough DNA synthesis m easurem ent shows clearly th a t  
th is response is poor in com parison to splenic B cells, for exam ple (5-fold 
increase in  thym idine incorporation of B-1 cells and  up to 20-fold in  
isolated splenic B-2 cells). S tim ulation via the BCR does not lead to a v a s t 
expansion of these cells, presum ably  since m any of them  in  fact die in  
response to th is trea tm en t (fig. 98). This death  is C aspase-dependent 
since co-culture w ith  zVAD-fmk prevents BCR-induced apoptosis to B-1 
cells (see below):
However, trea tm en t w ith  anti-CD40 and a low dose of an ti-Ig  was found 
to be an  efficient stim ulus of DNA synthesis, sim ilarly  to o ther p e rip h e ra l 
B cells (fig. 97). Moreover, in  agreem ent w ith  th e ir supposed role a t th e  
front line of an ti-bacteria l activ ity  [6], LPS also serves as a s tro n g  
proliferative signal for B-1 cells (not shown).
ES-62, the parasite-derived  glycoprotein, contains phosphorylcholine, a 
n a tu ra l epitope for B-1 cells [6] and therefore useful in  exam ining in vivo 
responses of B-1 cells. B-1 cell num bers were found to be slightly  reduced  
by in vivo exposure to ES-62 (not shown). B-1 cells from ES-62 tre a te d  
mice were proliferating more profoundly in  the absence of any stim uli (up 
to 50-fold increase in  thym idine incorporation). However, responses to 
anti-Ig  stim ula tions in vitro were relatively  lower (cf. 12-fold increase in  
thym idine incorporaion PBS control and 1.6- to 2.8-fold in  cells from ES- 
62 trea ted  mice), presum ably because these cells w ere already fully  
activated by the  parasite  product.
Rresponses to BCR stim ula tion  could be enhanced by C aspase in h ib itio n  
(fig. 99). This evidence suggests an tigen  exposed B-1 cells have only a 
restric ted  ability to respond to secondary BCR stim ulation . The
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involvem ent of C aspases in  BCR signalling resem bles tran sitio n a l B cells 
and supports a possible developm ental link betw een them  [17],
5.8.2 M olecular factors determ ining B-1 ceU responses
Both B tk and IgM expression and function are though t to be crucial for 
B-1 cell development. C onsisten t w ith  this, B-1 cell num ber in th e  
peritoneal cavity of IgM   ^ mice (essentially  IgD* B-1 cells [5]) is -60%  of 
th a t  of WT mice. In teresting ly , these cells exhibit rem arkab ly  less 
apoptosis (cf. 10% and 24%, respectively). The cell cycle profile of liv ing  
cells w as m ainly unchanged in com parison to w ild-type IgM* B-1 cells. 
A lthough thym idine incorporation in u n trea ted  cells w as poor, th e  
response of IgM^ B-1 cells to anti-Ig  trea tm en t alone w as norm al (about 
5-fold increase in com parison to control). Anti-CD40 plus an ti-Ig  
trea tm en t, however, did not lead to a significant induction of p ro lifera tion  
(cf. -20-Fold increase vs. control in  WT and 5-fold increase  in  IgM  ^ mice; 
fig. 100). Moreover, anti-Ig  stim ulation  was not enhanced by the  C aspase 
inhibitor, Ac-DEVD-CHO. This differential response to C aspase 
inhibition in IgM ^  and WT B-1 cells, resem bles th a t of the  loss of C aspase 
regulation  of IgM   ^ tran s itio n a l B cell expansion (section 4.6). Taken 
together, these resu lts  im ply th a t  IgD cannot fully su b titu te  for IgM in  
B-1 cells, a finding, w hich m ay be in  agreem ent w ith  the  well know n 
differences in  the signalling  pathw ays these different Ig isoforms a re  
known to u tilise  [14]. Moreover, it provides fu th er evidence to th e  
sim ilarities betw een B-1 cells and tran sitional B cells.
Perhaps as expected, B tk deficient peritoneal cavity B cells (from m ale 
Xid mice) had  no susta inab le  proliferative response to BCR sim u la tio n  
and although in itially  the ir num bers rose (by about 50% after 24hr) by 
48h m ost of the  cells were gone (fig. 101 and not shown).
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5 . 9  D i s c u s s i o n
It has become clearer recently  th a t  the  various B cell populations in  th e  
periphery require  different stim uli to move betw een lym phoid 
com partm ents and to respond to im m unogenic challenge [18, 146]. T hus, 
in the  spleen and  the  lym ph nodes, naive follicular B cells were com pared 
to G erm inal C entre B cells, and  resu lts  in both population were rela ted  to 
the  requirem ents of B-1 cells.
The GC B cell population differ in  its BCR responses in  com parison to 
resting  peripheral B cells, undergoing affinity m a tu ra tio n  and expansion  
of specific B cell clones [325]. This process is linked to the  GC 
environm ent - GC B cell selection u tilises additional signals received 
from T and dendritic  cells, such as CD40L and IL-4 receptor liga tion  
[326]. The behaviour of B-1 cells is less understood. These cells have  
restric ted  reperto ire  of receptors specific for m u ltiva len t an tigens [38]. 
The extent of the ir dependency on BCR signalling and w hich com ponents 
of it  are  crucial for the  response are largely unknow n [32].
5.9.1 D ifferences betw een G erm inal Centre and non-G erm inal 
Centre B cells
Throughout th is chapter, a  few novel differences became ap p aren t in th e  
responses of resting  B cells and G erm inal Centre cells:
F irst, G erm inal C entre and non-G erm inal Centre B cells respond very  
differently to an tigen  stim ulation , the  form er population u ndergo ing  
enhanced apoptosis in  response to BCR ligation (figs. 71, 75 and 79 and as 
reported elsewhere). A lthough after a  longer tim e th a n  th a t  is req u ired  
for non-GC B cells, GC B cells expand in  response to an tigen  in vitro (fig. 
75) and in vivo (fig. 93). The apoptosis of G erm inal C entre B cells is 
m itochondria-m ediated and could be prevented by C aspase inhibition (fig. 
80), unlike the  death  of im m ature  B cells (as detailed  in  chap ter 4). 
R esults concerning the  involvem ent of C aspases (and C athepsins) in  
BCR-induced apoptosis of GC B cells have also recen tly  been reported  
elsewhere [275, 324]. In  con trast to previous assum ptions, bu t in  
agreem ent w ith  more recen t reports [291, 324], the  death  of GC B cells
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was found not to be dependent on Fas expression as dem onstra ted  by 
using /pr-derived cultures (fig. 84).
The increased expression of CD 19 found on GC B cells in  com parison to 
non-GC B cells could reflect the  possible involvem ent of Btk, because th is  
protein kinase has been shown to act as an  in teg ra to r of BCR and CD 19 
signalling cascades [21, 146]. The B tk deficiency is known to cause th e  
absence of m ost B cells from the periphery  [308] and B cells from Xid 
mice have a largely im paired proliferative response to the  BCR in  m ost B 
cell populations exam ined. Surprisingly , it was found Btk'^ G erm inal 
C entre B cells could be induced to expand in vitro in  response to BCR 
cross-linking. GC B cells, therefore, resem ble in  th is  behav iou r 
im m ature  B cells (fig. 83; see also section 4.5 and [146]) and th is  
sim ilarity  could ^ suggest th a t B tk  m ay be involved in  BCR signals w h ich  
promote receptor editing/affinity  m atu ra tion , possibly v ia  induction of 
RAG activity.
Most of differences betw een IgM  and WT mice were rela tively  m inor, 
although some reduction in to tal B cell num ber in  the  spleen w as 
observed. Notably, IgM   ^ spleen GC B cells showed h igher apoptotic ra te  
th an  norm al mice upon sacrifice (fig. 85). In  contrast, in the  IgM   ^ lym ph 
nodes, sub-diploidity w as reduced in  both GC and non-GC B cell 
populations and grow th a rre s t w as enhanced (fig. 87). DNA sy n th esis  
was generally  reduced in IgM^' mice in  response to anti-Ig  s tim u la tio n  
(fig. 86). This evidence suggests th a t  although B cell d is tribu tion  in th e  
periphery  in the IgM^' mice is sim ilar to WT mice, they  are la rge ly  
dysfunctional.
5.9.2 Site-dependent behaviour of peripheral B cells during the 
prim ary and secondary responses
Perhaps one of the  m ost exciting observations in  th is  chap ter w as th a t  B 
cells in the spleen and the  lym ph nodes display different p rim ary  and  
secondary responses to antigen. Nonetheless, the  differences described 
here regarding B cells from the  spleen and the  lym ph nodes are not fu lly  
understood.
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D ata presented  here (fig. 77) showed th a t  although  the  lym ph nodes 
respond to lower an tigen  threshold , the  response is m ore specific. T his 
was dem onstrated  by using  a p a rtia l antigen, DEL w hich induced a less 
rem arkable proliferation in  the  lym ph nodes th a n  in  the  spleen. 
Investiga ting  into the  requ irem en t of specific an tigen  during  th e  
secondary response w as m ade using  im m unisation  of MD4 mice w ith  
either HEL or DEL. Perhaps not surprisingly , th is  response has v a ried  
betw een the spleen and the  lym ph nodes (figs. 90 and 92). D uring th e  
secondary response in  the  spleen, stim ulation  by HEL was enhanced  
w ith  e ither DEL or HEL im m unisation, while in  the  lym ph nodes th a t  
occured only for HEL. The model which seems to em erge from these  
resu lts is as follows:
(i) In the spleen the secondary response to HEL or DEL an tigen  could be 
enhanced by im m unisation  w ith  e ither specific (HEL) or p a rtia lly - 
specific (DEL) antigen. Moreover, im m unisation  w ith  DEL enhances th e  
response to DEL or to the  original antigen, HEL (fig. 93).
(ii) In  the lym ph nodes, im m unisation  w ith specific antigen, HEL, 
enhances responses to both HEL and DEL (fig. 92). This seems to be 
specific to HEL and can not be mim icked by DEL and m ay suggest th a t  
induction of som atic m u ta tion  in the  lym ph nodes requires more specific 
stim ulation of the  BCR.
ES-62 is a  protein  capable of inducing Th2 type response [311]. A m ore 
physiological approach to the  induction of GC B cells in vivo was tak en  
w ith  mice w hich were chronically exposed to th is  pa rasite -derived  
molecule. This is a  useful model for the  changes th a t  such prolonged 
exposure m anifest. I t w as shown here th a t the  num ber of GC B cells 
generated  w as dose dependent (fig. 93). W hile stim u la ted  by an ti-Ig  
trea tm en t, B cells from mice exposed to ES-62 had reduced p ro liferative  
response (fig. 94-95). In teresting ly , it  was shown th a t  in  different doses 
ES-62 has opposite effects on both apoptosis and pro liferation  of splenic B 
cells (fig. 96). However, the  m olecular basis to th is  phenom enon is still 
unclear.
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5.9.3 B-1 cell responses
Finally, the  responses of B-1 cells from the  peritoneal cavity w ere 
compared to o ther peripheral B cells. As reported previously [38], th ese  
cells proliferate a t a  sim ilar ra te  to other pe riphera l B cells upon BCR 
cross-linking. Furtherm ore , B-1 cells also undergo su b s tan tia l level of 
apoptosis during  th is response (fig. 98). U sing a  n a tu ra l epitope, th e  
phosphorylcholine on the  ES-62 molecule, it  w as possible to show th a t  
continuously exposed B-1 cells do proliferate a t a  h igher ra te  th a n  non ­
exposed cells (fig. 99). In teresting ly , a  second encounter w ith  an tigen  (as 
mimicked by in vitro an ti-Ig  stim ulation) has a  very  lim ited effect in  
enhancing fu rth er proliferation. This effect can be encouraged, though , 
by addition of Caspase inhibitors. The basis for th is  encouragem ent is 
unclear and has not previously observed. Together w ith  the  dependency 
of IgM expression (as opposed to its  replacem ent w ith  IgD), th is evidence 
draw s previously undescribed parallels betw een B-1 cells an d  
tran sitio n a l B cells in the  bone m arrow. Moreover, both populations a re  
strongly dependent on B tk expression as shown w ith  cells derived from 
Xid mice. I t is possible th a t adu lt mice B-1 cells are in  fact an  unique type 
of tran s itio n a l B cells which undergo positive and not negative selection 
and m igrate  to the  peritoneal cavity [17]. This m ay happen  due to th e ir  
two specific features: (i) no IgD expression, w hich is required  for 
m igration to other peripheral sites [6]; (ii) res tric ted  usage of m u heavy  
chains w ith  cross-reactiv ity  to selfantigens which exist in the  bone 
m arrow. Such cross-reaction w ith  selfantigens m ay provide sufficient 
signal for B-1 cells to survive and m igrate to the  periphery. I t  is also 
possible th a t  because B-1 did not complete the B-2 m a tu ra tio n  route th ey  
are diverted m ainly to a different site, nam ely the  peritoneal cavity. T his 
suggestion is supported by fresh evidence of the  sim ilarities betw een 
m arginal zone B cells and B-1 cells in  th e ir positive selection in the  bone 
m arrow  [21].
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5.10 Summary
This chap ter has focused on the  charac teristics of peripheral B cells and  
th e ir stim ula tion  via the  BCR. In  addition, the  q u an tita tiv e  and  
qualita tive  requ irem en ts for affinity m atu ra tio n  of GC B cells have  
differed, dependending on the  site of activation. I t w as show here th a t B 
cells in  G erm inal C entres act differently th a t those outside the  GCs - for 
example, displaying enhanced apoptosis, involving reduction  in th e ir  
m itochondrial po tential and  Caspase activation in  response to BCR cross- 
linking. They also have exhibit differential responses in  the  absence of 
B tk - thus, Btk'^' GC B cells are hyper-responsive to BCR stim u la tion , 
w hilst non-GC B cells are hypo-responsive.
B cells in the spleen and the  lym ph nodes were found to have d ifferent 
proliferation profiles in  response to BCR stim ulation , w hen norm ally th e  
lymph nodes typicaly requ iring  lower antigen  for activation.
B-1 cells have also been shown to undergo BCR-induced apoptosis, w h ich  
is C aspase-dependent and and were also strongly dependent on IgM an d  
Btk for th e ir responsiveness to BCR stim ulation.
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F ig u re  69: D ifferen ces  b e tw e en  sp len ic  and  lym p h  n od e  B cells.
Cells from spleens and lym ph nodes of the sam e mice (n=5) were s ta in ed  
upon sacrifice w ith  anti-B220-APC (1:40) subjected to P I incorporation . 
DNA content of (B220*) B cells was determ ined as descibed in M ateria ls  
and M ethods.
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F igu re  70: P ro lifera tio n  o f  w h o le  sp lee n  cu ltu res . Proliferation w as 
assessed by m easurem ent of DNA synthesis by whole spleen cells. Cells 
(5x10® cells/well) were trea ted  for 2d w ith  anti-Ig  (O-lOOpg/ml) w ith  or 
w ithout anti-CD40 (lOpg/ml), IL-4 (lOU/ml) or th e ir  com binations as 
indicated. The levels of [®H]-Thymidine incorporation into DNA w ere 
m easured after fu rther 4h. D ata  are expressed as m eans ± SD {n=3) from 
a single experim ent.
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F ig u re  71: P ro life ra tio n  o f  B c e lls  in  sp leen  c u ltu r es  in  r e sp o n se  
to  BCR stim u la tio n . Whole spleen cells (10® cells/sam ple) w ere 
incubated w ith  anti-Ig  (0-50pg/ml) for 2d. Cells w ere sta ined  w ith  an ti- 
B220-APC (1:100) and th en  subjected for PI incorporation to determ ine  
DNA content. Populations are  shown for B220^ B cells.
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F ig u re  72: C h an ges in  c e ll c y c le  p ro file  o f  sp le n ic  B c e lls  u p o n  
stim u la tio n . Isolated (CD43") B cells (10® cells/sam ple) from the spleen 
(a) or the  lymph nodes (b) were incubated  for 2d w ith  an ti-Ig  (0-50pg/ml), 
anti-CD40 (O-lOpg/ml), IL-4 (O-lOU/ml) or th e ir com binations as 
indicated. The cells were th en  subjected for PI incorporation to determ ine  
DNA content.
179
ab
Fernale-Spleen.O O 'î
o
Germinal Centre B cells
non-GC B cells
FL1-H
CD19
non-G C  B cells GC B cells
2N2N
S-
<2N
>2N >2N<2N
FL3-H FL3-H
DNA content
non-GC B cells 
GC B cells
<2N
7%
27%
ü
82%
57%
>2N
12%
16%
Fig. 73
F ig u re  73: Id e n t if ic a t io n  o f  G erm in al C entre B c e lls  an d  th e ir  
c e ll c y c le  p ro file . Typical d a ta  is shown for female CBA/N mice w h ich  
had upon sacrifice ~9% GC B cells. Cells from 5 spleens w ere stained  w ith
anti-CD 19 (l:100)+anti-rat-F IT C  (1:200) and PNA-biotin (1:500)+
>1
streptavidin-A PC (1:100) and then  subjected to PI incorporation. In  panel 
a the  gating  for GC B cells is shown (the CD 19^ PNA^ population). In  
panels b and c, gating  of DNA content is shown for each population. The 
<2N DNA population is apoptotic cells, the  2N DNA population is cell in  
G(/Gi and the  >2N DNA population is cells in  S, Gg and M phases.
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F ig u re  74: In d u ctio n  o f  IgD^ B ce ll e x p a n s io n  in  v itro . Iso lated  
(CD43 ) splenic B cells (10® cells/sample) were incubated  for 2d w ith  an ti- 
Ig (0-50pg/ml), anti-CD40 (0-15pg/ml), IL-4 (O-lOU/ml) or th e ir  
com binations as indicated. Cells were sta ined  w ith  an ti-d e lta  
chain+anti-rat-IgG -FIT C  and th e ir  percentage w as determ ined from th e  
whole population.
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F ig u re  75: In d u ctio n  o f  G erm in al C entre B c e ll e x p a n s io n  b y  
BCR s t im u la tio n . Whole spleen cu ltu res (10® cells/sam ple) w ere 
stim ulated  w ith  O-lOOpg/ml anti-Ig  for 18h. The cells th en  sta ined  w ith  
PNA-FITC (1:500) and percentage of PNA^ (GC B) cells w as determ ined  
by flow cytometry.
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F ig u re  76: I iid u c tio n  o f  a p o p to s is  by  a n ti-Ig  trea tm en t is  
e n h a n ce d  in  G erm in al C entre B cells . Whole spleen cells (10® 
cells/sample) were stim u la ted  w ith  0-50pg/ml an ti-Ig  for 2d. A fter 
sta in ing  w ith  CD19-FITC (1:20) and PNA-biotin (l:500)-hstreptavidin- 
APC (1:100), cells were subjected to PI incorporation. Non-GC B cells a re  
the CD 19^ PNA population, w hereas GC B cells are the  CD 19^ PNA^ 
population. Subdiploidity was determ ined as the  percentage of cells w ith  
less th an  2N DNA.
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Fig. 77
F ig u re  77; T he p r im ary  resp o n se  to  a n tig e n  o f  H EL-BCR m ice .
Proliferation in  whole spleen (a) or lym ph node (b) cells from MD4 mice 
(5x10® cells/well) were was assessed by m easurem ent of DNA syn thesis . 
Cells (5x10® cells/well) were trea ted  for 2d w ith  anti-Ig  (O-lOOpg/ml), DEL 
(O-lOOpg/ml), HEL (O-lOOpg/ml) or an ti-Ig  (5pg/m l)+anti-CD40 (lOpg/ml). 
The levels of [®H]-Thymidine incorporation into DNA w ere m easured  a fte r 
fu rth e r 4h. D ata  are expressed as m eans ± SD (n=3) from a single 
experim ent.
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F ig u re  78: E x p a n sio n  o f  GC B c e lls  in  resp o n se  to  a n tig e n  in  th e  
sp leen  an d  in  th e  lym p h  n o d es. Whole spleen (a) or lym ph node (b) 
cells (10® cells/sample) from MD4 mice were stim u la ted  w ith  anti-Ig  (0- 
50pg/ml), DEL (O-lOOpg/ml) or HEL (O-lOOpg/ml) for 2d. Cells w ere 
counted and sta ined  w ith  CD19-FITC (1:20) and PN A-biotin 
(l:500)+streptavidin-A PC  (1:100). GC B cells were CD 19^ PNA^ cells and  
non-GC the CD19+PNA cells.
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F ig u re  79: C h an ges in  th e  m ito ch o n d r ia l p o te n tia l o f  s t im u la te d  
sp len ic  B cells . Isolated (CD43 ) splenic B cells (10® cells/sample) w ere 
stim ulated  for 2d w ith  anti-Ig  (0-50pg/ml), anti-CD40 (0-15pg/ml), IL-4 (0- 
lOU/ml) or th e ir combinations as indicated. The cells were analysed w ith  
the  m itochondrial dye DiOCg (3). The m itochondrial po ten tial w as 
determ ined by the  m ean fluorescence of the  dye.
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F ig u re  80: C h an ges in  th e  m ito ch o n d r ia l p o te n tia l o f  G erm in a l 
C entre B c e lls  u p on  stim u la tio n . Whole spleen cells (10® cells/sam ple) 
were trea ted  for 3d w ith  0-50pg/ml anti-Ig  w ith  or w ithou t anti-C D 40 
(lOpg/ml), IL-4 (lOU/ml) or zVAD-fmk (lOOpg/ml). Cells were sta ined  w ith  
PNA-biotin (l:500)+streptavidin-A PC  (1:100) and th en  for th e  
m itochondrial dye DiOCg (3). The m itochondrial potential of PNA^ (GC B) 
cells w as determ ined by the  m ean fluorescence of the  dye.
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F ig u re  81; E n h a n cem en t o f  CD19 ex p r ess io n  b y  BCR s t im u la tio n .
Whole spleen (a) or lym ph node (b) cells (10® cells/sam ple) were in cuba ted  
w ith  or w ithout 50pg/ml anti-Ig  for 2d. After s ta in ing  w ith  CD19-FITC 
(1:20), CD 19 surface expression was determ ined by flow cytometry.
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F ig u re  82: CD19 is  ex p r essed  a t h ig h e r  le v e ls  on  GC B c e lls  th a n  
on  non-GC B ce lls . Whole spleen cells (10® cells/sam ple) were in cuba ted  
w ith  or w ithout 50pg/ml anti-Ig  for 2d. After s ta in ing  w ith  CD19-FITC 
(1:20) and PNA-biotin (l:500)+streptavidin-A PC  (1:100), CD19 su rface  
expression is shown for PNA cells (a) and PNA^ cells (b).
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F ig u re  83: D efec ts  in  BCR in d u c e d  p r o life r a tio n  o f  X id d e r iv e d  
sp len ic  B cells . Whole spleen cells (10® cells/sample) from e ither fem ale 
(WT) or m ale {Xid) CBA/N mice were stim ulated  w ith  0-50pg/ml an ti-  
Igfor 2d. Cells counted and sta ined  w ith  CD19-FITC (1:20) and  PNA- 
biotin (l:500)+streptavidin-A PC (1:100). Non-GC B cells (a) are  the  CD 19^ 
PNA population, w heres GC B cells a re  the CD 19^ PNA^ population (b).
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F igu re  84; C asp ase  in h ib it io n  sp e c if ic a lly  su p p o rts  e x p a n s io n  o f  
G erm in al C entre B c e lls  in  th e  a b sen ce  o f  F as. Whole lym ph node 
cells (10® cells/sample) from Ipr mice were stim u la ted  for 2d w ith  0- 
50pg/ml anti-Ig  w ith  or w ithout lOpM Ac-DEVD-CHO. After s ta in in g  
w ith  CD19-FITC (1:20) and PNA-biotin (l;500)+streptavidin-A PC  (1:100), 
the percentage of e ither non-GC B cells (CD 19^ PN A ) or GC B cells 
(CD19^PNA^) was determ ined by flow cytometry.
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F igu re  85: E n h a n ced  a p o p to s is  in  th e  G erm in al G en tres o f  IgM  
d er iv ed  sp leen s. B cell populations from the spleens of e ither WT or 
BALB/c mice were determ ined upon sacrifice by CD19-FITC (1:20) 
and PNA-biotin (l:500)+streptavidin-A PC  (1:100) sta in ing  and PI 
incorporation to determ ine DNA content. G erm inal B cells are  CD 19^ 
PNA^ and non-GC B cells are the  CD19^ PNA' population.
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F ig u re  86: R esp o n ses  o f  p er ip h era l B c e lls  in  IgM^ cu ltu res .
Proliferation in  whole spleen (a) or lymph node (b) cells from 
BALB/c mice was assessed by m easurem ent of DNA synthesis. Cells 
(5x10® cells/well) were trea ted  for 2d w ith  anti-Ig  (O-lOOpg/ml), Ac-DEVD- 
CHO (O-lOpg/ml), anti-CD40 (O-lOpg/ml), IL-4 (O-lOU/ml), LPS (50pg/ml) 
or th e ir com binations as indicated. The levels of [®H]-thymidine 
incorporation into DNA were m easured  after fu rth e r  4h. D ata  a re  
expressed as m eans ± SD (n=3) from a single experim ent.
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F ig u re  87: IgM   ^ lym p h  n o d es  d iffer  from  w ild -ty p e  lym p h  n o d e s  
in  th e ir  G erm inal C entre B c e ll  co n ten t. B cell populations from th e  
lymph nodes of e ither WT or BALB/c mice w ere determ ined upon
sacrifice by CD19-FITC (1:20) and PNA-biotin (l:500)+ strep tav id in-A PC  
(1:100) sta in ing  and PI incorporation to determ ine DNA content. 
G erm inal B cells are CD 19^ PNA^ and non-GC B cells are the  CD 19^ 
PNA population.
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F ig u re  88: BCR r esp o n ses  in  IgM  lym p h  n o d e s  lea d s  to  ce ll  
d ea th  and  n o t to  lo ss  o f  IgD  e x p ress io n . Whole lym ph nodes from 
IgM  ^ BALB/c mice were trea ted  w ith  0-50pg/ml an ti-Ig  for 2d. B cell 
populations were determ ined upon sacrifice by an ti-delta  c h a in  
(l:50)+anti-rat-IgG -FITC  (1:100) and  anti-B200-APC (1:40) sta in in g  an d  
PI incorporation to determ ine DNA content. B cells were B220^ cells.
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F ig u re  89; In d u c tio n  o f  G erm in al C en tres in  HEL BCR MD4 
m ice. MD4 mice were pre-im m unised w ith  PBS, lOOpg DEL or lOOpg 
HEL and sacrificed on day 8 w hen the  G erm inal C entre reaction  is a t its  
peak. The cells were counted and then  sta ined  w ith  an ti-C D  19 
(l:100)+anti-rat-F IT C  (1:200) and PNA-biotin (l:500)+ strep tav id in-A PC  
(1:100). (a) PN 4 binding of CD 19^ B cells from each spleen, (b) Total 
num ber of splenic (CD 19^) B cells upon sacrifice, (c) N um ber of splenic 
(CD19^PNA^) GC B cells upon sacrifice. Sim ilar resu lts  w ere observed in  
the lymph nodes (not shown).
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F ig u re  90: T he seco n d a ry  resp o n se  in  th e  sp le e n  o f  H EL-BCR  
m ice  an d  its  e ffe c t o n  in  v i t r o  B ce ll s t im u la tio n . MD4 mice w ere 
pre-im m unised w ith  e ither PBS control, lOOpg DEL or lOOpg HEL. A fter 
8d, proliferation in whole spleen cells was assessed by m easu rem en t of 
DNA synthesis. Cells (5x10® cells/well) were trea ted  for 2d w ith  an ti-Ig  (0- 
50pg/ml), DEL (O-lOOpg/ml), HEL (O-lOOpg/ml) or an ti-Ig  (5pg/m l)+anti- 
CD40 (lOpg/ml). The levels of [®H]-Thymidine incorporation into DNA 
were m easured after fu rth er 4h. D ata  are  expressed as m eans ± SD (n=3) 
from a single experim ent.
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F ig u re  91: E x p a n sio n  o f  GC B c e lls  d u r in g  se co n d a r y  r e sp o n se s  
in  th e  sp leen . MD4 mice were pre-im m unised w ith  e ith e r PBS control, 
lOOpg DEL or lOOpg HEL. After 8d, mice were sacrified and  whole spleen 
cells (10® cells/sample) stim ulated  for 2d w ith anti-Ig  (0-50pg/ml), DEL (0- 
Ipg/m l) or HEL (0-lpg/m l). Cells were counted and sta ined  w ith  CD19- 
FITC (1:20) and PNA-biotin (l:500)+streptavidin-A PC  (1:100). P ercen tage  
of GC B cells (CD 19^ PNA"*") in  each sam ple was calculated from th e  
num ber of to ta l B cells.
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Fig. 92
F ig u re  92: T he seco n d a ry  resp o n se  in  th e  lym p h  n o d es  o f  HEL- 
BCR m ice  an d  its  e ffe c t on  i n  v i t ro  B c e ll s t im u la tio n . MD4 mice 
were pre-im m unised w ith  e ither PBS control, lOOpg DEL or lOOpg HEL. 
After 8d, proliferation in  whole lym ph node cells was assessed by 
m easurem ent of DNA synthesis. Cells (5x10® cells/well) w ere trea ted  for 
2d w ith  anti-Ig  (0-50pg/ml), DEL (O-lOOpg/ml), HEL (O-lOOpg/ml) or an ti- 
Ig (5pg/m l)+anti“CD40 (lOpg/ml). The levels of [®H]-Thymidine 
incorporation into DNA were m easured  after fu rth e r  4h. D ata  a re  
expressed as m eans ± SD {n=3) from a single experim ent. ND = not done.
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F ig u r e  93: I n d u c t io n  o f  GC B  c e lls  in  sp le e n  o f  ES-62 t r e a te d  
m ice . Whole spleen cells (10® cells/sample) from mice tre a te d  
continuously w ith  0-2pg/h ES-62 were counted and sta ined  upon  
sacrifice w ith  PNA-FITC (1:500). Percentage of PNA^ (GC B) cells w as 
determ ined by flow cytometry.
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F ig u re  94; BÙR stim u la tio n s  o f  sp leen  c u ltu r e s  from  ES-62 
trea ted  m ice  an d  th e  e ffec t o f  C asp ase  in h ib it io n . Proliferation in  
whole spleen cu ltu res from mice exposed continuously w ith  0-2pg/h ES- 
62 (5x10® cells/well) were w as assessed by m easu rem en t of DNA 
synthesis. Cells (5x10® cells/well) were trea ted  for 2d w ith  anti-Ig  (0- 
50pg/ml) w ith  or w ithout lOpM zVAD-fmk. The levels of [®H]-Thymidine 
incorporation into DNA were m easured  after fu rth e r  4h. D ata  a re  
expressed as m eans ± SD {n=3) from a single experim ent.
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F ig u re  95: BCR stim u la tio n s  o f  lym p h  n od e  c u ltu r es  from  ES-62  
trea ted  m ice  and  th e  e ffec t o f  C asp ase  in h ib it io n . Proliferation in  
whole lym ph node cu ltures from mice exposed continuously  w ith  0-2pg/h 
ES-62 (5x10^ cells/well) w ere was assessed by m easu rem en t of DNA 
synthesis. Cells (5x10^ cells/well) w ere trea ted  for 2d w ith  anti-Ig  (0- 
50pg/ml) w ith  or w ithout lOpM zVAD-fmk, The levels of [^H] -Thym idine 
incorporation into DNA were m easured  after fu rth e r 4h. D ata  a re  
expressed as m eans ± SD (n=3) from a single experim ent.
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F ig u re  96: S p len ic  G erm in al C en tre  B c e lls  from  ES-62 trea ted  
m ice  - r esp o n ses  to  BCR stim u la tio n . Whole spleen cells (10® 
cells/sample) from mice trea ted  continuously w ith  0-2pg/h ES-62 w ere 
stim ulated  for 18h w ith  0-50pg/ml anti-Ig. Cells were th en  sta ined  w ith  
PNA-FITC (1:500) and  subjected to P I incorporation in  order to de te rm ine  
DNA content.
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F ig u re  97; P ro life ra tio n  o f  B-1 ce lls . Proliferation  of peritoneal 
cavity B cells w as assessed by m easurem ent of DNA synthesis. Cells 
(2.5x10^ cells/well) were trea ted  for 2d w ith  anti-Ig  (0-50pg/ml) for 2d. The 
levels of [^H]-Thymidine incorporation into DNA w ere m easured  a fte r 
fu rth er 4h. D ata  are expressed as m eans ± SD {n=3) from a single 
experim ent.
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F ig u re  98: T he B-1 p o p u la tio n  d o es  n o t e x p a n d  in  r e sp o n se  to  
BCR st im u la tio n  in  v itr o  b u t u n d erg o es  a p o p to s is . P eritoneal 
cavity B cells (10® cells/sam ple) were stim ula ted  w ith  0-50pg/ml an ti-Ig  
for 2d and counted. Cells were subjected to PI incorporation  and  
percentage of subdiploidity w as determ ined according to cells w ith  less 
th an  2N DNA.
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F ig u re  99: BCR stim u la tio n s  o f  p e r ito n ea l c a v ity  B c e lls  from  ES- 
62 trea ted  m ice  an d  th e  e ffec t o f  C asp ase  in h ib it io n . P ro lifera tion  
in  peritoneal cavity B cell cu ltu res from mice exposed continuously  w ith  
0-2pg/h ES-62 (5x10® cells/well) were assessed by m easu rem en t of DNA 
synthesis. Cells (5x10® cells/well) were trea ted  for 2d w ith  anti-Ig  (0- 
lOOpg/ml) w ith  pr w ithout lOpM zVAD-fmk. The levels of [^H]-Thymidine 
incorporation into DNA were m easured  after fu rth e r 4h. D ata  a re  
expressed as m eans ± SD (n=3) from a single experim ent.
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F ig u re  100: P ro life ra tio n  o f  p e r ito n e a l c a v ity  B c e lls  from  IgM   ^
m ice. Proliferation of peritoneal cavity B cells from IgM   ^ BALB/c mice 
was assessed by m easurem ent of DNA synthesis. Cells (2.5x10® cells/well) 
were trea ted  for 2d w ith  anti-Ig  (0-50pg/ml) w ith  or w ithout Ac-DEVD- 
CHO (lOpM). The levels of [®H]-Thymidine incorporation into DNA w ere 
m easured after fu rth er 4h. D ata  are  expressed as m eans ± SD (t2=5 ) from 
a single experim ent.
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F ig u re  101: The an ti-Ig  r e sp o n se  in  p e r ito n ea l c a v ity  B  c e lls  from  
Xid m ice . Peritoneal cavity B cells from m ale Xid (B tk ‘^ ) mice (10® 
cells/sample) were stim ula ted  w ith  0-50pg/ml an ti-Ig  for 2d and counted.
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Chapter 6. GENERAL DISCUSSION
This thesis has focused on identifying the  key cellu lar and  m olecu lar 
m echanism s underly ing  B cell selection. Special a tten tio n  has been  
a ttrib u ted  to the selection of im m ature  B cells using  both the cell line 
model, W EHI-231, and  experim ents investigating  B cell developm ent in  
ex vivo bone m arrow  cultures. Com paritive experim ents were also 
perform ed on bone m arrow  and peripheral B cell cu ltu res to compare and  
con trast selection processes during  other stages of B cell selection, 
particu larly  focusing on G erm inal C entres and the  peritoneal cavity.
6.1 The WEHI-231 cell line as a model for B cell 
selection
The resu lts in chapter 3 have focused on the  biochemical m echan ism s 
involved in  regulation  of com m itm ent to apoptosis of im m atu re  B cells. 
For these studies the  im m ature  B cell line W EHI-231 has been employed. 
Previous studies on th is  cell line have concentrated on two re la ted  a re a s  
concerned w ith  BCR-m ediated apoptosis, namely;
(i) D eterm ination  of the im m ediate signals dow nstream  of the  BCR, 
including tyrosine kinase activity  and  phosphorylation of ta rg e t p ro te ins 
[327], calcium m obilisation and PKC activation [196].
(ii) Cell cycle re la ted  events balancing  the cell fate decision, as 
determ ined by BCR and CD40 signalling  [98]. C ontradictory  evidence 
has a risen  concerning the  involvem ent of cyclins, cdks and  ckis in  these  
processes in WEHI-231 cells [217, 328].
Therefore, it  was of in te res t to study the  in term ediate  events con tro lling  
apoptosis and its inhib ition  in  th is model. Recent discoveries of 
m itochondrial-related  events, w hich are crucial for such processes, 
provided a wide area  for investigation. The m itochondria is also a focal 
point in term s of the  Bcl-2 family and effector Caspase activity, in w h ich  
have been shown to be crucial to the regu lation  of o ther types of 
program m ed cell death  in  the  im m une system  (reviewed in  [50]). 
Therefore the  m itochondria w as an  ideal ta rg e t for investigation.
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At the  s ta r t  of th is investigation  the  m ost im portan t evidence reg a rd in g  
the  Bcl-2 fam ilv proteins suggested th en  Bc1-Xl up regu la tion  (at th e  
mRNA level) comprised p a rt of the  rescue signal m anifested by CD40 in  
WEHI-231 cells [158]. Hence, in itia l studies concentra ted  on exam in ing  
the effects of apoptotic and rescue siganls on pro tein  levels of the  Bcl-2 
family in W EHI-231 cells. The Bcl-2 fam ily is cu rren tly  known to have  
more th a n  a dozen m em bers [61] and proteins of the  th ree  m ain  
subfam ilies were found to be represen ted  in  W EHI-231 cells: an ti-  
apoptotic (Bcl-2, Bcl-x^, M cl-l, A l), short pro-apoptotic (BH3-only; Bid and  
Bad) and long pro-apoptotic (Bax and  Bak). Surprising ly , m ost of th ese  
proteins were induced w ith  anti-Ig  trea tm en t alone. However, r a th e r  
th an  a simple upregulation  of expression of a p a rticu la r Bcl-2 fam ily 
member, the rescue signal was m apped to a bias in the  balance betw een 
Bcl-2 proteins, inducing Bcl-x^ levels and  blocking of Bad and Bid en try  to 
the m itochondria (fig. 27).
A m ajor observation w as th a t  although depolarisation  of th e  
m itochondrial potential occurs dow nstream  of the  BCR signal, it  is no t 
accompanied by cytochrome C release as in o ther system s (fig. 29). This 
evidence has been confirm ed now by others [78]. This u n iq u e  
m itochondrial m echanism  has prom pted careful investigation  into th e  
role Caspases play in  im m atu re  B cell deletion. M ost reports w hich w ere 
published during  the  course of th is  work have used very h ig h  
concentrations of Caspase inh ib ito rs to block cell death  [291, 328]. U sing  
lower and mcire specific inh ib ito r concentrations has provided 
contradictory  evidence to th a t  of previous reports. These experim ents 
have dem onstra ted  th a t  m any protease inhib itors can su b stitu te  for 
Caspase inhib itors a t such high concentrations >100pM (table 2). 
Furtherm ore, specific C athepsin  B activ ity  was observed dow nstream  of 
the  BCR signal. Specific blockage of C athepsin  B activity, and not of 
Caspase activity, could rescue WEHI-231 cells from BCR-induced 
apoptosis (fig. 34).
Previous work in  the  group has shown th a t cPLAg is specifically 
expressed in  lym phocytes only w hen they  are subjected to negative  
selection [171]. F u rth e r  studies shown here have confirm ed th a t  cPLA^ 
plays a m ajor role in  BCR-induced apoptosis of W EHI-231 cells. T his
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enzyme was she vn to m igrate  to the  m itochondria as determ ined  by bo th  
im m unohistochem istry  and activity  assays. A detailed screening for a 
possible fu rth e r m etabolism  of its product, arachidonic acid, failed to 
identify any candidates, which were involved in apoptosis (fig. 21-22). In  
contrary, the  d a ta  suggested th a t  AA w as the active m etabolite and th a t  
m etabolism  by COX or LOX pathw ays were u tilised by rescue signals. 
In terestingly , trea tm en t of cells w ith  arachidonic acid a t a  concen tra tion  
th a t  by itse lf is sufficient to cause apoptosis in these cells did not induce, 
in some cases (for example, Bcl-2 fam ily protein expression), the  sam e 
effects as IgM crosslinking, in  term s of regulation. N onetheless, bo th  
BCR-induced cPLAg activity  and AA by itse lf do not facilitate  PARP 
cleavage. A possible m echanism  w as identified here by the  fact th a t  some 
of the induced cPLA^ activ ity  is located in the  m itochondria (fig. 19). 
F u rth e r  resu lts  have shown th a t Bc1-Xl is sufficient to block AA (and 
anti-IgM ) induced apoptosis. This m ay indicate th a t  AA production  
serves in  the m itochondrial m em brane d istu rbance m echanism  and no t 
as a second m essenger by itself.
A nother im portan t aspect of the  m itochondrial pa rtic ipa tion  in  apoptosis 
is the  potential involvem ent of calcium  hom eostasis. Evidence here and  
by others [301], has shown th a t cyclosporin A is suffcient to reverse  
apoptosis in WEHI-231 cells. This im m unosupressor has been shown to 
have an  effect on a varie ty  of ion channels v ia m em brane-bound 
cyclophillins. CsA blocks IP3-sensitive Ca+  ^ channels in  the  ER as well as 
the m itochondrial PTP [250]. Calcium  release, together w ith  IP3 
production, are well docum ented events dow nstream  of BCR stim ula tion . 
Therefore, it is possible th a t  the  m itochondria takes p a rt in  d e te rm in in g  
calcium release p a tte rn s  from the ER th rough  local buffering, as 
suggested for other system s. There is a whole varie ty  of factors th a t  m ay 
be influenced by such modeling. cPLAg is calcium dependent, su g g estin g  
a d irect contribution of calcium  for cell death  in th is  cell line. I t is 
tem pting  to speculate th a t o ther calcium -sensitive factors, inc lu d in g  
PKC isoforms and calcineurin  [254], can also have an  active role in  
determ ining  cell fate, especially th rough  regulation  of tra n sc r ip tio n  
factors [166]. Possible links betw een all of these events are given in fig. 
102 .
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The rescue of WEHI-231 cells from BCR-induced apoptosis happens in th e  
tim e window betw een 16 and 24 hours (fig. 14). This indicates th a t  a 
“point of no re tu rn ” m ay exist, around 24h post-stim ulation , w hen cell 
fate cannot by reversed by CD40 signalling. Protease activ ity  w as show n 
to be essen tia l for complete effect of BCR stim ulation, grow th a rre s t and  
apoptosis. A lthough the  specific protease could not be identified, it  is 
likely to be C alpain [78]. A lthough blockage of C athepsin  B ac tiv ity  
prevented BCR-m ediated apoptosis, C athepsin  inh ib ition  did not block 
BCR-induced grow th a rre s t (fig. 35). I t  is also possible th a t  Caspase-7 is 
utilised as an  in tia to r Caspase, ra th e r  th a t an  effector Caspase, in th is  
model [78].
Im portantly, the  effect of IgM crosslinking on grow th and dea th  suggests  
the  involvem ent of cell cycle regu la to rs in th is  process. E a r lie r  
investigations by o thers used m anipu lated  W EHI-231 cells. This evidence 
is not necessarily  physiologically relevant, since m an ipu lation  such as 
over-expression of Bcl-x^, m ay effect cell cycle events [66, 329]. The 
resu lts p resented  here, however, m ay suggest th a t Mdm2 binding to p53 
and its resu lting  degradation, is essen tia l for the  surv ival of these cells. 
This evidence fu rth er supports the  theory of an  inna te  suicide m ach ine  
w ith in  the cell. T hat m ay also re la te  to resu lts  in vivo regard ing  a 
continuous signal which is essen tia l for the  survival of im m ature  B cells. 
The role of ROS in determ in ing  cell fate is not fully understood. Some 
evidence exists th a t lower levels of ROS production m ay contribute to 
proliferation. C onsistent w ith  this, observations w here m itochondria l 
inhib itors contribute to cell cycle progression in  W EHI-231 cells (fig. 13) 
support th is speculation. Inh ib ito r studies suggested NO and de novo 
ceram ide synthesis m ay have protective effect on B cell p ro liferation . 
These observation m ay also be linked to AA production which is 
docum ented to cause uncoupling of m itochondrial resp ira tion  and in  th is  
way to promote ROS production [330]. This m ay prove to be one of th e  
m issing links betw een the m itochondrial events and  cell cycle events in  
apoptosis. Fref^h evidence regard ing  p53 translocation  to th e  
m itochondria [126] and  its  known sensitiv ity  to ROS [331] m ay provide 
such a link. For example it  is possible th a t m itochondrial in stab ility  is
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detected by p53, which in  tu rn  is phosphorylated in order to exert its cell 
fate decisions in  the  nucleus.
6.2 B cell selection in the bone marrow and in the 
periphery
The discovery of tran s itio n a l B cells has questioned the classical model, 
which proposes th a t  B cell selection takes place a t the  im m atu re  stage. 
Previously it w as thought th a t  im m ature  B cells a re  fully selected in  th e  
bone m arrow  and non-self-reactive cells em igrate v ia the  sinuses to 
create the  naive B cell pool in  the  periphery. W ith the  identification of 
tran s itio n a l stages, some persisting  in the  periphery  [9], th is  model h a s  
been challenged in  some of its core assum ptions:
(i) W hich types of B cells are deleted?
(ii) W hich types of B cells undergo receptor editing?
(iii) Does deletion occur in  the  periphery?
N evertheless, there  is still strong evidence th a t m ost im m ature  B cells do 
not eventually  reach  the  periphery  [6]. Moreover, the  reperto ire  in  th e  
naive B cell pool is more res tric ted  th an  in  the  bone m arrow  an d  
therefore selection process m ust take  place before en try  to the  naive pool.
A sum m ary of the  observations m ade in  the  ex vivo bone m arrow  cu ltu res , 
and in  other p rim ary  B cell cu ltures, is given in  figure 103. Possibly, th e  
m ost im portan t finding is th a t  even upon polyclonal stim ulation , some 
im m ature  B cells escape the  negative selection and become m atu re  cells. 
This observation m ay re la te  to suggestions of continuous s tim u la tio n  
(“BCR tickling”) which is needed for B cell survival and  even developm ent 
[9, 332].
Two models of selection have been proposed based on the available data: 
T he in s tr u c tiv e  m od el
In  th is model the sole factor w hich determ ines the  fate of B cells before 
entry  to the naive pool is BCR specificity. Thus, exposure to se lfan tigens 
in the  bone m arrow  in stru c t B cell development - if  a  B cell is self-reactive 
it will e ither be deleted by apoptosis or undergo a  lim ited num ber of
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receptor editing a ttem pts. An in te res tin g  possibility is th a t  while some 
im m ature  B cells are  deleted in the  bone m arrow  due to selfreactiv ity , 
tran s itio n a l B cells in  the  periphery  will m ainly  undergo recep to r 
editing. This model is supported by some resu lts  show n in  chap ter 4: 80- 
90% of im m ature  B cells are deleted by BCR stim u la tion  (fig. 39) and  
grow th a rre s t has been induced in  parallel to apoptosis in tran s itio n a l B 
cells (fig. 42). Furtherm ore , only a sm all num ber of B cells escapes 
deletion via th e ir BCR, using  polyclonal stim ulation. Therefore, it  is 
feasible th a t B cells rely solely on BCR stim ula tion  to determ ine th e ir  
fate.
The s to c h a s t ic  m od el
This model proposes th a t  specificity is not the  only m echan ism  
underly ing  B cell selection. For example, it is possible th a t  com petition 
for environm ental niches in the  bone m arrow  and the  periphery  plays a 
m ajor role in  lim iting  B cell num bers. Two observations m ade in  th is  
thesis support th is model:
(i) T ransitional B cells are Fas-sensitive even in  the  absence of s tro n g  
BCR stim ulatioij. This sensitiv ity  has also been reported  by others [8].
(ii) Some B cells escape polyclonal stim ulation  of the  BCR - a  s tim u lu s  
which theoretically  should delete all im m atu re /transitional B cells.
In  such a stochastic model, genetic predisposition of the  im m ature  and  
tran s itio n a l B cells m ay play a p a rt in determ in ing  which of them  will 
u ltim ately  survive selection. Supporting  th is suggestion are resu lts  in  
im m ature B cells. At least some of these bone m arrow  cells induce, r a th e r  
th an  reduce, Bcl-x^ and Bcl-2 levels in  response to an ti-Ig  trea tm e n t (fig. 
41). Therefore it is possible, th a t  surviving cells are  the  cells which can  
induce survival factors in  response to B C R -stim ulation.
Obviously, the^e are m any aspects to be exam ined u n til th ese  
observations can allow the models described above to be reconciled. Two 
aspects m ay prove the  m ost im portan t, in rela tion  to determ ination  of 
stochastic elem ents in B cell selection:
F irstly , identification of factors assisting  im m ature B cell surv ival in th e  
bone m arrow. Thy.l*^^” cells, of as yet unidentified  lineage, have been
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identified as such a factor [12]. Moreover, T h y .l'’"'* cells in te rac t d irec tly  
w ith  im m atu re  B cells in  the  bone m arrow . O bservations here did no t 
support a role for CD40L or IL-4 (not shown) as possible factors involved 
in  the  rescue (ra th e r th a n  supporting  survival) of im m atu re  or 
tran sitional B cells from apoptosis. Therefore, the  n a tu re  of help from th e  
bone m arrow  environm ent is still to be found. Moreover, it  is possible th a t  
tran sitional B cells need ano ther T cell dependent rescue signal, such as 
via MHC class II or B7.2 [313].
Secondly, the  link betw een Fas expression and BCR stim u la tion  is 
aw aiting exploration. I t  is possible th a t  a certa in  level of Ig c ross-link ing  
causes upregu la tion  of Fas expression on the cell surface. A tem p tin g  
connection to receptor editing can be m ade - it  is possible th a t  
tran s itio n a l B cells w hich failed th is  process up regu la te  Fas and m ake 
them selves susceptible for deletion in  th is  m anner.
Most of chapter 5 characterised  the  responses of B cells in  the spleen an d  
the lym ph nodes. Special a tten tion  w as given to the  response to an ti-Ig  in  
GC and non-GC B cells a t both sites. In  the  p rim ary  response, GC and  
non-GC B cells differ in th e ir  ra te s  of proliferation and  survival. O utside  
the  GCs, resting  B cells a re  activated  quickly and pro liferate  w ith in  24h. 
In  contrast, GC B cells undergo first su b s tan tia l apoptosis before th e  
survivors s ta r t  to proliferate la te r (48h; fig. 76). F igure 103 illu s tra te s  
how B cells are  selected via different m echanism s du ring  th e ir  life span. 
Most notably, GC B cells appear to u tilise  sim ilar BCR-induced deletion 
m echanism s to these of tran s itio n a l B cells. The BCR signal is 
transduced  to the  m itochondria and excutes cell d ea th  in  a C aspase- 
dependent m anner (fig. 80). N onetheless, B tk plays a different role in  
these developm ental phases. For example, tran s itio n a l B cells can n o t 
develop fu rth e r in  the  absence of Btk. In  contrast, generation  of B tk  ^  GC 
B cells w as accelerated and  w as lim ited m ainly because of low p e rip h e ra l 
B cell num ber (fig. 83). In  fact, in  th is  aspect, these  GC B cells resem bled  
Btk^ im m ature  B cells, w hich showed b e tte r surv ival th a n  norm al cells. 
Taken together, th is evidence m ay suggest two independen t p a th w ay s 
which are in tia ted  via the  BCR - a m itochondrial pa thw ay  and a Btk-
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dependent pathw ay. In each selection step in  B cell developm ent these  
pathw ays can have different functional outcomes and therefore can  
differntialy determ ine the  fate of the  cell differently.
From the experim ents in  W EHI-231 cells one can speculate th a t  bo th  
calcium and cPLA^ m ay play an  im pro tan t role in the  m itochondria l 
activity downstrpam  of BCR stim ula tion  in vivo, probably in  im m ature  B 
cells, which resem bled overall the  observations in  the  cell line. A lthough  
there  is some evidence for differences in calcium  m obilisation in  a 
developm ental-stage dependent m anner [332], the  im plications of th is  
evidence are not clear. Precise observations regard ing  calcium  flux 
w ithin  the  cell are needed to link such differences to o ther developm ental- 
stage dependent m ediators, such as PKCp or c-Fos [9, 333].
6.3 Concluding remarks
In  the  course of th is thesis, the  work has progressed from dissecting a 
m echanism  of apoptosis of im m ature  B cells in  the  W EHI-231 model, to 
investigating  the  relevance of these m echanism s in vivo. Cell lines, su ch  
as WEHI-231, have two im portan t advantages: availab ility  and ease of 
m anipulation. Therefore, the  W EHI-231 model was used in  all a ssay s 
which required  a pure cell population, such as w estern  blotting, ac tiv ity  
assays etc. The evidence obtained by using th is system  w as useful in  
estab lish ing  the  BCR stim ula tion  of im m ature  B cells rec ru its  a 
m itochondria-dependent apoptotic process. This process involves a few 
components: m itochondrial phospholipase Ag activation, d isrup tion  of 
m itochondrial potential and  profound depletion of cellu lar ATP levels, b u t  
does not cause release of cytochrome C from m itochondria and is 
independent of Caspase activation. A lthough m itochondrial po ten tia l 
d isruption  is uncoupled from Caspase activation, activation  of p ro teases 
such as C athepsins does appear to play a role in  the  post-m itochondria l 
execution of apoptosis by WEHI-231 im m ature  B cells. Developm ent of 
the ex vivo bone m arrow  system  has enabled to invesigate  selection in  
prim ary  B cells. U sing th is  system , it  w as shown th a t  polyclonal 
activation of im m ature  B cells is sufficient to cause both  deletion an d
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m aturation . T ransitional B cells which were produced ex vivo were show n 
to be Fas-sensitive and B tk-dependent. In  addition, w hile BCR-induced 
apoptosis in im m ature  B cells was C aspase-independent, apoptosis of 
tran s itio n a l B cells w as C aspase-dependent. S im ilarly  to tran s itio n a l B 
cells, BCR-induçed apoptosis in GC B cells and B-1 cells was C aspase- 
dependent. V aria tion  in the  u tilisa tion  of pathw ays by BCR sig n a llin g  
during B cell developm ent w as dem onstra ted  once again  by the  fact th a t  
GC B cells had  g rea ter ra te  of proliferation in  the absence of Btk.
Recent progress in  separa tion  techniques will enhance fu tu re  
m anipulation  of these ex vivo/in vitro cultures. I t would have been of 
special in te res t to explore two particu la r directions:
(i) Isolation of different p rim ary  cell populations (im m ature  an d  
tran s itio n a l B cells, GC B cells) and  stim ulation  in vitro for d irec t 
m easures of cell cycle rela ted  events. S ignificant evidence in  th is  
direction is especially difficult to achieve using cell line models.
(ii) Sorting of B cell populations post-stim ulation  - com parison of p ro te in  
levels (for example: of the  Bcl-2 family), activ ity  (of pro teases and cPLA J 
and even heavy chain  usage (as a m easure of gene rea rran g em en t of th e  
BCR). Such experim ents can link  ex vivo the function of certa in  p ro te ins 
to signalling events in each developm ental stage. They can also be used to 
show w hether the  surviving cells are a genetically d istinc t population, 
for example, w ith in  the  whole im m ature  B cell population of the  bone 
m arrow .
Taken together w ith  the possibilities encom passed in  the  usage of 
different tansgenic mice as a  source for bone m arrow  cu ltu res, th e  
options for fa th e r studies are indeed very diverse. V aluable observations 
can be m ade also in  exploring possible additional signals to BCR an d  
CD40, which are needed for tran s itio n a l B cell survival. Novel d a ta  
obtained here regard ing  peripheral B cells have also suggested some 
additional fu ture  directions. For example:
(i) In  G erm inal C entre B cells - more com parisons are  needed in two 
different directions: betw een signals (BCR, CD40, IL-4 receptor and th e ir
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combinations); and  betw een the  behaviour of splenic and lym ph node GC 
B cells.
(ii) In  B-1 cells: exploration of th e ir C aspase-dependent BCR signal. LPS 
is also an  effctiye stim u la to r of these  cells and m ay help  to explore th e  
m echanism  of activation of these  cells.
Even from the d a ta  p resented  here  it  is a lready evident th a t  com parisons 
from different B cell selection processes are  fru itfu l. This is especially  
true  in extending the  u n d e rs tan d in g  of possible pa thw ays w hich a re  
used during  the  d istinc t stages of B cell developm ent to determ ine cell 
fate. Such knowledge can help in  trea tm e n t of various diseases re la tin g  
to the  im m une system . Lym phom as w hich could be re la ted  to a  specific 
stage in  B cell developm ent could u ltim ately  be trea ted  in  m an n er w h ich  
tackles an  unique pathw ay  com ponent used a t the  re levan t stage of 
development. Recently diffuse large B cell lym phom as w ere recognised to 
be generated  from both activated  follicular B cells and  GC B cells [334]. 
Such diseases could th u s  be trea te d  w ith  a  specific d rug  w hich ta rg e ts  
specifically the  dysfunctional pathw ay, in  a  way w hich does not ha rm  B 
cells of other developm ental stages. In  addition, c larification of th e  
selection m echanism s preceeding en try  to the naive B cell pool m ig h t 
assist in  the  trea tm e n t of various auto im m une diseases. S uch  
inform ation can lead, for exam ple, to drugs or tre a tm e n t w h ich  
encourage reinforcem ent of the  healthy  selection processes. If  selection of 
bone m arrow  B cells proves to rely  heavily on a stochastic  m echanism , 
such trea tm e n ts  m ay prove even less difficult. Such tre a tm e n t could be, 
for instance, site-specific ad m in is tra tio n  of an ti-F as antibodies to reduce 
tran sitiona l B cell num bers.
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